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List of abbreviations  
µL microliter 
µM micromolar 
ADL arbitrary decision limit 
ASP amnesic shellfish poisoning 
CFP ciguatera shellfish poisoning 
CPDB consensus path DB 
CTX ciguatoxin 
DA domoic acid 
DMSO dimethilsulfoxide 
DSP diarrhoeic shellfish poisoning 
DTX dinophysistoxin 
EC50 effect concentration 50 
EFSA European Food Safety Authority 
ELISA enzyme-linked immunosorbent assay 
ESI electrospray ionisation 
EU European Union 
EU-RL European Union Reference Laboratory 
FAO Food and Agriculture Organization 
GC-MS gas chromatography mass spectrometry 
GSEA gene set enrichment analysis 
h hour 
hYTX 1a homoyessotoxin 
HAB harmful algal bloom 
HPLC-UV high performance liquid chromatography with ultraviolet detection 
HRMS high resolution mass spectrometry 
IC50 inhibitory concentration 50 
K+ potassium ions 
LC liquid chromatography 
LC-FLD liquid chromatography with fluorescence detection 
LC-MS liquid chromatography with mass spectrometry detection 
LDH lactate dehydrogenase 
LMB lipophilic marine biotoxin 
LOD limit of detection 
MBA mouse bioassay 
MEA multi electrode array 
MFI median fluorescence intensity 
mg milligram 
min minute 
mL millilitre 
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mM millimolar 
MPL maximum permitted limit 
MTT 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide 
MU mouse unit 
Na+ sodium ions 
nm nanometre 
nM nanomolar 
NMDA N-methyl-D-aspartate 
NSP neurologic shellfish poisoning 
O/V ouabain/veratridine 
OA okadaic acid 
PBS phosphate-buffered saline 
PbTX brevetoxin 
PlTX palytoxin 
PP1 protein phosphatase 1 
PP2A protein phosphatase 2A 
PSP paralytic shellfish poisoning 
PTX pectenotoxin 
qRT-PCR quantitative real-time polymerase chain reaction 
RBA rat bioassay 
RIA radioimmunoassay 
RL regulatory limit 
RPM revolution per minute 
SPE solid phase extraction 
SPX spirolide 
STX saxitoxin 
Tof/MS time of flight mass spectrometry 
TTX tetrodotoxin 
UPLC ultra performance liquid chromatography 
VGSC voltage-gated sodium channels 
YTX yessotoxin 
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1. Background information 
 
1.1 Harmful algal blooms and marine biotoxins 
 
Marine biotoxins are a large group of compounds produced by several organisms in the 
marine environment, e.g. algae, corals and cyanobacteria, that can accumulate in filtrating 
shellfish and finfish [1, 2]. Human consumption of marine products such as molluscs 
(clams, razor clams, mussels, oysters), crustaceans (lobsters, crabs) and fish (sardines, 
barracuda, snappers, puffer fish, among others) contaminated with these toxins can lead to 
food poisoning, of which symptoms can vary from paralysis, diarrhoea, amnesia to death, 
depending on the ingested toxin [3-5]. Worldwide, algae toxins are responsible for 
approximately 60,000 human intoxications annually [6]. Monitoring the micro-organisms 
responsible for the production of marine biotoxins is of value, but the occurrence of these 
micro-organisms does not always correlate well with the presence of toxins in seafood 
samples. For instance, saxitoxins (STXs) are toxins produced by dinoflagellates from 
Alexandrium spp. e.g. A. catenella and A. ostendelfii [7], domoic acid (DA) by species of Pseudo-
nitzschia and okadaic acid (OA) and dinophysistoxins (DTXs) are mainly produced by 
Dinophysis fortii, D. acuminata, D. acuta, D. caudata, D. sacculus and D. norvegica; while in cases 
where these algae were detected, often no toxins were detectable in shellfish [8]. The 
opposite can also occur, i.e. DA, OA and DTX were found in shellfish, while no toxin 
producing algae were detected [9-13]. The yessotoxins (YTXs) are mainly produced by 
Proceratium reticulatum, Lingulodinium polyedrum, Gonyaulax polyhedra and Gonyaulax spinifera, but 
there are examples showing that while the algae are gone, the YTX levels exceed the 
permitted levels [14, 15]. Regarding the azaspiracids (AZAs), the toxin producing Azadinium 
spinosum is only known since 2009 and till now there are no data available on the correlation 
between its occurrence and the detection of AZAs in shellfish [16]. The correlation is thus 
complex and similar is valid for other marine biotoxins. However, it should also be noticed 
that in Florida the monitoring of Karenia brevis in order to prevent intoxications by 
brevotoxins (PbTXs), seems to work adequately [17]. Since it is not possible to avoid the 
uptake of toxins from shellfish and the lack on an efficient method to remove them before 
consumption, it is necessary to regulate and monitor levels in shellfish [18]. 
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Marine biotoxins can be classified based on their chemical structure, chemical properties 
or the effects produced in humans. From an analytical point of view, marine biotoxins can 
be separated in two groups based on chemical properties, i.e. hydrophilic and lipophilic 
toxins.  
 
1.2 Hydrophilic toxins 
 
The more water soluble hydrophilic toxins have low molecular weight including domoic 
acid (DA), saxitoxin (STX) and tetrodotoxin (TTX) [19]. Table 1 summarises the 
hydrophilic toxins and some of their characteristics including their mode of action. 
 
Table 1. Hydrophilic toxins 
Toxin Chemical 
structure 
Source Syndrome Mode of action Ref. 
Saxitoxins 
(STX) 
Purine derived Alexandrium 
spp, 
Gymnodinium 
and Pyrodinium 
spp. 
Paralytic 
shellfish 
poisoning 
(PSP) 
Inhibition of the 
voltage-gated 
sodium channels 
[7] 
Tetrodo-
toxins 
(TTX) 
Heterocyclic 
Guanidine 
derived  
Vibrio spp, 
Pseudomonas 
spp, Shewanella 
spp, 
Alteromonas 
tetraodontis 
Tetrodo-
toxin 
poisoning 
Inhibition of the 
voltage-gated 
sodium channels 
[20-22] 
Domoic 
acid (DA) 
Cyclic amino 
acid  
Pseudo-nitzschia 
pungens,  
Amnesic 
shellfish 
poisoning 
(ASP) 
Activation of 
glutamate 
receptors 
[23, 24] 
Palytoxins 
(PlTX) 
Complex 
polyhydroxylated 
compounds 
Osteoptisis spp, 
Palythoa spp 
Palytoxin 
poisoning 
Modification of 
NA+/K+ ATPase 
ion pump 
[25, 26] 
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1.3 Lipophilic toxins 
 
The lipophilic toxins are high molecular weight compounds including a variety of non-
related toxins, e.g. OA, AZAs and PbTX. OA and its derivatives DTXs are known for 
causing diarrhoeic shellfish poisoning (DSP) [27]. Other toxins such as YTXs, 
pectenotoxins (PTXs) and cyclic imines (CIs) do not cause any known syndrome. In 
addition, other toxins like pinnatoxins (PnTX), gymnodimines (GYM) and pteriatoxins 
(PtTX) will be present in the lipophilic extract as well [2, 19, 28, 29]. A summary of the 
lipophilic toxins and some of their characteristic including the mode of action is shown in 
table 2.  
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Table 2. Lipophilic toxins 
 
Toxin Chemical 
structure 
Source Syndrome Mode of action Ref.  
Okadaic acid 
(OA), 
dinophysistoxins 
(DTXs), 
pectenotoxins 
(PTXs) 
Polyether Dynophisis spp, 
Prorocentrum 
spp.  
Diarrhoeic 
shellfish 
poisoning 
(DSP) 
Inhibition of 
serine/ 
threonine 
phosphatases 
(OA and DTXs) 
PTX not known 
[28, 30, 
31] 
 
Azaspiracids 
(AZAs) 
Polyether Azadinium 
spp, 
Amphidoma 
spp.  
Azaspiracid 
poisoning 
(AZP) 
Unknown, in vitro 
multiple cellular 
effects 
[32-34] 
Yessotoxins 
(YTXs) 
Polyether  Protoceratium 
reticulatum, 
Lingulodinium 
polyedrum and 
Gonyaulax 
spinifera 
No record 
of human 
intoxication 
Unknown, in vitro 
multiple cellular 
effects, 
cardiotoxic  
[35, 36] 
 
 
Brevetoxins 
(PbTXs) 
Cyclic 
polyether 
Karenia brevis Neurologic 
shellfish 
poisoning 
(NSP) 
Activation of the 
voltage-gated 
sodium channels 
[17, 37] 
 
Ciguatoxins 
(CTX) 
Cyclic 
polyether 
Gambierdiscus 
toxicus 
Ciguatera 
poisoning1 
Activation of the 
voltage-gated 
sodium channels 
[38, 39] 
 
Other toxins: 
Cyclic imines 
Spirolide (SPX), 
Pinnatoxins 
(PnTXs), 
Gymnodimines 
(GYMs), 
Pteriatoxins 
(PtTXs) 
 
Cyclic 
imines 
Various 
species, 
Alexandrium 
spp, Karenia 
sp.  
No record 
of human 
intoxication 
Still unknown, 
probably 
interaction with 
nicotinic and 
muscarinic 
acetylcholine 
receptors 
[39, 40] 
1 By consumption of contaminated fish 
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2. Types of poisoning
2.1 Paralytic shellfish poisoning (PSP) 
Saxitoxin (STXs) and several closely related analogues form the group of toxins causing 
paralytic shellfish poisoning (PSP) [2]. They are produced by marine algae from the genus 
Alexandrium spp, Gymnodinium spp. and Pyrodinium spp. In the case of fresh water, these 
toxins are produced by some types of cyanobacteria from genus Anabaena, Cylindrospermopsis, 
Aphanizomenon, Planktothrix and Lyngbya [7, 41, 42]. 
STX is a hydrophilic toxin that can easily be extracted by water [43]. A total of 57 analogues 
of STX have been reported [7, 44, 45]. STX causes inhibition of voltage-gated sodium 
channels (VGSC) [43, 46]. This channel is responsible for the initial depolarization phase 
in neurons and other electrically excitable cells, such as cardiac cells or skeletal muscle cells, 
and its inhibition leads to paralysis in humans and other animals [41]. The symptoms can 
vary from slight numbness in the lips, mouth and tongue, numbness of extremities, 
headache, dizziness, vomiting, nausea and diarrhoea, to death due to paralysis of muscles 
involved in respiratory processes and death comes by asphyxia [18, 42]. Death can occur 
within 2 to 12 hours after ingestion of contaminated shellfish. Victims that survive more 
than 12 hours might recover. There is no antidote to STX intoxication and the only 
treatment consists on giving life support to the patient [43, 46]. 
R1 R2 R3 R4 
STX H H H 
GTX-2 H H OSO3- 
GTX-3 H OSO3- H 
Neo OH H H 
GTX-1 OH OH OSO3- 
GTX-4 OH OSO3- H 
Figure 1. Structure of Saxitoxin and analogues 
Chapter 1  
 
15 
 
2.2. Tetrodotoxin poisoning 
 
Tetrodotoxin (TTXs) is one of the oldest toxins described. It is not produced by microalgae 
like STX. Most likely TTXs are produced by bacteria and it has been described that Vibrio 
spp. and Pseudomona spp. are able to produce TTX [22]. Worldwide TTX is known because 
of the intoxications produced by the consumption of “Fugu” (raw meat of puffer fish) in 
Japan [21, 47]. The accumulation of this toxin occurs in species of fish from the 
Tetraodontidae family, in which TTX is concentrated mostly in the ovary and liver, 
although other organs including skin, intestine, and muscle can also contain the toxin 
depending on the species of puffer fish [20]. Lately, TTX is of concern because it has been 
found in shellfish from European coastal areas [48, 49]. The mode of action of TTX is 
similar to that of STX, i.e. the inhibition of the VGSC in a selective manner [50]. 
  R1 R2 R3 R4 
 
TTX H OH CH2OH OH 
4-epiTTX OH H CH2OH OH 
11-norTTX-6(S)-
ol H OH H OH 
11-norTTX-6(R)-
ol H OH OH H 
11-oxoTTX H OH CH(OH)2 OH 
 
Figure 2. Structure of Tetrodotoxin and analogues 
 
2.3 Amnesic shellfish poisoning (ASP) 
 
Domoic acid (DA) is a toxin produced by algal blooms of the diatoms Pseudo-nitzschia spp. 
and is an excitatory neurotransmitter amino acid. DA is an analogue of the neurotoxin 
kainic acid and binds to the glutamate receptor, resulting in sodium channel opening and 
membrane depolarisation [23]. It causes symptoms progressing from gastrointestinal 
distress and diarrhoea to death. Individuals can experience alteration of memory function, 
hallucination, confusion and amnesia: therefore, the name amnesic shellfish poisoning 
(ASP). Since amnesia does not always occur, the poisoning is also called domoic acid 
poisoning (DAP) [39, 51, 52]. DA was first found in Canada in 1989, but nowadays it is 
found worldwide [2]. 
General introduction 
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DA 
Figure 3. Structure of Domoic Acid 
2.4 Neurologic shellfish poisoning (NSP) 
Brevetoxin (PbTX) is a toxic compound produced by algae from the genus Karenia, e.g. K. 
brevis. PbTX is a VGSC activator, causing influx of Na+ ions into the cell leading to blocking 
of nerve excitability causing neurotoxic shellfish poisoning (NSP). The symptoms can vary 
from diarrhoea, vomiting, cramps, respiratory difficulties and eventually death. Cases have 
been reported mainly in the United States and New Zealand [17], therefore there are no 
regulatory limits in Europe or South America. 
PbTX-2 PbTX-3 PbTX-9 
Figure 4. Structure of Brevetoxins 
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2.5 Ciguatera poisoning  
 
Ciguatera toxin (CTX) is produced by the dinoflagellate Gambierdiscus spp. and ciguatera 
poisoning is a syndrome caused by consumption of subtropical or tropical marine 
carnivorous fish, e.g. barracuda, snapper, moray eel among others [53]. The accumulation 
of the toxin occurs through the food chain [2]. It is the most common form of intoxication 
reported in the US by consumption of seafood, and the most common poisoning caused 
by (shell)fish worldwide. Symptoms can occur within the first 12 hours after consumption 
of contaminated fish, starting with abdominal pain, diarrhoea, nausea and vomiting. 
Neurologic and cardiac problems can also occur later on, and the toxin can even cause 
respiratory distress, coma and death. The hallmark sign of ciguatera poisoning is the so-
called paradoxical thermal sensation, i.e. cold objects feel hot and hot objects feel cold. 
These symptoms together with the history of reef fish consumption are enough to diagnose 
ciguatera poisoning [52-54]. 
  
 
P-CTX-1 (CTX1B) 
 
P-CTX-2 (52-epi-54-deoxyCTX1B) 
 
P-CTX-3 (54-deoxyCTX1B) 
 
Figure 5. Structure of Ciguatera toxins 
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2.6 Azaspiracid poisoning (AZP) 
Azaspiracid (AZA) and its analogues are polyether toxins with two spiro-ring assemblies, a 
cyclic amine and a carboxylic acid [55-57]. AZA-1 and AZA-2 are produced by the 
dinoflagellates Azadinium spinosum. AZA-3 and the other 30 analogues described are 
metabolites of AZA-1 or AZA-2 that are formed within the shellfish [58, 59]. The primary 
mode of action of AZA underlying the induction of azaspiracid poisoning (AZP) is not 
known yet. Toxic effects include cytoskeletal rearrangement [60, 61], decreased levels of F-
actin [57] and induction of apoptosis [62, 63]. AZA-1 has been reported to induce mRNA 
expression of genes involved in cholesterol and fatty acid synthesis in Jurkat cells indicating 
that AZA-1 activates these processes. [64]. 
R1 R2 R3 R4 
AZA-1 H H CH3 H 
AZA-2 H CH3 CH3 H 
AZA-3 H H H H 
AZA-4 OH H H H 
AZA-5 H H H OH 
Figure 6. Structure of Azaspiracids 
2.7 Diarrhoeic shellfish poisoning (DSP) 
Okadaic acid (OA) and dinophysistoxins (DTX) are toxins causing diarrhoeic shellfish 
poisoning (DSP). They are produced by dinoflagellates from the genders Dynophysis spp. 
and Prorocentrum spp. [65]. OA has been reported to be a tumour promoter in vivo in mouse 
skin and rat stomach [31, 66]. OA and DTX analogues inhibit protein phosphatases, 
particularly PP1 and PP2A, causing permanent phosphorylation of proteins leading to 
effects on regulation of glycogen metabolism, transcription, cell differentiation, apoptosis 
and DNA replication in several cell lines [67, 68]. Other effects described are genotoxicity 
through the formation of DNA adducts in human fibroblasts and keratinocytes [69], 
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aneugenic effect in Caco-2 and CHO-K1 cell lines [70, 71], cytotoxicity in several cell lines 
in vitro, i.e. peripheral blood leukocytes, HepG2 hepatoma cells, and SHSY5Y 
neuroblastoma cells [72]. Yessotoxins (YTXs) and pectenotoxins (PTXs) do not cause 
diarrhoea but are co-extracted with the DSP toxins in the same lipophilic extract. YTXs are 
polycyclic ether toxins and are regulated apart from DSP toxins since they do not share the 
mode of action, i.e. inhibition of phosphatases. Over 30 analogues of YTX have been 
isolated. No human toxicity has been attributed to this toxin, even with high amounts 
reported in shellfish [36]. Mice injected with YTX die, but mice fed with high oral doses 
did not show diarrhoea or any other adverse effects [73]. The mode of action of YTX is 
still unknown, but at the cellular level, damage in cardiomyocytes has been observed, e.g. 
activation of autophagy signalling, suggesting a cardiotoxic potential [74], and also genomic 
alterations in vitro [75]. Pectenotoxins are a group of polyether toxins and are regulated 
together with the DSP toxins. No correlation with human cases has been described so far, 
and no acute oral toxicity has been described in mice when administered with PTX-2 [28]. 
In vitro, pectenotoxin has shown to be hepatotoxic and induced depolymerisation of F-actin 
[39]. 
  R1 R2 R3 
 
OA CH3 OH H 
DTX-1 CH3 CH3 H 
DTX-2 H CH3 H 
DTX-3 H or CH3 H or CH3 Acyl 
    
 
Figure 7. Structure of Okadaic Acid and Dinophysis toxins 
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n R1 
YTX 1 
Homo YTX 2 
45OH YTX 1 
45OH homo YTX 2 
Figure 8. Structure of Yessotoxins 
R1 
PTX-1 CH2OH 
PTX-2 CH3 
PTX-2sa 
Figure 9. Structure of Pectenotoxins 
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3. Detection methods 
 
3.1 Mouse bioassay 
 
The oldest method for the detection of marine biotoxins is the mouse bioassay (MBA). In 
general, the method consists of injecting a sample intraperitoneal in three mice, and the 
occurrence of death in a period of 24 hours is monitored. The sample is considered positive 
if at least 2 of 3 mice die within 24 hours. There are 2 different protocols, i.e. for the 
detection of PSP toxins and for the detection of DSP toxins. 
The MBA for PSP toxins consists on the injection of three 20-gram mice with 1mL of an 
acidic extract obtained from shellfish products. The time taken for the mice to die is 
recorded, and samples should be diluted to ensure that death occurs within 5 and 15 
minutes. Then, the toxicity of the sample can be calculated referring to dose-response 
curves established using STX standards. This quantification of the toxins is established in 
mouse units (MU), being “1 MU is the amount of injected toxin which would kill a 20g 
mouse in 15 minutes, and it is equivalent to 0.18 µg of STX” [2]. This MBA has several 
drawbacks, e.g. death time is not always linear with toxin levels, the assay is labour intensive, 
and because sacrifice of large amounts of animals is needed it is considered unethical. 
However, the method has been properly validated (AOAC Official Method 959.08: 
Paralytic Shellfish Poison, biological method) and it is still in use in several countries [2].  
The MBA for DSP toxins was developed in 1978 in Japan, after several people showed 
gastrointestinal complaints such as diarrhoea, nausea and vomiting after shellfish 
consumption [76]. Since 1981 the MBA has been the official method for detection of DSP 
toxins in Japan and other countries [77]. The method for lipophilic marine biotoxins (LMB), 
i.e. DSPs, AZPs and NSPs, consists of an extraction with acetone, followed by partition 
with diethyl ether or dichloromethane and water, which is subsequently evaporated and 
suspended in tween 20. For testing, 1 mL of the suspension is injected intraperitoneally to 
three 20-gram male mice. The death of at least 2 of 3 mice in 24 hours is the indication that 
the sample is positive [77]. The protocol has had several modifications concerning solvents 
and number of animals, with the aim of improving the detection capacity and to increase 
animal welfare [78]. However, the MBA for lipophilic toxins has never been properly 
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validated and -as indicated above- the MBA does not consider humane endpoints to avoid 
animal suffering, i.e. the endpoint to declare the test as positive is death [79]. 
Although the MBA for the detection of lipophilic marine biotoxins has been replaced in 
several countries, e.g. Australia, Canada, New Zealand and in the European Union, it is still 
the reference method in some countries [80] and in Europe the use of the MBA is still 
allowed at production areas as surveillance for unknown toxins. In January 2015, the MBA 
has been banned as a reference method for testing final products, mainly because it is 
unethical, not appropriate due to a high variability in results, showing insufficient detection 
aptitude, and limited specificity [81].  
Efforts have been made in replacing the MBA. Alternatives for PSP toxins are being 
investigated extensively [45, 82-85], and although it is important to also consider the 
hydrophilic toxins in the replacement of the mouse bioassay, the work presented in this 
thesis focuses on the alternatives for the detection of LMB. 
3.2 Analytical methods 
Chemical methods focus on the detection and identification of compounds based on their 
chemical properties. The extraction method for detecting either the hydrophilic or 
lipophilic toxins is different. For the detection of PSP toxins, one chemical method has 
been validated, i.e. the AOAC method 2005.06, which is based on the fluorescence of STX 
and its analogues after oxidation and subsequent separation on a HPLC column [45]. 
Another official method is the AOAC Official Method 2011.27, a receptor binding assay 
making use of the PSP toxin receptor in a competitive binding assay with [3H] STX [86]. 
In 2011, the LC-MS/MS method of the EURL on marine biotoxins became the reference 
method for detecting lipophilic marine biotoxins in Europe [87, 88]. Other methods such 
as LC-MS and HPLC, immunoassays and functional assays (e.g. the phosphatase inhibition 
assay) are allowed as alternative or supplementary to the reference method, only if they are 
properly validated [81]. 
Absence of certified standards of each toxin and their analogues, and the incapacity to 
detect presently unknown toxins or analogues are known disadvantages of the LC-MS/MS 
method [89]. Chemical detection is thus not able to detect all toxins or the toxins that are 
presently unknown. This makes use of the LC-MS/MS method for detecting all potential 
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harmful LMB very challenging. Additionally, analytical methods are unable to predict 
toxicity of complex mixtures or detect emerging risks. As a result, many countries hesitate 
to trust solely on analytical methods. Therefore, the MBA it is still used, mainly because it 
facilitates detection of yet unknown toxins and emerging risks. 
 
3.3 Other alternative methods 
 
3.3.1 Biological methods 
 
Biological functional assays are based on the mode of action of a compound to cause 
toxicity. These assays include receptor-based binding assays, enzyme assays and cell-based 
bioassays [90]. The receptor and enzyme assays use the biological target of the toxin as the 
element for toxin detection. Enzyme inhibition assays, i.e. inhibition of phosphatases, have 
been developed for the detection of OA and DTX. These assays allow the quantification 
of a toxin present in a sample, often by colour (absorbance) or fluorescence measurements 
[91]. These methods are fast and have been proven sensitive enough to detect all analogues 
and able to determine the total potency of a sample extract without the need for certified 
standards for each analogue. The main disadvantage is that these bioassays require a second 
identification step in case a sample is suspect/positive, i.e. in order to identify the 
compound causing the effect [92]. Cell-based bioassays can measure a particular cell 
function, e.g. measurement of membrane potential and ion influx, or can be based on the 
measurement of cytotoxicity [92, 93]. The neuro-2a assay is based on mouse neuroblastoma 
cells which are exposed to shellfish extracts for a period of time, usually 24 hours, using the 
reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) as a 
readout of cell viability. This assay has been shown to be suitable for the detection of PSPs, 
NSPs and DSPs [83, 93-95]. 
The reasoning behind replacing animal tests like the MBA by cell-based bioassays, is that 
these bioassays will detect the effect of an unknown compound/analogue too, i.e. an 
analogue of the known toxin (known unknown), or in some cases, a completely new toxin 
(unknown unknown). 
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3.3.2 Immunological methods 
With immunological methods, detection is based on a specific interaction between the toxin 
and an antibody. ELISAs and lateral flow devices (LFDs) are well-known examples of 
immunoassays. The high specificity of the antigen-antibody interaction allows to detect low 
amounts of the toxin in a sample, but cross reactivity with analogues can be an issue for 
quantification. Inaccuracy may be either due to overestimation of toxicity when relatively 
inactive analogues are also strongly bound or to underestimation when active analogues are 
not bound [90]. Optical immunosensors have been developed for detection of DSP toxins, 
PSP toxins and DA as surface plasmon biosensors. Advantages are the low costs and speed. 
However, the main drawback is the lack of antibodies for all the toxins and due to cross-
reactivity, quantification is often not accurate enough [79, 92, 96]. 
Table 3. Summary of alternative methods for the MBA. Adapted from Campbell et al, 
2011 and Stewart and McLeod 2014 [79, 90]. 
Toxins Chemical method Biological method Immunological 
method 
STX s 
and 
TTXs 
− HPLC-FLD pre-
column
oxidation1
− HPLC-FLD post
column
oxidation1
− LC/MS
− Capillary
electrophoresis
− Ion exchange
chromatography
− Quantitative
NMR
spectrometry
− HPLC-MS
− HILIC-MS
− Chemosensors
− Receptor-binding
assay1
− Saxiphilin
competitive binding
assay
− Neuro-2a bioassay
− Membrane potential
in vitro assays
− Membrane
biosensor (frog
bladder membrane)
− Fluorimetric assay
− Insect bioassay
− Lateral flow
immunoassay2
− ELISA2
− Surface Plasmon
Resonance assay
(optical
biosensor)
− SPR coupled to
HILIC
− RIA (obsolete)
DA − HPLC-UVD
− HPLC-MS
− Thin layer
chromatography
− Kainic-acid
receptor-binding
assay
− ELISA
− SPR Biosensor
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OA and 
DTXs 
− LC-MS/MS1 
− HPLC-FLD 
− HPLC-MS 
− Protein phosphatase 
inhibition assay3 
− F-actin cell-based 
fluorimetric 
microplate assay 
− Cell morphology 
 
− ELISA 
− SPR biosensor 
− Quartz crystal 
microbalance 
biosensor 
− Electrochemical 
biosensor 
PTXs − LC-MS/MS1 
− HPLC-
FLD/UVD 
− HPLC-MS 
− F-actin cell-based 
fluorimetric 
microplate assay 
− Cell morphology 
 
− ELISA 
 
AZAs − LC-MS/MS1 
− HPLC-MS 
 
− Cell morphology  
YTXs − LC-MS/MS1 
− HPLC-FLD 
− HPLC-MS 
− Capillary 
electrophoresis 
− E-cadherin 
fragmentation 
− Phosphodiesterase 
enhancement, using 
SPR, resonant 
mirror biosensors 
or microplate assay 
− ELISA 
PbTXs − HPLC-MS − Sodium channel 
receptor binding 
assay 
− Neuro-2a bioassay 
− Fluorimetric assay  
 
− RIA 
− ELISA 
1 AOAC and/or EU official methods 
2 Used for screening in some monitoring programs 
3 Waiting for regulatory acceptance 
HPLC: High performance liquid chromatography, FLD: fluorescence detection, LC: Liquid 
chromatography, MS: Mass spectrometry, HILIC: hydrophilic interaction liquid chromatography, UVD: 
Ultra violet detection, RIA: Radioimmunoassay, ELISA: Enzyme linked immunosorbent assay, SPR: surface 
plasmon resonance 
 
4. Regulations 
 
Different regulations are in place in several countries based on the codex guidelines [97] 
where maximum limits for each group of toxins are established. In general, five groups of 
marine biotoxins are regulated in Europe, i.e. okadaic acid group (OA), which includes the 
dinophysistoxin analogues (DTXs), also known as diarrheic shellfish poisoning (DSPs) 
toxins; azaspiracid group (AZAs), which can also cause diarrhoea; yessotoxin group 
(YTXs); domoic acid group (DA), which causes the amnesic shellfish poisoning (ASP); and 
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saxitoxin group (STXs), also known as paralytic shellfish poisoning (PSPs) toxins (EFSA, 
2009). Current regulation in Europe established maximal levels of these toxins in seafood 
in order to protect human health. For OA and DTX-1, -2 and -3, 160 µg OA equivalents 
per kilo of shellfish meat is allowed, where equivalences are calculated based on toxic 
equivalent factors (TEF). OA and DTX-1 are considered equally toxic and have a TEF of 
1. DTX-2 is considered less potent, with a TEF of 0.6. DTX-3 are acylated derivatives of 
OA, DTX-1 and DTX-2. After hydrolysis, DTX-3 is detected by LC-MS/MS as the parent 
OA compound, DTX-1 or DTX-2, which are expressed as OA equivalents using their 
corresponding TEFs [65]. Although AZA is not included in the DSP group of toxins, it 
causes diarrhoea as well. The regulation allows for azaspiracids AZA-1, -2 and -3, 160 µg 
AZA-1 equivalents per kilo of shellfish meat. The TEFs of AZA-1, AZA-2, and AZA-3 are 
1, 1.9 and 1.4, respectively [98]. YTXs initially were classified within the DSP toxins but 
now there is a separated regulation, which allows 3.75 mg YTX equivalents/kg shellfish 
meat. More than 30 analogues have been isolated, with homo-yessotoxin (hYTX) and 45-
OH-homoYTX (45-OH-hYTX) being the most common, both with TEFs of 0.5 relative 
to YTX. 
 
Table 4. Limits for lipophilic marine biotoxins in countries with regulation in place (source 
[99]) 
Toxin Codex EU USA Australia/NZ Chile Japan 
OA, DTX, PTX (µg OA eq/kg 
shellfish) 160 160 160 200 nd 160 
AZA (µg AZA eq/kg shellfish) 160 160 160 nr nd 160 
YTX (mg YTX eq/kg shellfish) nr 3.75 nr nr nd nr 
PbTX (µg PbTX2 eq/kg 
shellfish) 800 nr 800 800 nr 800 
nr: not regulated 
nd: non-detectable by bioassay 
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5. General objective 
 
The presence of toxin producing algae or marine biotoxins in shellfish can cause closure of 
extraction areas, often needed in order to prevent human intoxications, but sometimes also 
unnecessary damaging economic activities in many countries around the world [100, 101]. 
The impact of closures of coastal areas is huge, not only in terms of global economy losses, 
but also in terms of local economies and human wellbeing, regarding the use of coastal 
areas for recreation, fishing, shellfish collection and tourism. For instance, small fishing 
communities, mainly in developing countries, often are entirely centred on the extraction 
of shellfish products. The impact of closing areas of extractions for these communities is 
dramatic, affecting their local economy, food security and wellbeing [99, 102]. Improving 
the methods for detection of shellfish toxins contributes to an efficient management of 
extraction areas, avoiding unnecessary or long and permanent closures, and could thus 
improve the economic activity of certain areas, protecting human health and considering 
animal welfare at the same time. 
Regarding the detection of marine biotoxins in shellfish, the MBA has been used for a long 
time. Alternatives have been developed, but the MBA is still used and a general switch to 
an in vitro or chemical method is needed. Replacement of an animal testing method is not 
an easy task, mainly because it is difficult to abandon a trusted method that has been in 
place for a long period. However, this trust in the MBA is not based on clear evidence. It 
has been shown that the MBA is not flawless, and it has failed to detect new toxins. For 
instance, the MBA was not able to detect DA in an incident in Ireland, which resulted in 
human illness [103]. The MBA for DSP toxins is itself a non-validated method, and 
validating new alternatives against the results of the MBA for these toxins seems thus 
inappropriate [103]. However, at least a comparison with the MBA is needed to show that 
the alternative method provided protects consumers at least equally well. 
The aim of this thesis was to develop new in vitro bioassays for the detection of marine 
biotoxins that can be used for high throughput quality control of seafood and replacement 
of the current unethical in vivo bioassays, and to evaluate use of the assay in an integrated 
testing strategy, in which bioassays and an analytical chemical method were combined, as 
an in vitro alternative for the MBA for lipophilic marine toxin testing. 
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6. Thesis outline 
 
Chapter 1 of the thesis (this chapter) presents an introduction to the field of marine 
biotoxins and the methods for their detection. It also presents the aim of the thesis. Since 
a new bioassay is needed in order to replace the MBA, it was investigated if a cell-based 
bioassay could be used for broad screening. The neuro-2a bioassay, a well-known assay for 
detection of PSP toxins, was previously assessed for the detection of lipophilic marine 
toxins by Cañete and Diogène [94]. The assay was not further investigated since a so-called 
“matrix effect” caused false positives. In Chapter 2, the neuro-2a bioassay was investigated 
in combination with improvements in the clean-up procedure for preparing extracts from 
shellfish samples in order to eliminate the false positives due to matrix effects. In chapter 
3 the effects of the lipophilic marine toxins OA, DTX-1 and AZA-1 on the whole-genome 
mRNA expression of undifferentiated intestinal Caco-2 cells was investigated. The gene 
expression data were analysed in order to reveal modes of action and obtain hints on 
potential biomarkers suitable to be used in additional bioassays to be developed. Chapter 
4 presents such newly developed methods using the selected genes for detection or 
identification of the lipophilic marine toxins, based on qRT-PCR and multiplex magnetic 
bead-based assays. The focus was on possible marker genes to detect OA/DTX, 
AZA/YTX and/or PTX. Certified standards as well as blank and contaminated shellfish 
samples were tested. In chapter 5 a selected set of samples tested in the MBA in Chile, 
where the mouse bioassay is still in use, were analysed using a strategy in which the neuro-
2a bioassay as a screening method for the detection of lipophilic toxins was combined with 
LC-MS/MS analysis for confirmation and outcomes where compared with those of the 
MBA. Finally, Chapter 6 presents an overall discussion and future perspectives. 
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Summary 
The neuro-2a bioassay was considered as one of the most promising cell-based in vitro 
bioassays for the broad screening of seafood products for the presence of marine biotoxins. 
The neuro-2a bioassay has been shown to detect a wide array of toxins like paralytic 
shellfish poisoning (PSP) toxins, ciguatoxins, and also lipophilic marine biotoxins (LMBs). 
However, the neuro-2a bioassay is hardly used for routine testing of samples due to matrix 
effects that, for example, lead to false positives when testing for LMBs. As a result, there 
are only limited data on validation and evaluation of its performance on real samples. In 
the present study, the standard extraction procedure for LMBs was adjusted by introducing 
an additional clean-up step with n-hexane. Recovery losses due to this extra step were less 
than 10%. This wash step was a crucial addition in order to eliminate false-positive 
outcomes due to matrix effects. Next, the applicability of this bioassay was assessed by 
testing a broad range of shellfish samples contaminated with various LMBs, including 
diarrhoeic shellfish poisoning (DSP) toxins. For comparison, the samples were also 
analysed by LC-MS/MS. Standards of all regulated LMBs were tested, including analogues 
of some of these toxins. The neuro-2a cells showed good sensitivity towards all compounds. 
Regarding the samples, extracts of 87 samples, both blank and contaminated with various 
toxins, were tested. The neuro-2a bioassay outcomes were in line with those of the LC-
MS/MS analysis and support the applicability of this bioassay for the screening of samples 
for LMBs. However, for use in a daily routine setting, the test might be further improved, 
and several recommendations are made before a full validation is being performed. 
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1. Introduction 
 
Marine biotoxins are naturally occurring compounds mostly produced by certain algae. 
These toxins can affect human health mainly through foodborne intoxications, i.e. 
consumption of contaminated seafood, and occasionally through direct exposure to 
seawater aerosols [1, 2]. Consumption of seafood contaminated with marine biotoxins may 
result in relatively mild symptoms, such as diarrhoea, dizziness, numbness and tingling of 
the mouth and digits, but also paralysis and in severe cases even death [3, 4]. Several major 
types of poisoning are described: amnesic shellfish poisoning (ASP), diarrhoeic shellfish 
poisoning (DSP), neurologic shellfish poisoning (NSP) and paralytic shellfish poisoning 
(PSP) [4]. A fifth syndrome, azaspiracid poisoning (AZP), has been characterised during 
the last 20 years [5]. To avoid intoxications, monitoring is obligatory in many parts of the 
world. Within the EU, limits have been set by the European Commission (Regulation No 
853/2004) for ASP toxin and PSP toxins, as well as several lipophilic marine biotoxins 
(LMBs) [6]. 
Worldwide, the main assay applied is the mouse bioassay (MBA), where mice are 
intraperitoneal (i.p.) injected with a sample extract, using lethality as the critical endpoint 
[7-9]. Besides ethical issues, the MBA gives high rates of false-positive and false-negative 
results [10, 11]. In Europe, the use of the MBA has been banned for LMBs since 2015, but 
not for PSP toxins analysis and not for the control of production areas, aiming at detection 
of possibly unknown LMBs [6]. The reference method for the detection of LMBs is now 
the LC-MS/MS method of the EURL on marine biotoxins [6, 12, 13]. LC-MS/MS based 
methods are fit for purpose, but for many toxins certified standards and reference materials 
are barely or not available. This makes their use for detecting all marine biotoxins very 
difficult, if not impossible. For example, there are at least 24 saxitoxin analogues [14], 13 
okadaic acid-ester derivatives [15], 90 yessotoxin analogues [16], 15 brevetoxin analogues 
[17] and around 30 azaspiracid analogues [18, 19] and in proximity there are only 20-30 
certified reference standards available. Furthermore, analytical methods are by definition 
unable to predict toxicity of complex mixtures or pick up new risks. As a result, many 
countries hesitate to rely solely on analytical methods and keep using the MBA. 
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Because of the drawbacks of the MBA and the analytical chemical methods, EFSA 
emphasised the need for developing animal friendly alternatives [10]. There is thus an 
urgent need for in vitro tests that allow the detection of marine biotoxins that are currently 
known and those which might emerge [20, 21]. Biochemical assays and especially cell-based 
bioassays have the potential to fulfil these requirements [22, 23]. The neuro-2a bioassay, 
using the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
or water-soluble tetrazolium salts (WST) as a viability end-point, is considered to be one of 
the most promising cell-based bioassays for the broad screening of marine neurotoxins [22, 
24]. It is already used to some extent for the detection of ciguatoxins (CTXs), tetrodotoxin 
(TTX) [25] and the lipophilic brevetoxins (PbTxs) [26, 27]. However, although the neuro-
2a bioassay has been tested intensively for PSP toxins, this is mainly with standards and 
very limited with routine samples [28-31]. Thus far, the assay seems not widely applied in 
routine for PSP toxins nor DSP toxins testing and certainly not within the EU. According 
to an extensive collaborative study that involved testing of OA, PTX-2 and AZA-1 in three 
cell lines, i.e. Caco-2, HepG2 and Neuro-2a, matrix effects seems to be an important issue 
that needs to be addressed in case these assays are applied for real samples [32]. Therefore, 
developing a suitable extraction method is critical to allow the routine use of the neuro-2a 
bioassay for shellfish samples [33]. 
The aim of the present study was therefore to evaluate and optimise the neuro-2a bioassay 
for routine testing of shellfish on the presence of LMBs. First, a comparison was made 
between the use of the murine neuroblastoma cells (Neuro-2a) and another previously 
applied cell line, murine neuroblastoma x rat glioma hybrid cells (NG108-15) in order to 
establish the sensitivity of both cell lines in our laboratory. We tested all EU regulated 
lipophilic marine biotoxins for which standards were available, i.e. okadaic acid (OA), 
dinophysistoxin-1 (DTX-1), dinophysistoxin-2 (DTX-2), pectenotoxin-2 (PTX-2), 
azaspiracid-1 (AZA-1), azaspiracid-2 (AZA-2), azaspiracid-3 (AZA-3), yessotoxin (YTX) 
and 1a-homo yessotoxin (hYTX). Subsequent testing of shellfish samples was carried out 
with the neuro-2a cells, as these turned out to be slightly more sensitive. Based on first test 
results with real samples, an improved clean-up procedure was developed by introducing 
an additional n-hexane wash step in order to reduce false positives due to matrix effects. 
Potential recovery losses due to this extra wash step were checked by LC-MS/MS analysis 
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of blank sample extracts spiked just before and after the n-hexane wash step. Next, extracts 
of both blank and contaminated shellfish were tested, and results were compared with LC-
MS/MS outcomes in order to examine whether this bioassay is applicable to real samples 
in a daily routine setting and to identify possible issues for further improvement prior to a 
full validation. This is necessary, as, besides the extensive efforts needed, such a validation 
will be very expensive due to the high costs of the required marine toxin standards. 
 
2. Materials and Methods 
 
2.1 Reagents and standards 
Certified reference materials (CRMs) of OA (13.7 ± 0.6 µg mL-1), DTX-1 (15.1 ± 1.1 µg 
mL-1), DTX-2 (7.8 ± 0.4 µg mL-1), PTX-2 (4.40 ± 0.13 µg mL-1), AZA-1 (1.24 ± 0.07 µg 
mL-1), AZA-2 (1.28 ± 0.05 µg mL-1), AZA-3 (1.04 ± 0.04 µg mL-1), YTX (5.6 ± 0.2 µg mL-
1), and hYTX (5.8 ± 0.3 µg mL-1) were purchased from the National Research Council, 
Institute for Marine Biosciences (NRC CNRC, Halifax, Canada). Stock solutions of these 
toxin standards were prepared in dimethyl sulfoxide (DMSO) after evaporation of the 
original solvent. DMSO, ammonium hydroxide (25%) and n-hexane were obtained from 
Merck (Darmstadt, Germany). Acetonitrile (Ultra LC/MS), methanol (Ultra LC/MS) and 
water (Ultra LC/MS) were purchased from Actu-All (Oss, The Netherlands). 
 
2.2 Samples 
In-house samples, both blank mussel samples from the Netherlands, and contaminated 
samples obtained from various locations and used for previous validation studies of the 
LC-MS/MS method, were tested [34]. In addition, 50 samples (crude methanol extracts) 
from various types of marine gastropods and bivalves, potentially naturally contaminated 
with LMBs, were kindly donated by Dr Carlos García from the Faculty of Medicine, 
Universidad de Chile, Santiago, Chile [35] (Table 3). 
 
2.3 Preparation of extracts 
Prior to extraction of the lipophilic marine biotoxins (i.e. DSP toxins and AZAs), shellfish 
material was homogenised with a T25 Ultra Turrax mixer at 24,000 rpm (IKA® Works 
Screening lipophilic marine biotoxins in shellfish using the neuro-2a bioassay 
40 
 
Inc., Wilmington, NC, USA). One gram of shellfish homogenate was vortex mixed with 3 
mL methanol for 1 min and centrifuged for 5 min at 2,000 × g. The supernatant was 
transferred to a volumetric flask and the residue was extracted twice more with 3 mL 
methanol. After the third extraction the volume of the collected supernatant was adjusted 
to 10 mL with methanol. For the neuro-2a bioassay additional clean-up steps using n-
hexane and solid phase extraction (SPE) were applied (see 2.4), which were not required 
for the LC-MS/MS analysis. 
2.4 Clean-up by n-hexane wash step followed by SPE 
A 4.8 mL aliquot of the crude methanol shellfish extract was diluted with 1.2 mL Milli-Q 
water and extracted twice with 6 mL n-hexane in order to remove matrix substances that 
led to false-positive test outcomes. The hexane layer was discarded and the aqueous 
methanolic extract was further diluted by adding 10 mL Milli-Q water and the total extract 
of 16 mL was transferred to an SPE StrataTM-X cartridge (200 mg/6 mL; Phenomenex, 
Utrecht, the Netherlands), previously conditioned with 4 mL methanol/water (30:70 v/v). 
Subsequently, the cartridge was washed with 8 mL methanol/water (20:80 v/v) and the 
toxins were eluted with 4.8 mL methanol. The eluate was evaporated to dryness under a 
stream of nitrogen gas and reconstituted in 20 µL DMSO. 
 
2.5 Recovery of the n-hexane wash step 
Blank mussel samples were pooled (10 g) and 1-gram portions were extracted using the 
method described above. Fortification of extracts equivalent to 3, 1 and 1/3 of the 
maximum permitted level (MPL) of OA, DTX-1 and AZA-1 (i.e. 480 µg kg-1, 160µg kg-1 
and about 53µg kg-1) and about 1/4 MPL for YTX (i.e. 1000 µg kg-1) before and after the 
n-hexane clean-up were carried out by adding a corresponding volume of a highly 
concentrated standard in methanol. The recovery was calculated by LC-MS/MS analysis of 
subsamples taken from the fortified extracts. The rest of the sample extracts fortified before 
and after the n-hexane extraction, were purified on SPE (see above) and analysed in the 
neuro-2a bioassay. The exposures were performed in three different experiments and all 
samples within an experiment were tested in triplicate. Due to the high costs and amounts 
needed, YTX experiments were performed twice and samples were tested in triplicate. 
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2.6 Cell culture and exposure 
Murine neuroblastoma neuro-2a cells were purchased from the American Type Culture 
Collection (ATCC; CCL-131) and cultured in 75 cm2 culture flasks containing 15 mL 
RPMI-1640 medium (R0883, Sigma-Aldrich, Zwijndrecht, the Netherlands) supplemented 
with 10% (v/v) Fetal Bovine Serum (FBS, Fisher Emergo, Landsmeer, the Netherlands), 
1% (v/v) of a 100 mM sodium pyruvate solution (Sigma-Aldrich, Zwijndrecht, the 
Netherlands) and 1% (v/v) of a 200 mM L-glutamine solution (Sigma-Aldrich). NG108-15 
cells were also obtained from ATCC (HB-12317) and cultured in 75 cm2 culture flasks 
containing 30 mL Dulbecco’s Modified Eagle’s Medium (DMEM) obtained from Lonza 
(Verviers, Belgium) supplemented with 10% (v/v) FBS and 2% (v/v) of 50× HAT 
supplement (5 mM hypoxanthine, 20 µM aminopterin and 0.8 mM thymidine, Sigma-
Aldrich). Both cell lines were routinely maintained in a humidified incubator at 37 °C under 
5% CO2 and sub-cultured three times per week (dilution 1/5) up to approximately 90% 
confluence. 
The experimental conditions for the assay were adapted from Cañete and Diogène 2008. 
Neuro-2a and NG108-15 cells were seeded separately into 96-well plates with an initial 
density of 25,000 and 14,000 cells/well, respectively. After growing the cells for 24 h, 
exposure to increasing concentrations of pure marine biotoxins or sample extracts was 
performed in quadruplicate in 200 µL medium for 24 h. The method of exposing the cells 
was changed in order to adjust it to our sample extracts and standards that were dissolved 
in DMSO, i.e. exposure media were prepared by using e.g. 3 µL standard or sample extract 
in DMSO (see 2.3 and 2.4) and 1200 µL of culture medium. Dilutions, 5 or 10 times, were 
made in culture medium with 0.25% DMSO to keep the solvent concentration at 0.25%. 
At the end of the exposure time, cell viability was measured using the MTT assay. 
 
2.7 Cell viability assay (MTT) 
Briefly, MTT (Sigma-Aldrich) was prepared in PBS at 5 mg mL-1, and mixed with serum-
free medium. Then, the media from the cells was removed and 60 µL of MTT mixed with 
serum-free medium was added to each well (final concentration of MTT in the well is 0.8 
mg mL-1). After 30 min incubation at 37 °C, the medium was removed, and the formed 
formazan crystals were dissolved in 100 µL DMSO. Plates were placed in a plate shaker for 
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10 min at 600 rpm after which the absorbance was measured at 540 nm and corrected for 
background absorption at 650 nm. EC50 values were determined using a nonlinear 
regression model (GraphPad Prism software version 5.04, San Diego, CA, USA). 
 
2.8 Chemical analysis 
Chemical analysis was directly performed on crude methanol extracts. The method applied 
for the determination of lipophilic marine biotoxins (i.e. DSP toxins and AZAs) was 
previously described by Gerssen et al. (2009, 2010). Chromatographic separation was 
achieved using a Waters Acquity I-Class UPLC system (Waters, Milford, MA, USA). The 
system consisted of a binary solvent manager, sample manager and a column manager. The 
column temperature was kept at 60 °C and the temperature of the sample manager was 
kept at 10 °C. A 5 µL injection volume was used. Mobile phase A was water and mobile 
phase B was acetonitrile/water (9:1 v/v), both containing 6.7 mM ammonium hydroxide. 
A flow rate of 0.6 mL min-1 was used. A gradient started at 30% B and after 0.5 min was 
linearly increased to 90% B in 3 min. This composition was kept for 0.5 min and returned 
to 30% B in 0.1 min. An equilibration time of 0.9 min was allowed prior to the next 
injection. The effluent was directly interfaced in the electrospray ionisation (ESI) source of 
the AB Sciex QTrap 6500 mass spectrometer (Ontario, Canada). The mass spectrometer 
was operated in both negative and positive electrospray ionisation by rapid polarity 
switching. For each toxin two transitions were measured. For quantification of the toxins, 
so-called ‘matrix matched’ calibration curves were constructed. These calibration curves 
were constructed by fortifying blank shellfish extracts with different concentrations of 
toxin. The area of the toxin in the unknown sample is then calculated using the linear 
equation of the calibration curve. The concentration is expressed in µg kg-1 shellfish meat. 
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3. Results and Discussion 
 
3.1 Effects of individual lipophilic marine biotoxins 
 
A number of different toxins were tested on both neuro-2a and NG108-15 cells using MTT 
reduction as measure for cell viability. Overall, all lipophilic marine biotoxins and their 
analogues induced a concentration dependent decrease in viability of both neuro-2a and 
NG108-15 cells. Figure 1 shows the effect of the lipophilic marine biotoxins OA, DTX-1, 
DTX-2, AZA-1, AZA-2, AZA3, PTX-2, YTX and hYTX on the cell viability of neuro-2a 
cells. Table 1 shows the calculated EC50 values for both cell lines, being the concentration 
reducing the MTT response by 50% of the maximal observed difference. Although AZAs 
and YTXs caused a decrease in cell viability at relatively low concentrations, MTT response 
was only reduced to about 50% of the initial response, while OA, DTXs, and PTX-2 were 
able to further reduce the MTT activity. Using NG108-15 cells and a similar MTT protocol, 
Cañete and Diogène also observed that AZA-1 induced a maximum reduction to about 
40%. The EC50 values determined for OA, DTX-1, AZA-1 and YTX-1 in the NG108-15 
assay are also in line with those published by Cañete and Diogène [36]. Serandour et al.[37] 
also observed a levelling off for AZA-1, but around 10% and they also observed that AZA-
1 is more potent than OA and PTX-2, but the EC50 value of 6.8 nM was sevenfold higher 
than the one we and Cañete and Diogène obtained. The EC50 values determined for OA, 
DTX-1 and PTX-2 in the neuro-2a bioassay, being respectively 23.4, 5.5 and 76.4 nM, differ 
from those published by Cañete and Diogène [24], being respectively 21.9, 20.6 and 28.3 
nM. Thus, similar EC50 values were obtained for OA, but lower and higher values for DTX-
1 and PTX-2 respectively. Serandour et al. [37] reported values of 41.2 and 35.5 nM for OA 
and PTX-2, respectively, being twofold higher for OA than obtained by us and Cañete and 
Diogène and twofold lower for PTX-2 than observed in the present study. These 
differences are possibly caused by differences in quality of the standards, the applied 
solvents and solvent concentration, or the culturing and exposure conditions of the cells, 
e.g. 48 h compared to 24 h in our study.  
Table 1 also shows the Toxicity Equivalency Factors (TEFs) as derived from the EC50 
values in the neuro-2a bioassay and the TEFs for the OA/DTX and the AZA class of 
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toxins, as published in a joint FAO/WHO technical paper [38], both the ones based on 
experimental data, as well as recommended TEFs. The latter are quite similar to those 
proposed by EFSA, which should be used in routine testing. No full dose-response curves 
were obtained for DTX-2 within the concentration range tested and the EC50 values 
determined for DTX-2 should therefore be considered as less accurate. However, figure 1 
demonstrates that DTX-2 is less toxic than DTX-1 (similar in NG108-15 cells, but curves 
not shown) and these observations are in line with those of the FAO/WHO and EFSA, 
and also with results obtained by Aune et al. (2007) with i.p. treated mice, showing a TEF 
of 0.6 for DTX-2 compared to OA. Still, the toxic potency of OA resembled more that of 
DTX-2 than that of DTX-1, which is in agreement with other in vitro data suggesting that 
DTX-1 is more potent than OA [39-41]. However, eventually both EFSA and FAO/WHO 
assigned a similar TEF to OA as DTX-1 (EFSA 2008, FAO/WHO 2016). 
In the case of AZA-1, AZA-2 and AZA-3 relative potencies of 1, 0.53 and 0.67 were 
observed, which seems to disagree with the TEFs assigned by EFSA (2008) of 1, 1.8 and 
1.4. However, based on more recent data from i.p. treated mice, FAO/WHO assigned 
TEFs of 1.0, 0.7 and 0.5, which are much more in line with our data. Overall, it is clear that 
there is still some uncertainty attached to the currently established and applied TEF values. 
Overall, the present study shows that neuro-2a cells are slightly more sensitive than NG108-
15 cells, respond to all tested LMBs and their analogues, and display toxic potencies which 
are reasonably in line with the TEFs for these marine biotoxins as established by EFSA and 
the FAO/WHO. The assay based on neuro-2a cells was therefore used for testing shellfish 
samples. 
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Figure 1. Effect of several lipophilic marine biotoxins on the viability of neuro-2a cells as 
measured with the MTT assay compared to the average of the solvent control (0.25% 
DMSO): (a) OA: okadaic acid; DTX-1, DTX-2: dinophysistoxin-1,-2; PTX-2: 
pectenotoxin-2; (b) AZA-1, AZA-2, AZA-3: azaspiracid-1,-2,-3; YTX: yessotoxin; hYTX: 
1a homo yessotoxin. Data are expressed as mean ± SD (n = 3). 
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Table 1. Calculated EC50 values for the effect of lipophilic marine biotoxins on the viability 
of murine neuroblastoma neuro-2a cells, and murine neuroblastoma rat glioma hybrid 
NG108-15 cells, the resulting TEF values in the neuro-2a bioassay, and recommended 
TEFs by FAO/WHO and EFSA. 
 
 This study FAO/WHO EFSA 
Toxin Neuro-2a 
EC50 (nM) 
NG105-15 
EC50 (nM) 
Neuro-2a 
TEFd 
Observed 
 
Recommended TEFc 
OA 23.0 22.9 1.0 1.0b 1.0 1.0 
DTX-1 5.5 8.4 4.15 3.1b 1.0 1.0 
DTX-2 34.4 28.9 0.67 0.52b 0.5 0.6 
PTX-2 76.4 nd 0.30 nd nd 1 
AZA-1 1.0 2.6 1.0 1.0a 1.0 1.0 
AZA-2 1.9 4.5 0.53 0.6a 0.7 1.8 
AZA-3 1.6 4.3 0.66 0.45a 0.5 1.4 
YTX 1.6 3.4 1.0 nd nd 1 
hYTX 1.1 2.7 1.56 nd nd 1 
a  TEF based on mice i.p. injected [38] 
b  TEF based on in vitro assays, using mammalian cell lines and measuring cytotoxicity [38] 
c  TEFs recommended by EFSA [42] 
d  Derived by dividing the EC50 of the reference compound (OA, AZA-1 or YTX) by that of the analogue. 
A higher TEF means a higher potency. 
nd     not determined  
 
3.2 Sensitivity of the assay in relation to the maximal allowed levels 
 
The current EU limits for the regulated LMBs and the above determined sensitivities of 
the neuro-2a cells for these toxins were used to calculate the required sample amount and 
the dilution of the prepared sample extract in the cell culture medium. All regulated LMBs 
should be detected at levels below their established limits. As such, the worst-case scenario 
is the limit for the sum of OA, DTXs and PTXs, being 160 µg OA-eq kg-1, as this is the 
lowest maximum permitted level (MPL), whereas these toxins display the highest EC50 
values. Following our extraction protocol (i.e. 0.48 grams shellfish diluted in an equivalent 
of 8 ml medium), and assuming 100% recovery, a sample contaminated with 160 µg OA 
per kg would theoretically result in a medium concentration of 11.9 nM OA (Mw 805). This 
is just high enough to cause an effect in the neuro-2a cells (figure 1; table 1). This also 
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applies for DTX-2 (11.9 nM, Mw 805), whereas a similar level of DTX-1 (11.7 nM, Mw 
819) would cause an almost complete inhibition of the MTT-activity. On the other hand, 
PTX-2 (11.2 nM, Mw 859) would not be detected at this level. Whether the test would work 
in practice for pectenotoxins would depend on the actual combinations of toxins occurring 
in shellfish samples. As PTX-2 is produced by the same algae as DTX and OA, and any 
sample containing PTX-2 above the limit would contain even higher levels of DTX and 
OA [43-46], the relatively high EC50 value for PTX-2 is probably not limiting the suitability 
of the neuro-2a bioassay for selecting contaminated samples. Moreover, in shellfish PTX-
2 is known to be converted into the non-toxic PTX-2 seco acid metabolite [47]. 
It is important to realise that as a consequence of the used sample amount and dilution 
factor required to detect OA, the test will be relatively sensitive for samples contaminated 
with yessotoxins. Since YTXs have a high EU limit of 3750 µg YTX-eq kg-1, this amount 
would theoretically correspond to a well concentration of 196.9nM YTX (Mw 1143) with 
the applied protocol, and thus display clearly reduced MTT-activity in the neuro-2a bioassay 
(table 1: EC50 1.6 nM). Therefore, samples containing YTX-eq levels well below 3750 µg 
kg-1, will also be screened as suspect. For azaspiracids, the limit is 160 µg per kg and this 
level would result in a medium concentration of 11.4 nM AZA-1 (Mw 842), 11.2 nM AZA-
2 (Mw 856) and 11.6 nM AZA-3 (Mw 828). Given the low EC50 values, these toxins should 
easily be detected with the current test protocol. 
 
3.3 Blank samples and the effect of the improved clean-up with n-hexane 
 
An additional clean-up step using n-hexane (see experimental section) was introduced to 
eliminate matrix effects that would otherwise result in a high percentage of false-positive 
outcomes in the neuro-2a bioassay, as was observed before by Ledreux et al. (2012). This 
additional cleaning step was introduced before the SPE clean-up was performed. The 
matrix effect is demonstrated in Figure 2a, showing the results of 10 blank mussel samples 
without the additional n-hexane wash step, both without and with an additional 10-fold 
dilution. All undiluted blank sample extracts caused a marked reduction in the MTT activity 
and were thus falsely screened as suspect. A blank chemical control was included, and this 
extract caused no cytotoxicity. Tenfold diluted sample extracts were not toxic anymore, but 
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as explained above, this results in too low sensitivity of the assay for most toxins. Figure 2b 
shows the results of 20 blank mussel samples when the n-hexane wash step was included. 
Undiluted blank sample extracts did no longer show a strong decrease in MTT activity, 
implying that the n-hexane wash step worked very well in order to remove false positives 
due to matrix effects. The observed cytotoxic effects without the extra n-hexane wash step, 
i.e. matrix effects, are most probably caused by free fatty acids, also known to interfere with 
the outcome of the MBA [48]. 
Based on the data obtained with the new procedure including the n-hexane step and blank 
mussel samples (figures 2b), an ‘arbitrary’ decision limit (ADL) was set at a reduction of the 
MTT activity of 25% or more. Samples with an MTT value above this decision limit are 
classified as negative (safe) and samples resulting in MTT values below this decision limit 
are classified as suspect (potentially unsafe). 
Figure 3 shows the results of blank mussel samples spiked at 1/3, 1 and 3 times the MPLs 
for OA, DTX-1 and AZA-1, i.e. 53, 160 and 480 µg kg-1, and at about 1/4 MPL for YTX, 
i.e. 1000 µg kg-1, using the n-hexane wash and the subsequent SPE clean-up. The spiking 
was performed to an aliquot of the methanol extract, i.e. in order to reduce the required 
amount of the expensive standards. Moreover, the methanol extraction is already known to 
result in high extraction efficiencies for the different LMBs [49]. The results show that all 
spiked samples reduced the MTT-activity to 75% or lower when spiked at or above their 
MPL in case of OA, DTX-1 and AZA-1 and in case of YTX even at 1/4 MPL, implying 
that all toxins could be detected at levels above their MPLs. This includes the above 
described worst case of OA, the toxin with the lowest MPL (160 µg OA-eq kg-1) and 
relatively high EC50 value (23.4 nM, table 1). In addition, LC-MS/MS analyses of samples 
spiked at their MPL for OA, DTX-1, AZA-1 and at 1/4 MPL for YTX just before and 
after the n-hexane clean-up elicited recoveries of 90, 123, 96 and 104%, respectively. This 
shows that no toxins were lost in the n-hexane. Since the comparison is based on extracts 
spiked just before and after hexane extraction, recoveries above 100% point to the 
effectiveness of the n-hexane wash step for removing small matrix effects for LC-MS/MS 
analysis too, i.e. probably removing compounds that otherwise would cause a little bit of 
ion suppression. Although the recovery losses from the use of SPE were not determined 
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in the present study, previous studies demonstrated that losses due to the SPE were lower 
than 15% [50]. 
 
 
Figure 2. Effect of the introduction of an additional n-hexane wash step in the sample 
extraction procedure: (a) undiluted and 10fold diluted sample extracts of blank mussel 
samples prepared without the n-hexane wash step (b) undiluted and fivefold diluted sample 
extracts of blank mussel samples prepared by introducing the n-hexane wash step. ADL is 
the “arbitrary” decision limit, set at 75% cell viability. Data are expressed as mean ± SD (n 
= 3). 
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Figure 3. Mussel samples spiked at 3, 1 and 1/3 times the maximal permitted levels (MPLs) 
of 160 µg kg-1 for OA, DTX-1 and AZA-1, and at about 1/4 MPL for YTX, i.e. 1000 µg 
kg-1, extracted with the procedure including the extra n-hexane wash step and analysed in 
the neuro-2a bioassay. An ‘arbitrary’ decision limit (ADL) of 75% was used. Positive 
control: DTX-1 12nM. Data are expressed as mean ± SD (n = 3). 
 
3.3 Shellfish samples contaminated with lipophilic marine biotoxins 
 
To allow a first evaluation of the performance of the newly developed clean-up method, 
extracts were prepared from eight samples (S1-S8) naturally contaminated with various 
LMBs that were previously used in an inter-laboratory validation study of the LC-MS/MS 
method [34]. These contaminated samples were prepared by blending naturally 
contaminated samples with various toxin profiles with blank samples in order to get a 
variety of materials with different profiles and levels. Figure 4a shows the results as obtained 
in the neuro-2a bioassay. A summary of the bioassay and LC-MS/MS results is given in 
table 2, showing that these validation samples were contaminated with levels of OA/DTXs 
or AZAs above regulatory limits. As all samples elicited a decrease in cell viability below 
that of the ‘arbitrarily’ set decision limit, they were all correctly classified as suspect. Three 
additional blank control samples caused no decreased response. It should be pointed out 
that six of the eight samples contained YTXs, and S2 and S3 at relative high amounts of 
1702 and 1110 µg kg-1 respectively. This would most likely result in a suspected response 
also when present alone. However, samples S4 and S8 do not contain YTXs and were also 
classified correctly as being suspect, due to the presence of OA/DTX alone (S8) or in the 
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presence of AZAs (S4). Based on this, it seems possible that also the response obtained 
with samples S1, S5, S6 and S7 are to a large extent caused by toxins other than YTXs. 
Figure 4b shows the results of eight unblended samples naturally contaminated with LMBs 
that were previously analysed by LC-MS/MS (table 2, lower part). All samples resulted in 
MTT values below the decision limit and were classified as suspect. As shown in table 2, all 
samples contained detectable toxin levels, some well above (samples 3 and 4), or just below 
(samples 1 and 2) the EU-limits (160 µg OA-eq kg-1, 160 µg AZA-eq kg-1 and 3750 µg YTX-
eq kg-1). Samples 6, 7 and 8 contained elevated levels of YTXs, but far below the limit, 
confirming the sensitivity of the assay for this class of toxins. Sample 5, which showed a 
response just below the ADL, only contained low amounts of AZAs, less than 1/5 of the 
regulatory limit. The bioassay classification of these samples was thus in line with the toxin 
levels measured by LC-MS/MS, taking into consideration the sensitivity of the assay for 
YTXs. 
 
   
Figure 4a. Effect on the viability of neuro-2a cells (as measured with the MTT assay) of 
shellfish products (validation samples S1-S8) contaminated with okadaic 
acid/dinophysistoxins, yessotoxins and/or azaspiracids (table 2) and three blank shellfish 
samples (samples 9-11) 
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Figure 4b. Effect on the viability of neuro-2a cells (as measured with the MTT assay) of 
eight mussel samples (1-8) naturally contaminated with detectable levels of one or more 
LMBs (table 2). An ‘arbitrary’ decision limit (ADL) of 75% was used and 0.25% DMSO 
was included as a control in each experiment. Data are expressed as mean ± SD (n = 3). 
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Table 2. LC-MS/MS determined levels of lipophilic marine biotoxins in 16 naturally 
contaminated shellfish samples compared to the outcome of the neuro-2a bioassay. 
Samples (S1-S8) were mixed samples used for validation of LC/MS. 
 
 
Sample 
 
OA, DTXs, PTX-
2 (1) 
 
AZAs (2) 
 
 
YTXs (3) 
 
 
Outcome 
neuro-2a 
bioassay 
 
S1 299 175 255 Suspect 
S2 168  1702 Suspect 
S3 243 280 1110 Suspect 
S4 401 386  Suspect 
S5 757  462 Suspect 
S6 85 310 615 Suspect 
S7 1293 381 351 Suspect 
S8 371   Suspect 
1 151   Suspect 
2 123  481 Suspect 
3 275 2422  Suspect 
4 68 1528  Suspect 
5  32.4  Suspect 
6   770 Suspect 
7   330 Suspect 
8   620 Suspect 
(1) (µg OA-eq kg-1), (2) (µg AZA-1-eq kg-1), (3) (µg YTX-eq kg-1) 
OA: okadaic acid, DTX: dinophysistoxin, AZA: azaspiracid, YTX: yessotoxin, n: negative 
missing values means below limit of detection (<LOD) 
 
Next, 48 sample extracts obtained from Chile, derived from different species of bivalves 
and gastropods, were tested in the neuro-2a bioassay and also analysed by LC-MS/MS for 
lipophilic marine biotoxins (OA, DTXs, PTX-2, AZAs and YTXs). Although many 
samples concerned the hepatopancreas or viscera and as such levels should be divided by 
at least a factor of 3 [51], this was not considered for the evaluation of the assay 
performance. Figure 5 shows the results of these Chilean samples as tested in the neuro-2a 
bioassay. Samples 4, 6, 17, 25, 28, 30, 34 and 45 decreased the cell viability as determined 
with the MTT assay and were screened as suspect in the neuro-2a bioassay. Table 3 shows 
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the LC-MS/MS results, revealing that all suspected samples, except sample 30, presented 
relatively high amounts of YTX-eq. The highest levels were observed in the viscera of a sea 
snail (17, 28, 45), followed by the hepatopancreas of two types of mussels (34, 38). Four of 
these samples (17, 28, 34 and 45) also contained low levels of OA-eq, unlikely to have 
contributed much to the response. None of the 48 samples contained PTXs or AZAs. 
From a qualitative point of view, there is a good correlation between the neuro-2a bioassay 
outcomes and the LC-MS/MS analysis. All 40 samples with no detectable toxins or only 
trace amounts (<10% of the limit) showed a negative result. Of the eight samples that tested 
suspected, seven contained relatively high levels of YTX (477-3472 µg YTX-eq kg-1). 
 
Figure 5. Effect of extracts of 48 seafood products obtained from Chile and both positive 
and blank mussel sample controls, on the viability of neuro-2a cells as measured with the 
MTT assay. Positive sample control: mussels naturally contaminated with YTX. The 
decision limit was ‘arbitrarily’ set at 75% viability (ADL) and 0.25% DMSO was included 
as a control. Data are expressed as mean ± SD (n = 3). 
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Table 3. Effect of Chilean seafood extracts on the viability of neuro-2a cells and levels of 
lipophilic marine neurotoxins measured by LC-MS/MS. 
 
Number Scientific name Tissue 
OA, 
DTXs, 
PTX-2(1) 
YTXs(2) 
Outcome 
neuro-2a 
bioassay 
1 Argobuccinum ranelliforme  foot     n 
2 Chorumytilus chorus mantle     n 
3 Mytilus chilensis adductor muscle   9.9 n 
4 Aulacomya atra hepatopancreas   477.4 suspect 
5 Venus antiqua mantle     n 
6 Aulacomya atra hepatopancreas   660.2 suspect 
7 Venus antiqua hepatopancreas     n 
8 Fissurella sp. foot     n 
9 Venus antiqua hepatopancreas     n 
10 Aulacomya atra hepatopancreas   47 suspect 
11 Concholepas concholepas viscera   191.7 n 
12 Gari solida hepatopancreas     n 
13 Mytilus chilensis hepatopancreas     n 
14 Chorumytilus chorus hepatopancreas   49.9 n 
15 Chorumytilus chorus hepatopancreas     n 
16 Venus antiqua hepatopancreas     n 
17 Argobuccinum ranelliforme  viscera 27.5 4026.9 suspect 
18 Pleuroncodes monodon  whole body   27.4 n 
19 Aulacomya atra hepatopancreas   117.3 n 
20 Concholepas concholepas foot     n 
21 Argobuccinum ranelliforme  foot   5.4 n 
22 Venus antiqua hepatopancreas     n 
23 Concholepas concholepas viscera   701.4 n 
24 Chorumytilus chorus mantle   34.5 n 
25 Chorumytilus chorus hepatopancreas   654.7 suspect 
26 Aulacomya atra mantle   2.1 n 
27 Aulacomya atra gill   3.8 n 
28 Argobuccinum ranelliforme  viscera 5.7 3471.8 suspect 
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29 Argobuccinum ranelliforme  foot   2.7 n 
30 Chorumytilus chorus adductor muscle   185.4 suspect 
31 Venus antiqua hepatopancreas     n 
32 Gari solida hepatopancreas     n 
33 Cancer spp. cheliped     n 
34 Chorumytilus chorus hepatopancreas 5.7 2098.1 suspect 
35 Concholepas concholepas foot     n 
36 Gari solida hepatopancreas     n 
37 Gari solida foot     n 
38 Aulacomya atra hepatopancreas   1787.3 n 
39 Venus antiqua hepatopancreas     n 
40 Chorumytilus chorus foot   35.2 n 
41 Aulacomya atra adductor muscle     n 
42 Venus antiqua hepatopancreas     n 
43 Venus antiqua adductor muscle     n 
44 Venus antiqua foot     n 
45 Argobuccinum ranelliforme  viscera 2 4682.6 suspect 
46 Argobuccinum ranelliforme  foot   23.4 n 
47 Fissurella sp. foot     n 
48 Fissurella sp. hepatopancreas   121.7 n 
(1): µg OA-eq kg-1, (2): µg YTX-eq kg-1 *missing samples are negative in the neuro-2a bioassay and LC-
MS/MS, e.g. just as sample# 1*; n: negative; missing values means below limit of detection (<LOD) 
 
Nevertheless, there are some discrepancies when analysing the data on a semi-quantitative 
level, in particular when focussing on samples 23, 30, 38, and 45. Sample 45 was screened 
suspect based on testing the diluted extract. A similar decrease in activity upon dilution was 
observed for sample 34 and this requires further investigation. Samples 23 and 38 were 
screened as negative, but contained relatively high amounts of YTX-eq, 701 and 1787 µg 
YTX-eq kg-1 respectively. Sample 30 was suspect in the bioassay, but according to the LC-
MS/MS contained YTX only and at a low level (185 µg YTX-eq kg-1). This level would 
result in a medium concentration of 3 nM and thus could be enough to cause an effect in 
the neuro-2a bioassay (Figure 1), but it cannot fully be ruled out that this sample may 
contain yet unknown lipophilic toxins, missed by LC-MS/MS. This might be unknown 
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YTX analogues, but also another type of lipophilic toxin. Brevetoxins (PbTXs) and 
palytoxins (PlTxs) are known to be extracted with methanol as well [25, 52]. However, to 
detect PbTXs, the addition of ouabain and veratridine (o/v) during exposure of the cells is 
needed. These compounds interact with the sodium voltage-gated channels in the cells, 
causing cell death [3, 53]. The addition of o/v in a concentration causing a 20% reduction 
of cell viability is needed to detect PbTXs, which then cause a further decrease of the cell 
viability [54]. PlTx is also able to decrease the MTT activity without the addition of o/v 
(EC50 for PbTX-3, PbTX-9 and PlTx in the neuro-2a bioassay of 8, 8.4 and 0.04 nM 
respectively, data not shown). Although dedicated LC-MS/MS methods for PbTXs and 
PlTx are available, these methods are not routinely applied as there are no certified 
standards and legislation is lacking for these toxins. Overall the bioassay classification of 
these Chilean samples was in line with the lipophilic toxin levels measured by LC-MS/MS. 
However, it should be pointed out that samples contained primarily yessotoxins.  
 
4. Conclusions and Recommendations 
 
Although the neuro-2a bioassay is regarded as suitable for PSP toxins and has occasionally 
been used to analyse samples for the presence of PSP toxins [28-30], its routine application 
for these toxins is still rather limited. And although the test has also been shown to detect 
various classes of LMBs, up till now it is not considered for routine testing of shellfish for 
LMBs. Lack of routine use is due to observed matrix effects, and as a result a lack of studies 
on performance with routine samples and (international) validation studies. The present 
paper is the first describing the performance of the neuro-2a bioassay for routine testing of 
seafood samples on the presence of LMBs using a newly developed clean-up procedure 
including an n-hexane wash step, thereby allowing identification of potential issues to be 
improved and whether the assay is worth the further intensive and expensive efforts needed 
for a full validation. Although the rationale between the toxic effects of LMBs as observed 
in mouse and humans and the cell viability of neuro cells is missing, the study confirms 
previous reports showing that the neuro-2a bioassay allows the detection of the regulated 
LMBs at the required levels. Also, the few commercially available analogues of these LMBs 
could be detected and there is a reasonable correlation between toxic potencies and TEFs 
Screening lipophilic marine biotoxins in shellfish using the neuro-2a bioassay 
58 
 
established by EFSA and WHO/FAO. Compared to the current analytical and immuno-
based alternatives, the neuro-2a bioassay will most likely be able to detect unknown 
analogues and yet unknown marine biotoxins too. 
 
The newly introduced n-hexane wash step is an important improvement in order to 
eliminate matrix effects causing too many false-positive screening outcomes, which would 
preclude its routine application. These effects were most probably caused by free fatty acids 
known to interfere also with the outcome of the MBA. The new clean-up procedure worked 
well for mussels but was also successful with some cockles and oysters that we tested (latter 
data not shown) and the Chilean samples that included several species (this study). 
An ‘arbitrary’ decision limit was set for the routine screening of real samples, which might 
be refined based on further experience and validation studies. In a qualitative way, the 
neuro-2a bioassay outcomes correlated well with the LC-MS/MS analysis. Among the 87 
samples screened for the presence of lipophilic marine biotoxins by the neuro-2a bioassay, 
25 were screened as suspect and 62 as negative, while LC-MS/MS identified 12 positives 
out of the 25 suspected samples (ignoring that some samples were viscera and not whole 
flesh). No false-negative screening results were obtained. Many of the 13 false-positive 
samples turned out to contain elevated levels of toxins, some just below the regulatory 
limits.  
 
However, in particular the relatively high sensitivity of the assay for yessotoxins resulted in 
a number of clearly false-positive results. Whether this is a problem in routine screening 
depends on the actual occurrence of these toxins in a certain production area. In the 
Netherlands for example, samples rarely contain any of the LMBs, and detection of samples 
with even low levels of marine biotoxins would probably be welcomed as an early warning. 
However, this may be different in areas where yessotoxins occur regularly. For such cases, 
a different clean-up procedure could be developed in order to separate the YTXs from the 
other marine toxin classes. Moreover, it should be noticed that the n-hexane step will 
remove esterified forms of okadaic acid and the dinophysis toxins, which are mentioned in 
the legislation under the generic term DTX-3. Thus, for application to real samples in the 
future, a hydrolysis step prior to the n-hexane wash step and SPE clean-up should be 
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incorporated as well (which is already performed prior to LC-MS/MS analysis for the 
determination of DTX-3). Finally, the suitability of the neuro-2a bioassay should be further 
assessed by testing samples that have been tested negative and positive for LMBs in the 
MBA. 
 
In summary, the present data show that the neuro-2a bioassay is worth the intensive and 
expensive efforts needed for a full validation which could result in a cheap and fast 
screening method for testing shellfish for the presence of DSP toxins and AZAs, i.e. 
separating negative samples from those potentially contaminated above MPLs, which are 
then further analysed by LC-MS/MS. Since it can detect unknown analogues, it is the best 
alternative to the MBA, both for LMBs and other marine biotoxins. 
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Summary 
 
 A study with DNA microarrays was performed to investigate the effects of two diarrhoeic 
and one azaspiracid shellfish toxins, okadaic acid (OA), dinophysistoxin-1 (DTX-1) and 
azaspiracid-1 (AZA-1) respectively, on the whole-genome mRNA expression of 
undifferentiated intestinal Caco-2 cells. Previously, the most responding genes were used 
to develop a dedicated array tube test to screen shellfish samples on the presence of these 
toxins. In the present study the whole genome mRNA expression was analysed in order to 
reveal modes of action and obtain hints on potential biomarkers suitable to be used in 
alternative bioassays. Effects on key genes in the most affected pathways and processes 
were confirmed by qRT-PCR. OA and DTX-1 induced almost identical effects on mRNA 
expression, which strongly indicates that OA and DTX-1induce similar toxic effects. 
Biological interpretation of the microarray data indicates that both compounds induce 
hypoxia related pathways/processes, the unfolded protein response (UPR) and 
endoplasmic reticulum (ER) stress. The gene expression profile of AZA-1 is different and 
shows increased mRNA expression of genes involved in cholesterol synthesis and 
glycolysis, suggesting a different mode of action for this toxin. Future studies should reveal 
whether identified pathways provide suitable biomarkers for rapid detection of DSP toxins 
in shellfish. 
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1. Introduction 
 
Marine biotoxins are a large group of compounds produced by various types of organisms 
in the marine environment, i.e. algae, bacteria and coral. These toxins can accumulate in 
filter feeding shellfish and finfish [1, 2]. Human consumption of marine products 
contaminated with these toxins can lead to food poisoning with symptoms varying from 
paralysis, diarrhoea, amnesia to even death [3, 4]. Shellfish poisons that induce diarrhoea 
(DSP toxins) include okadaic acid (OA) and its analogues dinophysis toxins 1 (DTX-1) and 
2 (DTX-2), and their esterified forms (DTX-3). They are produced by dinoflagellates from 
the genders Dinophysis spp. and Prorocentrum spp. [5, 6]. Another important group of marine 
biotoxins concerns azaspiracids (AZAs) causing effects like vomiting, diarrhoea, stomach 
cramps and nausea. These are polyether toxins with two spiro-ring assemblies, a cyclic 
amine and a carboxylic acid [7-9]. AZA-1 and AZA-2 are produced by the dinoflagellate 
Azadinium spinosum. AZA-3 and another 30 analogues are metabolites of AZA-1 or AZA-2 
that are formed within the shellfish [10, 11]. 
Until recently, the mouse bioassay (MBA) was the reference method in the EU for the 
detection of lipophilic marine biotoxins (LMB) like OA, DTXs and AZAs and it is still the 
reference method in some countries outside the EU [12]. Since January 2015, however, the 
mouse bioassay has been replaced in the EU by LC-MS/MS as the reference method for 
routine monitoring of lipophilic shellfish toxins, mainly because the mouse bioassay shows 
high variability in results, has insufficient detection capability and limited specificity [13]. 
Methods such as other LC based methods with appropriate detection, immunoassays and 
functional assays (e.g. the phosphatase inhibition assay) are allowed as alternative or 
supplementary to the LC-MS/MS method, provided that they are properly validated [13]. 
However, the LC-MS/MS method also has some drawbacks, i.e. certified standards of 
many toxins are unavailable or very expensive, and analytical methods are unable to detect 
presently unknown toxins or analogues [14]. For this reason, many EU countries hesitate 
to rely solely on LC-MS/MS analysis and for monitoring of production areas for the 
presence of (unknown) marine biotoxins, the use of the MBA is still allowed in the EU [13]. 
In vitro cell-based assays offer potentially useful alternative approaches, since these bioassays 
detect toxins on the basis of their effect and most likely will detect unknown analogues as 
well [15]. The neuro-2a cell line has been shown to detect various marine biotoxins, using 
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a method based on measuring cell viability, e.g. based on MTT-activity [16]. However, in 
routine monitoring, it is not only interesting to apply a bioassay that would be able to detect 
all relevant biotoxins, but ideally can also discriminate between the various toxin classes. 
Functional assays have e.g. been developed for OA, DTX and their analogues based on 
their inhibition of protein phosphatases (PPs), particularly PP1 and PP2A. This inhibition 
causes permanent phosphorylation of proteins leading to effects on regulation of glycogen 
metabolism, transcription, cell differentiation, cell adhesion, apoptosis and DNA 
replication, as shown in several cell lines [17-19]. The mode of action of AZA-1 is still 
unknown, but this toxin has been reported to induce mRNA expression of genes involved 
in cholesterol and fatty acid synthesis in Jurkat immune cells, indicating that AZA-1 
activates these processes [20]. 
In order to identify other toxin specific biomarkers, the present study aimed to investigate 
the mode of action of two important classes of DSP toxins, being OA and its analogue 
DTX-1, as well as AZA-1. Undifferentiated human intestinal Caco-2 cells, a potentially 
suitable cell-line for toxin detection, were exposed to these three toxins and effects on 
whole genome mRNA expression were investigated by DNA microarray analysis. Caco-2 
cells were initially selected because they represent the target tissue. However, it was decided 
to use undifferentiated cells because they are easier to handle for a bioassay that should be 
applicable in routine, where a test result should be provided within a couple of days and 
where the demand for testing can rapidly increase in case of an incident. Furthermore, 
undifferentiated cells have been shown to be more sensitive to the action of the protein 
phosphatase inhibition exerted by OA and DTX-1 [21]. In a previous work, a set of the 
most responding genes was selected and used to develop a dedicated array tube method to 
detect these toxins in shellfish samples [22]. However, this assay was considered not to be 
ideal in routine testing since it required too much time. In the present study, the whole 
genome mRNA expression dataset was therefore thoroughly analysed in order to reveal 
further insight in the mode of action of these toxins. Affected pathways might be further 
explored to identify both general and specific biomarkers for these groups of toxins. 
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2. Materials and methods 
 
2.1 Chemicals 
OA and AZA-1 were obtained from the National Research Council, Institute of Marine 
Biosciences (NRC CNRC, Halifax, Canada). DTX-1 was kindly donated by Dr. M. Sandvik 
(National Veterinary Institute, Oslo, Norway). For the toxins dissolved in methanol: the 
solvent was evaporated under a nitrogen flow and toxins were dissolved in DMSO. DMSO, 
ethanol and chloroform were obtained from Merck (Darmstadt, Germany). Isopropanol 
was obtained from Biosolve (Valkenswaard, the Netherlands), Trizol from Invitrogen 
(Bleiswijk, the Netherlands), and phosphate buffered saline (PBS) from Oxoid (Hampshire, 
England). 
 
2.2 Cell culture 
The human colonic adenocarcinoma cell-line Caco-2 (ATCC, Manassas, VA) was grown in 
Dulbecco’s Modified Eagle Medium (DMEM) obtained from Lonza (Verviers, Belgium) 
supplemented with 10% (v/v) foetal bovine serum (FBS) from Gibco BRL (Life 
Technologies Ltd., Paisly, Scotland), non-essential amino acids from MP Biomedicals 
(Illkirch, France) and penicillin 0.1% v/v (50 mg mL-1) from Sigma (St. Louis, MO). The 
cells were grown in 75 cm2 flasks at 37 °C and 5% CO2. 
 
2.3 Cytotoxicity assays 
For the MTT assay (Sigma, Zwijndrecht, the Netherlands), 100 µL of Caco-2 cell 
suspension was seeded per well in a 96-well plate (Ref. Number 3595, Corning, NY), using 
8 x 104 cells per mL and incubated for 48 h at 37 °C and 5% CO2, to reach 80-90% 
confluence. Then, cells were exposed to a range of 2.5 to 50 nM of OA, DTX-1 and AZA-
1 for 24 h. DMSO 0.25% (v/v) was included as vehicle control. Thereafter, media were 
aspirated and 60 µL of MTT reagent (final concentration of 0.8 mg mL-1) dissolved in 
medium was added per well. Cells were incubated for 30 min at 37 °C, 5% CO2, media were 
aspirated and 100 µL DMSO was added per well. After shaking thoroughly for 10 min, the 
absorbance was measured at 540 nm and corrected for background absorption at 650 nm. 
Data were expressed as percentage of control, i.e. DMSO, which is considered as 100% cell 
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viability. Three independent experiments were done, and the standard deviation of the 
control in each individual experiment was not higher than 10%.  
For the LDH leakage assay, 100 µL of Caco-2 cell suspension was seeded in a 96-well plate 
(Ref. Number 3595, Corning, NY), using 8 x 104 cells per mL and incubated for 48 h at 37 
°C and 5% CO2, to reach 80-90% confluence. Cells were exposed for 24 h to the same 
concentration range of AZA-1 as was used for the MTT assay. DMSO was used as a vehicle 
control at 0.25% (v/v). After the incubation period, the LDH leakage assay was performed 
according to the manufacturer’s instructions measuring absorbance at 492 nm (Cytotox 
96Ò Non-Radioactive cytotoxicity assay, Promega, Leiden, the Netherlands). 
 
2.4 Exposure for mRNA expression analysis by microarrays  
Caco-2 cells were seeded in 6-well plates (Ref. Number 3516, Corning, NY), using 6 x 104 
cells per mL, 3 mL per well and cultured for 48 h at 37 °C and 5% CO2 to reach 80-90% 
confluence. Four hours before exposure, the medium was refreshed. Then, cells were 
exposed to final concentrations of 25 nM OA, 6.25, 12.5 or 25 nM DTX-1, 6.25 or 25 nM 
AZA-1, or DMSO (0.25% (v/v), vehicle control). Exposures were performed in triplicate 
(3 wells per treatment in the same plate). 
 
2.5 RNA isolation and purification for microarray analysis 
Medium was removed and cells were lysed using TRIzol:chloroform (5:1) followed by 
centrifugation and collection of the aqueous phase containing RNA. The RNA was 
precipitated using isopropyl alcohol and washed with 70% ethanol:water (v/v). The 
obtained pellet was dried and dissolved in RNAse-free water. The RNAs were further 
purified using the RNeasy Mini Kit (Qiagen, Venlo, the Netherlands) following the 
instructions of the manufacturer. The amount and quality of the RNA were evaluated by 
UV spectrophotometry (260 and 280 nm wavelength) on the Nanodrop spectrophotometer 
(Nanodrop technologies). RNA integrity was measured by automated gel electrophoresis 
(Experion, Biorad, Veenendaal, the Netherlands). The quality of the RNA samples obtained 
was 10, being the highest quality. 
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2.6 Microarray hybridizations 
RNA samples were amplified and converted into Cy5-labeled cRNA using the Agilent low 
RNA input fluorescent amplification kit according to the manufacturer's instructions 
(Agilent Technologies, Amstelveen, the Netherlands). Universal human reference RNA 
(Stratagene, La Jolla, CA) was used as common reference and was labelled with fluorescent 
Cy3 dye (Perkin-Elmer/NEN). Equal amounts of Cy5-labeled cRNA and Cy3-labeled 
reference cRNA were mixed. Hybridizations were carried out on the 4 × 44K human whole 
genome Agilent microarray platform following the Agilent two-color microarray-based 
gene expression analysis protocol. Microarray slides were incubated for 16 to 17 h at 65 °C 
in a microarray incubation chamber with continuous rotation. After hybridization, the 
arrays were washed and dried at RT according to the manufacturer's protocol. Arrays were 
scanned using an Agilent microarray scanner (G2565B). In total, 21 arrays were hybridized. 
Due to technical failure, two arrays were excluded from further analysis: one of cells 
exposed to 6.25 nM AZA-1 and one of cells exposed to 25 nM AZA-1, leaving 19 arrays 
for analysis. Feature extraction 9.1 software (Agilent Technologies) was used for 
quantification of spot intensities. Quality check of arrays was carried out with LimmaGUI 
using the statistical package R. GeneMaths XT (Applied Maths, Sint-Martens-Latem, 
Belgium) was used for background correction and normalization [23]. 
 
2.7 Microarray data treatment 
Agilent microarrays (4 × 44K human whole genome) containing 41,108 spots were used. 
After background correction, 29,828 spots representing 20,442 unique gene IDs remained. 
Part of the genes are thus represented by multiple spots. Data were floored to reduce noise 
due to spots with very low spot intensities (not or very lowly expressed genes). For this, all 
spots with an intensity below 300 were annotated an intensity of 300. Subsequently, the 
intensity values were log2 mean centred. First, for each spot log2 ratios vs. the average of all 
arrays was calculated. Thereafter, log2 ratios of treatments vs. the average of the control 
samples (DMSO) were calculated in order to assess treatment effects. 
Hierarchical clustering was performed with the programs Cluster (uncentred correlation; 
average linkage clustering) and Treeview [24]. The heatmap shows a red colour when the 
log2 values are higher than +0.2 and the maximum red colour when it is higher than +1.0. 
The green colour is showed when values are higher than -0.2 and the maximum green 
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colour when the values are higher than -1.0. Black represents ‘no regulation’, i.e. when the 
values are in between -0.2 and +0.2.  
 
2.8 Biological interpretation 
For genes within subclusters of the hierarchical cluster heatmap, pathway analyses were 
performed using Metacore and Consensus Path DB (CPDB) analysis. Metacore is an online 
program for functional and biological interpretation of gene expression data. Metacore uses 
hypergeometric distribution to assess significances for overrepresentation of affected genes 
in signalling and metabolic pathways [25]. CPDB analysis was applied using the web tool 
http://cpdb.molgen.mpg.de which combines and compares the results of multiple pathway 
databases [26]. For both methods, pathways with a p-value <10-5 were considered to be 
affected significantly. 
 
2.9 Gene set enrichment analysis (GSEA) 
GSEA is a statistical analysis tool for biological interpretation of microarray data [27]. For 
the present study we used the visualization tool of GSEA to make heatmaps of pathways 
that were indicated to be affected based on pathway identification.  We used gene sets from 
various sources, including “Reactome” (http://www.reactome.org/), “Gene Ontology 
human symbols” downloaded from Gene Ontology consortium (www.geneontology.org), 
“Entire route ER stress UPR” (self-made) based on the study of Katika et al. [28] and 
“Marine biotoxins” (self-made) based on the study of Twiner et al. [20]. 
 
2.10 Exposures for qPCR confirmation 
Three independent exposures of Caco-2 cells were performed in order to confirm the up 
or downregulation of selected genes that play a role in the pathways that were identified by 
the transcriptome analysis. 600 µL of Caco-2 cell suspension were seeded in 24 well plates 
(Ref. Number 3524, Corning, NY), using 8 x104 cells per mL and incubated for 48 h at 37 
°C and 5% CO2 to reach 80-90% confluence. Cells were exposed to OA (25 nM), DTX-1 
(6.25, 12.5 and 25 nM) and AZA-1 (6.25 and 25 nM) for 24 h. Final concentration of DMSO 
(vehicle control) in the well was 0.25%. Exposures were performed in triplicate. RNA was 
extracted using the QIA shredder and RNeasy Mini Kit (Qiagen, Venlo, the Netherlands) 
following the instructions of the manufacturer. In short, the medium was removed and the 
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cells were lysed with 600 µL of RTL buffer with 1% β-mercaptoethanol. After the 
extraction, RNA quality and amount were evaluated according to the procedure described 
in section 2.5. The quality of the RNA obtained was 10, being the highest quality. cDNA 
was synthetized using 1 µg of RNA per sample and from an RNA pool mix of the 21 
treatments using the Biorad iScript cDNA Synthese Kit with iScript and reverse Transcript 
(Biorad, 170-8891) in the BioRad iCycler. The program used was 5 min at 25 °C, 30 min at 
42 °C, 5 min at 85 °C, and 5 minutes on ice. After the cDNA synthesis, the samples were 
diluted 100 times and the pool was diluted 10, 31.6, 100, 316, 1000 and 3160 times (i.e. 
needed to make a calibration line) and all cDNA samples were stored at -20 °C.  
 
2.11 Real time qRT-PCR 
Selection of genes to be confirmed by PCR was done using the highest 
induction/repression value obtained from the gene expression analysis (i.e. CPDB results), 
which were simplified in table 1 using the highest value of the triplicates or duplicated 
obtained after data analysis (see also section 2.6).  
qRT-PCR was performed with certified QuantiTect primers from Qiagen (Venlo, the 
Netherlands) using 15 µL of final volume containing 8.5 µL SYBR green (BioRad 170-
8880), 2.5 µL of the QuantiTect forward/reverse primer mix, 2 µL RNAse free water and 
2 µL of diluted cDNA. Reactions were performed in a BioRad HSP9645 PCR plate. Water 
and ‘pooled RNA without reverse transcriptase’ were used as negative controls. The plate 
was covered with a micro seal and centrifuged for 1 min. Thermal cycling was performed 
in a CFX96 Real-Time System (BioRad), starting with a denaturation step at 95 °C for 3 
min, followed by 45 cycles at 65 ° C for 35 s for annealing, 10 s at 95 °C for denaturation, 
and 1 min at 65°C for extension. Data were analysed using CFX manager 3.0 (BioRad) with 
the ∆∆Cq approach. Gene TMEM179B was used for normalization as described in 
previous experiments [22]. Statistical significance of the qRT-PCR results was obtained 
from the same program. P values lower than 0.01 are indicated with ** and P values lower 
than 0.05 are indicated with *. Data are expressed as relative normalized expression levels 
vs the control (DMSO) ± SEM. Formulas are available in the CFX manager 3.0 program.  
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3. Results
3.1 Cell viability 
Undifferentiated Caco-2 cells were exposed for 24 h to concentrations of OA, DTX-1 or 
AZA-1 ranging from 2.5 to 50 nM and effects on viability were assessed by the MTT assay. 
Cytotoxicity was defined as a decrease in cell viability of ≥20% relative to the solvent 
control (DMSO). Results are shown in Figure 1. OA did not decrease viability at the 
concentrations tested. For DTX-1, a reduction in the cell viability by over 20% was 
observed at 25 nM and higher concentrations. In contrast, AZA-1 increased the conversion 
of the MTT reagent up to 150% at all concentrations tested. This unexpected effect was 
highly reproducible. As the effect of AZA-1 in the MTT assay was unexpected and very 
specific, the toxicity of AZA-1 was also assessed using the LDH leakage assay. That assay 
demonstrated that none of the AZA-1 concentrations tested resulted in an increased or 
decreased LDH leakage into the medium (data not shown). 
Figure 1. Effects of 24 h exposure to OA, DTX-1 and AZA-1 on viability of Caco-2 cells 
as determined by the MTT assay and expressed as % of the control (DMSO). Data 
presented as mean ± SD of three independent experiments at three different days, all 
exposures per test day being performed in triplicate. Concentrations in log scale. SD is 
expressed as a percentage of the control. SD of the control on individual experiments is 
not higher that 10%.  
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3.2 Microarray and pathway analysis 
For the mRNA expression studies, non-cytotoxic concentrations of OA (25 nM), DTX-1 
(6.25 and 12.5 nM) and AZA-1 (6.25 and 25 nM) were selected. Cells were also exposed to 
25 nM DTX-1, but as this dose caused a slight decrease in MTT-activity, the cognate data 
were not included in further analysis of the results. However, despite the effect on MTT-
activity, the results were very similar to those observed for 12.5 nM DTX-1. Hierarchical 
clustering was first performed on the 2824 genes (represented by 3634 spots) that were 
more than 2-fold (log2 ratio of > |1.0|) up- or downregulated compared to the control 
samples (DMSO) in at least two of the thirteen microarrays analysed. The resulting heatmap 
(Figure 2) shows four main clusters. Cluster 1 contains genes that were up-regulated by OA 
and DTX-1 but differently affected by AZA-1. Clusters 2 and 3 contain genes that were 
up- or downregulated, respectively, by all three toxins. Cluster 4 contains genes that were 
downregulated by OA and DTX-1 but upregulated by AZA-1. The data strongly indicate 
that DTX-1 has a similar mode of action as OA, since almost all genes affected by OA were 
affected in the same direction by DTX-1. This also applies to some extent for AZA-1 
(clusters 2 and 3), but two other groups of genes, indicated as clusters 1 and 4, are affected 
in an opposite direction. All differential changes in gene expression are suggesting to some 
extent a different mode of action among these two classes of toxins. Tables S1 to S4 
(supplementary files) show the most up- and downregulated genes based on the highest 
concentrations of either DTX-1 or AZA-1. However, the focus of this study was on 
potential pathways rather than single genes. 
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Figure 2. Hierarchical clustering of OA, DTX-1 and AZA-1 responsive genes in Caco-2 
cells. Gene selection is based on an average fold change of ≥2 (log2 ratio ≥ |1.0|) in at least 
two of 13 microarrays, leading to a total of 3,634 spots representing 2,824 genes. Green 
indicates downregulation, red upregulation, and black not affected. Pathways significantly 
affected within clusters are indicated at the right. Additional pathways are mentioned in the 
text. A maximal red or green colour indicates 2-fold up- or downregulation or more versus 
the control (DMSO). Each column represents triplicates (OA and DTX-1) or duplicates 
(AZA-1). 
 
Therefore, the four clusters of the heatmap were analysed for genes representative for 
specific pathways or processes affected by the toxins. Cluster 1 contains 241 genes 
(represented by 301 spots) that are upregulated by OA and DTX-1, while part of these 
genes are slightly downregulated by AZA-1 and most not affected by AZA-1. There is a 
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small subset of genes on top of the heatmap that appear to be strongly downregulated by 
AZA-1 but upregulated by OA/DTX-1. This subset is composed of 61 spots, representing 
38 genes. Overall, cluster 1 did not reveal significantly overrepresented pathways using the 
criteria selected for this analysis, and as such did not reveal any potentially relevant effect. 
Only two genes seemed of interest, i.e. ACADSB and MYLIP, both involved in lipid 
metabolism. The question is if the effect could be related to the specific effect of AZA-1 
on cholesterol metabolism (see later).  
Cluster 2 contains 1,330 genes (1,802 spots) that are upregulated by OA and DTX-1 and 
some also by AZA-1. These genes are involved in processes/pathways related with 
“Hypoxia Induced factor” (HIF) (P < 5 x 10-13), “Glycolysis” (P = 5 x 10-8), “FoxO 
signalling” (P = 2 x 10-8), SREBP signalling (P = 5 x 10-7), “Mineral absorption” (P < 3 x 
10-6), and “Activator Protein 1” (AP-1) (P < 7 x 10-5). Some other pathways, like “Oxidative 
stress” (P = 2 x 10-5) and “Protein processing in endoplasmic reticulum” (P < 10-3) were 
also affected but to a lesser extent.  
Cluster 3 contains 1,207 genes (1,400 spots) that are mainly downregulated by OA and 
DTX-1 (almost all by 12.5 nM DTX-1) and a part also by AZA-1. These genes are involved 
in pathways related to “DNA methylation” (P < 3 x 10-12), “Telomere maintenance” (P < 
4 x 10-12), “Cell cycle” (P < 5 x 10-9) and “Detoxification” (P < 2 x 10-5).  
Cluster 4 comprises 92 genes (120 spots), which are mainly downregulated by OA and 
DTX-1 but upregulated by AZA-1. Genes of this cluster are involved in “Cholesterol 
biosynthesis” (P < 6 x 10-18). 
 
3.3 Gene expression confirmation by qPCR 
 
For confirmation of the observed effects and consistency between experiments, the mRNA 
expression of specific genes involved in the affected pathways/processes identified by 
transcriptomics analysis were examined by qRT-PCR analysis of undifferentiated Caco-2 
cells exposed to the toxin standards on three different days. Eight pathways were chosen 
and for each pathway/process two or three genes were selected, based both on the 
induction values as obtained in the microarray analysis and their known importance in the 
identified pathway (Table 1). UPR and ER stress, which are related and therefore combined 
in Table 1 under the pathway/process ER stress, were selected as well, although these 
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pathways seemed less affected. This pathway appears in section 3.2 (see cluster 2) as 
“Protein processing in endoplasmic reticulum”. Although the p value was higher than 10-5, 
we decided to select it since is an important pathway to consider and because the induction 
values of the genes were high enough to do so. As shown in Figure 3, the qRT-PCR 
experiments confirmed the effects on mRNA expression for 18 out of 21 genes, in general 
with similar or higher induction or repression values than in the microarray analysis. Three 
genes involved in the cell cycle, HIST1H1E, HIST1H4C and HIST1H2AC, were selected 
because they were involved in the pathways “DNA methylation”, “Telomere maintenance” 
and “Cell cycle” with low p values. Unfortunately, these genes could not be confirmed by 
qRT-PCR and those pathways were excluded from further analyses. It should be noticed 
that the repression values of these genes on the microarrays were rather low, less than 2-
fold, maybe making it difficult to confirm them by qRT-PCR (Table 1). 
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Table 1. Representative genes of pathways that were selected for qRT-PCR confirmation. 
Numbers represent fold-induction of treatments vs. the control (untreated) obtained by 
gene expression analysis of the microarray data. 
 
Pathway/process Gene symbol Expression (1) Included in 
heatmap 
(Figs. 4-5) 
OA DTX-1 AZA-1 
AP-1 EGR1 4.0 3.5 1.6 No  
FOS 4.9 9.2 2.6 No  
JUN 1.5 2.0 1.2 No 
Cell Adhesion MMP1 2.5 5.3 2.3 No  
CD44 2.5 4.3 3.0 No 
Cell cycle HIST1H1E 0.4 0.3 0.6 No 
HIST1H4C 0.4 0.3 0.9 No 
HIST1H2AC 0.5 0.4 0.5 No 
Cholesterol biosynthesis HMGCR 0.8 0.5 1.7 Yes  
LDLR 1.7 1.7 3.2 Yes 
ER stress BCL2L11 1.6 3.5 0.9 No  
ERN1 1.4 2.3 0.8 Yes  
MAP2K3 2.1 2.1 0.8 No 
Glucose metabolism HK2 3.2 4.3 3.0 Yes  
SLC2A1 2.5 3.0 4.6 No 
Glutathione GSTA1 0.8 0.4 0.3 Yes2  
GSTA2 0.8 0.5 0.3 Yes2 
Hypoxia induced factors EGLN3 2.5 6.1 1.4 Yes  
EGLN1 1.6 1.7 1.9 Yes 
Mineral absorption MT1G 1.9 2.8 5.3 Yes2  
MT1H 1.9 2.6 6.1 Yes2 
(1) fold-induction values (numerical ratios). Values higher than 1 represent upregulation, values lower than 
1 represent downregulation. Values represent the highest value of any treatment (see materials and 
methods).  
(2) Involved in “detoxification” (see figure 2) 
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Figure 3. Validation of the microarray results by qRT-PCR for genes involved in key 
pathways/processes affected by OA, DTX-1 and/or AZA-1. Graphs show the qRT-PCR 
results of 18 genes from three independent exposures of Caco-2 cells; within each exposure 
each toxin concentration was tested in triplicate. Values are shown as a log2 relative 
normalized expression (∆∆Cq). Values above 20 indicate upregulation, values below 20 
indicate downregulation. * = P ≤ 0.05, ** = P ≤ 0.01.  
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3.4 Effects on pathways or processes 
 
To obtain more insight in the genes that are affected within the different pathways, separate 
heatmaps per pathway were made. For this, we applied the heatmap tool of GSEA that 
visualizes also relatively small differences in mRNA expression [27]. The various heatmaps 
include all genes that are related to the process, for example enzymes, transporters and 
regulatory genes. Only the most dominant and relevant findings of the GSEA tool are 
presented and discussed. 
Using this tool, the differences of induction values among pathways were more clear, e.g. 
for pathways/processes in cluster 2 of Fig. 2. It was shown that genes involved in “Cellular 
response to hypoxia” (Figure 4A) were mainly induced by OA/DTX-1, and much less by 
AZA-1. Genes most affected by OA/DTX-1 were EPAS1 (HIF2α), CREBBP, EGLN3, 
UBE2D1 and UBE2D3, whereas VEGFA and EGLN1 were affected by all toxins. Glucose 
metabolism (Figure 4B) appeared to be affected by both groups of compounds, however, 
the gene expression patterns seem to some extent different. Both groups induce HK2 
(hexokinase) and fructose-bisphosphate aldolase (ALDOC), but the gene expression of 
phosphofructokinase (PFKP), a key enzyme in glycolysis, seems more upregulated by AZA-
1, as are some genes at the end of the glycolysis, i.e. phosphoglycerate kinase (PKK1), 
phosphoglucomutase 1 (PGM1), and enolase (ENO1 and ENO2), some of which (PGM1, 
ENO2) seem actually downregulated at 12.5 nM DTX-1. At the higher concentration of 
DTX-1, also downregulation of some genes involved in the citric acid cycle (MDH1 and 2, 
OGDHL, DHTKD1) was observed. Another difference was the upregulation of 2,3-
bisphosphoglycerate mutase (BPGM) by DTX-1 and OA, but down-regulation by AZA-1. 
Genes involved in ER stress related processes like “Unfolded or misfolded protein binding” 
(Figure 4C) and “ER associated apoptosis” (Figure 4D) are clearly induced by OA and 
DTX-1, while only few of these genes were affected by AZA-1. In agreement with the 
findings in Figure 2 (sub cluster 4), genes involved in cholesterol biosynthesis were induced 
by AZA-1 but not by OA or DTX-1 (Figure 5A). Another set of genes involved in 
cholesterol synthesis (e.g. HSD17B7, DHCR24) were downregulated by OA and DTX-1, 
but not clearly affected by AZA-1. Genes involved in glutathione conjugation, mainly 
glutathione-S-transferases of the A family (GSTAs), were downregulated at both 
concentrations of AZA-1 (Figure 5B) and, to a lesser extent, by 12.5 nM DTX-1. 
Whole genome mRNA transcriptomics analysis 
80 
 
Metallothionein genes were strongly upregulated by AZA-1 and much less by OA/DTX-1 
(Figure 5C). 
 
Figure 4. Effects on expression of genes of key pathways affected by OA, DTX-1 and 
AZA-1. A: “Cellular response to hypoxia”, B: “Glycolysis/Glucose metabolism”, C: 
“Unfolded or misfolded protein response”, D: “Endoplasmic reticulum associated 
apoptosis”. The heatmaps contain log2 ratios of treatment vs. the average of the control 
samples. For each gene, the sample with the highest expression obtains a maximal red 
colour and the sample with the lowest expression obtains a maximal blue colour. 
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Figure 5. Effects on expression of genes of key pathways affected mainly by AZA-1. A: 
“Cholesterol biosynthesis”, B: “Glutathione transferase activity”, C: “Metallothionein”. 
 
4. Discussion 
 
The present study aimed to acquire more insight into the modes of action of the marine 
toxins OA, DTX-1 and AZA-1 through in-depth analysis of microarray data generated for 
the purpose of biomarker identification. The focus was on pathways rather than specific 
genes, that were previously selected for another approach based on the use of a selective 
gene set for detection of these toxins using a tube array [22]. Although the primary mode 
of action of OA and DTX-1 is well-known, being inhibition of protein phosphatases (PPs), 
particularly PP1 and PP2A [29, 30], and to some extent PP5 [31, 32], it is still of interest to 
investigate the potential downstream effects of this inhibition and identify other potential 
effects. The bioinformatics analysis was started by making a heatmap including all samples 
based on a selection of 2,824 genes, that were at least 2-fold up or downregulated in at least 
two of the thirteen microarrays (nontoxic concentrations only and arrays that passed the 
quality check) (Figure 2). The concentrations selected for our analyses were based on 
determination of cell viability but also the regulatory limits used in the EU, since the 
eventual aim is the development of a bioassay for the detection of DSPs in shellfish. A 
maximum level of 160 µg OA equivalents per kilogram shellfish meat is allowed for OA 
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and DTX-1. The same limit is applied for AZA equivalents. In our routine protocol of 
shellfish extraction, a level of 160 µg kg-1 shellfish meat would result in a concentration of 
12 nM in the well, so similar to those used in this study.  
Exposure to 25 nM OA and 6.25 nM DTX-1 resulted in almost identical gene expression 
patterns, confirming that these two analogues induce the same effects. In addition, the 
transcriptomic analysis indicates that at least in vitro, DTX-1 is approximately 4-fold more 
potent than OA. It is important to consider that according to the current regulations, OA 
and DTX-1 are regarded as equally toxic, i.e. both have a toxic equivalency factor (TEF) of 
1 [33]. However, a higher toxic potency of DTX-1, compared to OA, has also been reported 
by others. Ferron et al. found that undifferentiated Caco-2 cells were 2-fold more sensitive 
for DTX-1 than OA on the basis of the neutral red uptake assay and five-fold more 
sensitive on the basis of proportions of Ki-67 positive cells, i.e. a marker for proliferating 
cells [21]. A higher sensitivity to DTX-1 than OA has also been reported for other cell 
types, including Neuro-2a, NG108-15, MCF7 [34] and HT29-MTX cells [21]. Data on 
absorption, distribution, metabolism and excretion are still needed to extrapolate these in 
vitro findings to in vivo, although the current TEF values are based on the induction of death 
after intraperitoneal injection in mice [35, 36] and thus exclude certain toxicokinetic 
parameters as well. 
The induction of hypoxia by OA and DTX-1 is indicated by the increased expression of 
target genes involved in hypoxia, as shown in figures 3G and 4A. These genes are 
particularly induced as an adaptive response of the cell to decreased oxygen levels by 
activating adaptive pathways including induction or stabilization of the transcription factors 
HIF-1 (which consists of the oxygen-regulated subunit HIF-1α and the constitutively 
expressed subunit HIF-1ß) and HIF-2 [37]. Increased expression of HIF genes is in line 
with the known inhibition of protein phosphatases, as it has been proposed that the 
inhibition of PP2A by okadaic acid activates the Akt/mTOR pathway, leading to increased 
HIF-1 protein levels and increased expression of the HIF-1 target gene VEGF which is 
known to play a role in angiogenesis [38]. HIF-1 target genes are involved in multiple 
processes including erythropoiesis, angiogenesis, extracellular matrix proteins and enzymes, 
glucose transport and glycolysis [39]. In the present study in particular the upregulation of 
EPAS1 (or hypoxia-inducible factor-2alpha (HIF-2α)) was observed for OA and DTX-1, 
but less by AZA-1. The difference in gene expression was even more clear for CREPBP 
Chapter 3 
83 
 
(cAMP response element-binding protein binding protein), a cofactor required for the 
action of HIF on gene expression, and UBED1 and UBED3 involved in the degradation 
of HIFs. Also EGLN genes, encoding prolyl-hydroxylases, are involved in the inactivation 
of HIF and increased expression of these EGLN genes is known to be a negative feedback 
mechanism against HIF response [40]. Under normoxic conditions, these enzymes catalyse 
the hydroxylation of HIF, promoting its degradation. In hypoxic conditions, HIF 
hydroxylation is reduced, allowing the formation of the HIF complex, which translocate to 
the nucleus, binds to a hypoxia responsive element and upregulates hypoxia responsive 
genes [41]. As shown in the heatmap of figure 4A, EGLN1 and EGLN3 were upregulated 
by OA/DTX-1 and effects on these genes were confirmed by qRT-PCR. This seems in line 
with the negative feedback mechanism against the observed HIF response. It should 
however be noted that EGLN1 was also upregulated by AZA-1 and according to qRT-
PCR also EGLN3. However, also the upregulation of 2,3-bisphosphoglycerate mutase 
(BPGM) by DTX-1 and OA (down-regulated by AZA-1), an enzyme converting the 
glycolysis intermediate 1,3-bisphosphoglycerate into 2,3-bisphosphoglycerate, seems 
related to hypoxia and has been proposed as a biomarker [42]. Levels of 2,3-
bisphosphoglycerate are increased under hypoxic conditions, in particular in erythrocytes, 
its role in other cells being less clear. A further examination revealed that some of the genes 
most upregulated by OA/DTX-1, like CDKN1C (cyclin-dependent kinase inhibitor 1C) 
and RGS16 (regulator of G-protein signalling 16), previously used as specific marker genes 
for OA/DTX-1 [22], and also CXCR4 (C-X-C chemokine receptor type 4), play a role in 
hypoxia [43-45] (Table S1, supplementary files). Overall, these observations suggest that a 
hypoxia-like response is induced by OA/DTX-1, but not or much less by AZA-1. 
Additional pathways, including ER stress, UPR activation and ER associated apoptosis 
were induced by OA and DTX-1, but not or much less by AZA-1, as clearly indicated by 
the heatmaps shown in Figure 4C and 4D. ER stress and the UPR are known to be triggered 
in response to several stimuli, e.g. environmental stress, exposure to certain xenobiotics or 
deprivation of nutrients, with the purpose to restore cell homeostasis [46, 47]. When the 
response is inadequate to recover the normal cell functions, the cell turns to apoptosis [47]. 
This might be one of the mechanisms involved in OA induced apoptosis as published 
previously for other cell types, e.g. leucocytes, the liver cell-lines HepG2 and HL7702 and 
the neuronal cell line SHSY5Y [18, 48]. The combination of induction of hypoxia, the UPR, 
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ER stress, and apoptosis is not uncommon. Accumulation of unfolded or misfolded 
proteins in the ER is known to induce UPR, which aims to restore ER homeostasis. This 
includes a temporary inhibition of protein synthesis. However, when the stress signal is 
severe and/or prolonged, the ER stress triggers cell death pathways including apoptosis 
[37, 49]. Induction of UPR by OA has also been reported to occur in primary cultures of 
rat cortical neurons [50]. 
AP-1 (Activating protein-1) is a transcription factor constituted by fos and jun proteins and 
involves the control of a variety of inducible genes containing AP-1 sites or a TPA response 
element [51]. It is regulated by a broad range of stimuli, including cytokines, stress, growth 
factors, among others [52]. Our data indicate that OA and DTX-1, but also AZA-1, induce 
the AP-1 response, which was confirmed by the increased gene expression of EGR1, FOS 
and JUN as assessed by qRT-PCR (Figure 3A). A downstream effect of AP-1 activation is 
the induction of genes involved in the extracellular matrix that is associated with 
remodelling of tissue [53, 54]. As shown in Figure 3B, the matrix related genes MMP1 and 
CD44 are upregulated by all toxins reaching a 16-fold induction both by 12.5 nM of DTX-
1 and 6.25 and 25 nM AZA-1. The upregulation of MMPs has been reported previously 
for OA [55, 56], but not for AZA-1. AP-1 is reported to increase the glucose production 
by exerting an accumulation of the glucocorticoid receptor (GR) in the nucleus that in turn 
activates gluconeogenesis [32, 57]. Genes involved in glucose metabolism were actually 
induced by OA, DTX-1 and AZA-1 (Figure 3E), the increased expression of two of these 
genes being confirmed by qPCR. HK2 (hexokinase 2) encodes an enzyme involved in the 
first step of the glucose metabolism pathway [58]. SLC2A1 is a major glucose transporter, 
located in the cell membrane, and facilitates the entrance of glucose in the cell [59]. 
Moreover, SLC2A1 has been reported to be induced by HIF [60, 61]. Interestingly, AZA-
1 appeared to have an even greater effect on the increased expression of these two genes, 
as well as on genes encoding for several other enzymes of the glycolysis. This may indicate 
an increased activity of the glycolysis, a phenomenon called the Warburg effect. This 
actually might also underlay the increased MTT-activity (Figure 1), that indicates increased 
NADH levels in the cell [62], generated during increased glycolysis and not metabolized in 
the mitochondria. Combined, this may indicate that AZA-1 has an effect on the coupling 
between the glycolysis and the Krebs cycle, potentially due to inhibition of a key enzyme, 
like pyruvate dehydrogenase, converting pyruvate into acetyl-CoA. This should be further 
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investigated, e.g. by measuring intermediates in the metabolism of glucose or the 
production of lactate. 
The gene expression analysis also demonstrates that AZA-1 specifically and highly induces 
the expression of genes involved in cholesterol biosynthesis (Figure 5A). This includes 3-
hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), a rate-limiting enzyme in the 
cholesterol biosynthesis pathway. In addition, AZA-1 clearly increases the expression of 
the gene encoding the low density lipoprotein receptor (LDLR) that is involved in the 
uptake of cholesterol by the cells and is stimulated by low cholesterol levels in the cell. The 
mRNA expression of LDLR was also increased by OA and DTX-1, but to a lesser extent 
(Table 1). These observations are in line with earlier findings of Twiner et al. [20] in Jurkat 
cells, showing that AZA-1 decreases the levels of cellular cholesterol. The induction of 
genes involved in cholesterol biosynthesis and uptake likely aims to counteract this 
reduction in cholesterol levels. Cholesterol biosynthesis genes have also been reported to 
be upregulated in Caco-2 cells upon exposure to alpha-chaconine, a well-known potato 
glycoalkaloid [63]. The toxicity symptoms of this latter compound are mainly 
gastrointestinal, including vomiting, diarrhea and abdominal pain, which appear very similar 
to the symptoms elicited by AZAs. It was proposed that the disturbance of the balance in 
cholesterol due to complexation with alpha-chaconine may be the cause of the upregulation 
of cholesterol biosynthesis genes. The exact mechanism how cholesterol levels are impaired 
by AZAs remains to be elucidated, but it is tempting that there may be a relation with the 
effects on glycolysis and that a reduced synthesis of acetyl-CoA plays a role.  
As shown in Figures 3F and 5B, all 3 toxins caused a reduction in the expression of 
glutathione S-transferases (GSTs), a group of detoxification enzymes, involved among 
others in detoxification of xenobiotics. They are also involved in the biosynthesis of 
steroids, prostaglandins and leukotrienes, and in the detoxification of products of lipid 
peroxidation and oxidative stress [64, 65]. In addition, GSTs are involved in cell cycle 
progression [66]. This effect has been observed after the knock-out of GSTA genes in 
Caco-2 cells [67]. Thus, we might speculate that the effect on GSTA genes may be related 
with cell cycle and impairment of the cell differentiation, in response to the exposure to 
toxins. 
Exposure to AZA-1 resulted in a rather specific upregulation of various metallothionein 
genes, not clearly observed with OA and DTX-1 (Figures 3H and 5C). These genes can be 
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upregulated as part of an inflammatory response [68], but also in response to metals as part 
of the detoxification process, and during oxidative stress and hypoxia [68, 69]. At this stage 
it is unclear how AZA-1 affects these genes. 
Performing bioinformatics analysis with relatively low cut-off values, as used in this work 
(i.e. from 2-fold up- or downregulated onwards), allowed us to identify pathways potentially 
affected by three lipophilic marine biotoxins belonging to two major classes. Some of the 
relevant genes in certain pathways were highly upregulated and may be suitable as 
biomarkers by themselves, as described previously [22]. qRT-PCR-analysis of a number of 
genes in independent repeats showed that the gene expression was highly reproducible. A 
more general picture on the mode of action may be helpful to develop more functional 
tests that are based on specific effects, like those observed on cholesterol synthesis or 
glycolysis. It would be interesting to explore the mechanisms behind the effect of AZA-1 
on cholesterol biosynthesis, glycolysis and/or the increase of the MTT activity, and the 
potential increase in metallothionein expression. For DTX/OA, effects on hypoxia and 
UPR seem more selective but it might be more difficult to find specific biomarkers other 
than gene expression or the inhibition of phosphatases. More general, it is important to 
understand the mechanisms behind the toxic effects of these compounds, both for risk 
assessment and for treatment of people affected by them. Some of the observed effects on 
gene expression may give a hint on the underlying mechanism of the cause of e.g. diarrhea, 
but this requires more work. The potential similarity between AZA and glycoalkaloids on 
cholesterol synthesis might also be an interesting lead to follow-up. Other models and 
approaches may be needed, where the use of a more physiological model could be relevant, 
e.g. the use of differentiated Caco-2 cells co-cultured with mucus cells, or an organ-on-a-
chip approach. Some effects may require validation by in vivo studies.  
In conclusion, the bioinformatics analysis on the transcriptomics data of Caco-2 cells 
yielded additional information about the potential modes of action of OA, DTX-1 and 
AZA-1. Based on the very high similarity in response of mRNA expression, OA and DTX-
1 exert identical effects, like those on hypoxia related pathways/processes, the unfolded 
protein response (UPR) and endoplasmic reticulum (ER) stress. AZA-1 mainly increased 
mRNA expression of genes involved in cholesterol synthesis and possibly glycolysis. 
Follow-up studies may reveal suitable biomarkers for developing specific in vitro bioassays 
but also give more insight in the mode of action of these toxins. 
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Summary 
The mouse bioassay for the detection of marine biotoxins in shellfish products is 40 years 
old and still in use. A full ban or total replacement of this in vivo test has been postponed 
because of the fear that current chemical-based detection methods could miss a new 
emerging toxin. In order to fully replace the mouse bioassay, more efforts are needed on 
the search for functional assays with specific endpoints. A previous study on gene 
expression elicited by diarrhoeic shellfish poisoning toxins in Caco-2 cells allowed us to 
determine three ‘DSP toxins profiles’, i.e. OA/DTX, AZA-YTX and PTX profiles. In the 
present study twelve marker genes were selected that envision these three profiles. qRT-
PCR is relatively cheap and easy, and although its multiplex capacity is limited to five genes, 
this turned out to be sufficient to show the three expected profiles. The use of the multiplex 
magnetic bead-based assay turned out to be even a slightly better alternative, allowing the 
use of all twelve selected marker genes and two reference genes, and resulting in clear 
profiles with for some genes even higher induction factors as obtained by qRT-PCR. When 
analysing blank and contaminated shellfish samples with this multiplex magnetic bead-
based assay, the contaminated samples could easily be distinguished from the blank 
samples, showing the expected profiles. This work is one step further on the final 
replacement of the mouse bioassay, e.g. by combining the neuro-2a bioassay for broad 
screening and detection (nonspecific cytotoxicity) with analytical chemical analyses for the 
confirmation of known toxins and the multiplex magnetic bead-based assay (specific 
mRNAs) for confirmation of unknown toxins. 
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1. Introduction  
 
Marine biotoxins are toxins produced by phytoplankton and/or bacteria, that can 
accumulate in several types of marine animals, e.g. shellfish, crabs and fish [1]. Bivalve 
molluscs feed through filtration and concentrate these toxins in their bodies and digestive 
glands [2, 3]. Mussels for example filtrate 7.5 litres of seawater per hour, leading to the 
accumulation and concentration of pollutants and toxins [4]. When humans consume 
seafood with toxins in amounts that exceed the established safety levels, it may lead to 
intoxication. Marine biotoxins can cause clinical features that vary from diarrhoea and 
amnesia to paralysis and even death. Five groups of marine biotoxins are regulated within 
the European Union, i.e. okadaic acid group (OA), which includes the dinophysistoxin 
analogues (DTXs), this group is also known as the diarrheic shellfish poisoning (DSP) 
toxins; azaspiracid group (AZAs), which can also cause diarrhoea; yessotoxin group 
(YTXs); domoic acid group (DA), also known as amnesic shellfish poisoning (ASP); and 
saxitoxin group (STX), also known as paralytic shellfish poisoning (PSP) toxins [5]. Within 
these groups, several different types and analogues can be found. It is described that 
worldwide algae toxins are responsible for approximately 60,000 human intoxications 
annually [6]. 
In order to prevent intoxications, several countries have legislation regarding permitted 
levels of the different marine biotoxins in shellfish that need to be checked by monitoring 
programs. These monitoring programs to detect marine biotoxins make use of different 
methods [3]. The method of surveillance most used worldwide is the mouse bioassay 
(MBA), where an extract of shellfish is injected intraperitoneal into a number of mice and 
death is the endpoint to determine whether the sample is safe to consume or not [7, 8]. 
Besides ethical issues regarding the use of laboratory animals, the MBA gives high rates of 
false-positive and false-negative outcomes [5, 9]. In Europe, the use of the MBA is banned 
since 2015, but not for PSP toxins analysis and not for the control of production areas, 
aiming at detection of possibly unknown toxins [10]. The EU reference method for the 
detection of lipohilic shellfish toxins (mainly DSP toxins and AZAs) is the LC-MS/MS 
method of the European Reference Laboratory (EU-RL) on marine biotoxins [10, 11]. 
However, the use of the MBA has been kept over time and is not fully replaced by analytical 
chemical methods. This is mainly due to a lack of standards for the known toxins, and 
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because toxin patterns might change, which generates a concern about new toxins 
appearing that would be missed by such chemical analysis and not by the MBA [12, 13]. 
Nowadays, when possible, toxicity testing should comply with the so called 3R principle, 
i.e. to refine, reduce and replace experiments with animals [9, 14, 15]. Some cell-based assays
have been tested in order to obtain information about the mode of action or biological
activity of the marine biotoxins, and to replace the MBA [12, 16, 17]. The neuro-2a bioassay
is considered as one of the most promising cell-based bioassays for the broad screening of
marine biotoxins, i.e. DSP toxins, neurotoxic shellfish poisoning (NSP) toxins, and PSP
toxins [18-21]. The readout in this neuro-2a bioassay is reduction of MTT (as measurement
of cell viability) and suspect screened samples should be confirmed by additional LC-
MS/MS analysis [22]. However, in case a suspect screened sample is not confirmed by
analytical chemical methods, it might contain a known unknown or yet unknown toxin. In
these cases, an additional cell-based bioassay confirming the presence of a toxin and that is
also able to determine the type of toxin present would be very helpful, e.g. a bioassay based
on gene expression [2]. To do so, previously a whole genome mRNA expression analysis
was performed with the human intestinal Caco-2 cell line exposed to OA, DTX-1 and
AZA-1 using DNA microarrays. Patterns obtained for toxins or other bioactives are
specific and commonly used to characterise new compounds, i.e. compare the profile of
the compound with those available in data banks (read across). Exposure to the regulated
toxins, i.e. OA, DTX-1, AZA-1, PTX-2 and YTX, yielded specific gene expression patterns.
From the information provided by these microarray analyses, insights on mode of action
were described for OA, DTX-1 and AZA-1 [17]. In summary, OA and DTX-1 induced
almost identical mRNA expression patterns, in agreement with the fact that both molecules
are analogues that belong to the same toxin group and cause similar effects. For instance,
OA and DTX-1 increased expression of genes involved in the hypoxia induced factor
pathway/process (HIF), in line with the inhibition of phosphatases and a subsequent
activation of the Akt/mTOR pathway, which is involved in the activation of the HIF. OA
and DTX-1 also affected pathways like unfolded protein response (UPR) and endoplasmic
reticulum (ER) stress. The mRNA expression pattern from AZA-1 was different, where an
increase of genes involved in cholesterol biosynthesis and glycolysis pathways was
observed, suggesting a different mode of action [17]. Since full genome microarray analysis
is not suitable for rapid screening, alternative platforms to detect gene expression levels of
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highly up or down-regulated genes as markers for detection and identification were 
evaluated. A first approach involved a so-called tube array with a limited number of selected 
marker genes. Although promising, the test was rather expensive, labour intensive and long 
(it took about 3 days). Moreover, the sensitivity of several of the 17 selected genes on this 
dedicated array was limited [16]. 
The present study describes two new approaches for detecting marker mRNAs in exposed 
Caco-2 cells, i.e. the development of a multiplex qRT-PCR and a multiplex magnetic bead-
based assay. The newly developed multiplex qRT-PCR was performed successfully with 
five markers (using the maximum number of six fluorescent markers resulted in 
interference). The newly developed multiplex magnetic bead-based assay was able to 
correctly quantify the expression levels of twelve selected marker genes. The present study 
shows that detection of marker mRNAs in exposed Caco-2 cells could be a promising tool 
to confirm the presence of yet unknown toxins in mussel samples screened suspect in the 
neuro-2a bioassay which cannot be confirmed by LC-MS/MS. We thus propose a strategy 
where the neuro-2a bioassay is used as a screening method, LC-MS/MS for confirmation 
of suspects, and a second cell-based bioassay to confirm the presence of a toxin and detect 
a toxin profile related to gene expression when suspects from the neuro-2a cannot be 
confirmed by LC-MS/MS. This work will contribute to the search for new endpoints to 
detect known and yet unknown marine biotoxins, will help in the identification of unknown 
toxins, and does so without the need for animal testing. 
 
2. Material and methods 
 
2.1 Reagents and standards 
Certified reference materials (CRMs) of OA (13.7 ± 0.6 µg mL-1), DTX-1 (15.1 ± 1.1 µg 
mL-1), DTX-2 (7.8 ± 0.4 µg mL-1), PTX-2 (4.40 ± 0.13 µg mL-1), AZA-1 (1.24 ± 0.07 µg 
mL-1), AZA-2 (1.28 ± 0.05 µg mL-1), AZA-3 (1.04 ± 0.04 µg mL-1), YTX (5.6 ± 0.2 µg mL-
1), and hYTX (5.8 ± 0.3 µg mL-1) were purchased from the National Research Council, 
Institute for Marine Biosciences (NRC CNRC, Halifax, Canada). Pinnatoxin E (PnTX-E) 
was obtained from Cawthron Institute, New Zealand. Stock solutions of these toxin 
standards were prepared in dimethyl sulfoxide (DMSO) after evaporation of the original 
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solvent. DMSO and n-hexane were obtained from Merck (Darmstadt, Germany). Methanol 
(Ultra LC/MS) was purchased from Actu-All (Oss, The Netherlands). 
2.2 Cell culture 
The human colonic adenocarcinoma cell-line Caco-2 (ATCC, Manassas, VA) was grown in 
Dulbecco’s Modified Eagle Medium (DMEM) obtained from Lonza (Verviers, Belgium) 
supplemented with 10% (v/v) foetal bovine serum (FBS) from Gibco BRL (Fisher Emergo, 
Landsmeer, the Netherlands), non-essential amino acids (NEAA) from MP Biomedicals, 
(Illkirch, France) and penicillin 0.1% v/v (50 mg ml-1) from Sigma (Zwijndrecht, the 
Netherlands). The cells were grown in 75 cm2 flasks at 37 °C and 5% CO2. 
2.3 Samples 
In-house samples, both blank mussel samples from the Netherlands, and contaminated 
samples obtained from various locations in the EU and used for previous validation studies 
of the LC-MS/MS method [23] were tested. 
2.4 Preparation of extracts 
Prior to extraction of the blank samples and the ones containing lipophilic marine 
biotoxins, shellfish material was homogenized with a T25 Ultra Turrax mixer at 24,000 rpm 
(IKA® Works Inc., Wilmington, NC, USA). One gram of shellfish homogenate was vortex 
mixed with 3 mL methanol for 1 min and centrifuged for 5 min at 2,000 × g. The 
supernatant was transferred to a volumetric flask and the residue was extracted twice more 
with 3 mL methanol. After the third extraction the volume of the collected supernatant was 
adjusted to 10 mL with methanol. For exposure of Caco-2 cells, additional clean-up steps 
using n-hexane and solid phase extraction (SPE) were applied. 
2.5 Clean-up by n-hexane wash step followed by SPE 
A 4.8 mL aliquot of the crude methanol shellfish extract was diluted with 1.2 mL Milli-Q 
water and extracted twice with 6 mL n-hexane in order to remove matrix substances that 
led to false-positive test outcomes [22]. The hexane layer was discarded and the aqueous 
methanolic extract was further diluted by adding 10 mL Milli-Q water and the total extract 
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of 16 mL was transferred to an SPE StrataTM-X cartridge (200 mg/6 mL; Phenomenex, 
Utrecht, the Netherlands), previously conditioned with 4 mL methanol/water (30:70 v/v). 
Subsequently, the cartridge was washed with 8 mL methanol/water (20:80 v/v) and the 
toxins were eluted with 4.8 mL methanol. The eluate was evaporated to dryness under a 
stream of nitrogen gas and reconstituted in 20 µL DMSO. 
 
2.6 Exposure, RNA isolation and cDNA synthesis for multiplex qRT-PCR analysis 
Caco-2 cells were exposed to the standards and sample extracts. For this, 600 µL of Caco-
2 cell suspension were seeded in 24 well plates (Ref. Number 3524, Corning, NY), using 8 
x104 cells per mL and incubated for 48 h at 37 °C and 5% CO2 to reach 80-90% confluence. 
DMSO 0.25% (v/v) was included as vehicle control. Exposures were performed in 
triplicate. Cells were exposed to the standards and samples for 24 h, medium was removed, 
cells were washed with PBS and lysed with 600 µL of RTL buffer with 1% β-
mercaptoethanol. RNA was extracted using the QIA shredder and RNeasy Mini Kit 
(Qiagen, Venlo, the Netherlands) followed by a DNAse treatment with RNAse free DNAse 
(Qiagen, Venlo, the Netherlands), both by following the instructions of the manufacturer. 
After the extraction, the amount and quality of the RNA were evaluated by UV 
spectrophotometry (260 and 280 nm wavelength) on the Nanodrop spectrophotometer 
(Nanodrop technologies). cDNA was synthetized using 1 µg of RNA per sample and from 
an ‘RNA pool mix’ of all treatments with and without reverse transcriptase using the Biorad 
iScript cDNA Synthesis Kit with iScript and reverse Transcript (Biorad, 170-8891) in the 
BioRad iCycler (Biorad, Veenendaal, the Netherlands). The program used was 5 min at 25 
°C, 30 min at 42 °C, 5 min at 85 °C, after which the samples were put on ice for 5 min. 
After the cDNA synthesis, the samples were diluted 10 and 100 times and the pool was 
diluted 10, 31.6, 100, 316, 1000 and 3160 times and used to make a calibration line. The 
samples were stored at -20 °C. 
 
2.7 Singleplex qRT-PCR method 
Singleplex qRT-PCR was performed for the selected marker genes with certified 
QuantiTect primers from Qiagen (Venlo, the Netherlands) using 15 µL of final volume 
containing: 8.5 µL SYBR green (BioRad 170-8880), 2.5 µL of the QuantiTect 
forward/reverse primer mix, 2 µL RNAse free water and 2 µL of 100x diluted cDNA. 
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Reactions were performed in a BioRad HSP9645 PCR plate. Water and ‘RNA pool mix 
without reverse transcriptase’ were used as negative controls. The plate was covered with a 
micro seal and centrifuged for 1 min. Thermal cycling was performed in a CFX96 Real-
Time System (Biorad), starting with a denaturation step at 95 °C for 3 min, followed by 45 
cycles at 65 °C with 35 s for annealing, 10 s at 95 °C for denaturation, and 1 min at 65 °C 
for extension. Data were analysed using BioRad software. Expression ratios of the genes 
were calculated for exposures versus DMSO control. 
2.8 Multiplex qRT-PCR method 
Multiplex qRT- qPCR was performed with primers as shown in table 1, from Qiagen 
(Venlo, the Netherlands) and Biolegio (Nijmegen, the Netherlands). All the probes were 
provided by Biolegio. The sequences are confidential. The reactions were performed using 
25 µL final volume containing 12.5 µL 2x Quantifast multiplex PCR master mix (Qiagen, 
Venlo, the Netherlands, cat number 204752), 1.25 µL of each primer probe mix, 3.75 or 
6.25 µL RNAse free water and 2µL of 10x diluted cDNA. Reactions were performed in a 
BioRad HSP9645 PCR plate. Water and ‘RNA pool mix without reverse transcriptase’ were 
used as negative controls. The plate was covered with a micro seal and centrifuged for 1 
min. Thermal cycling was performed in a CFX96 Real-Time System (Biorad), starting with 
an initial denaturation step at 95 °C for 5 min, followed by 44 cycles at 60 °C with 45 s for 
annealing, 45 s at 95 °C for denaturation, and 45 s at 60 °C for extension. 
Data were analysed using BioRad software CFX manager v.3.0. Plate set up and standard 
curve were selected, and the results are shown as log2 values. Relative quantities (∆Cq), 
which express the quantity of the gene under a certain treatment (toxin) vs the quantity 
under control treatment (vehicle) are plotted and expressed as log2 values versus the 
control. The expression of the reference gene TMEM179B was not affected by any 
treatment and left out in the newly developed multiplex qRT-PCR method. 
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Table 1. Primers, probes and dyes selected for the development of a multiplex qRT-PCR. 
Gene name Primers Specification Cat number Probe dye 
NPPB Qiagen Hs_NPPB_1_SG QT00031934 6FAM 
RGS16 Biolegio na na Texas Red 
DDIT4 Qiagen Hs_DDIT4_1_SG QT00238588 HEX 
CXCR4 Qiagen Hs_CXCR4_2_SG QT02311841 Quasar 705 
TGFB2 Biolegio na na Cy5 
2.9 Multiplex magnetic bead-based assay 
Caco-2 cells were seeded in a 96 well plate (Ref. Number 3595, Corning, NY) using 100 µL 
of a suspension containing 8 x 104 cells per mL and incubated for 48 h at 37 °C and 5% 
CO2, to reach 80-90% confluence. Then, cells were exposed to samples and standards for 
24 h. DMSO 0.25% (v/v) was included as vehicle control. After 24 h exposure of Caco-2 
cells in the 96 well format (every exposure performed in triplicate, e.g. 3 wells per 
treatment), mild lysis of cells was achieved according to the manufacturer instructions 
(QuantiGene 2.0 plex assay user manual, Affymetrix, the Netherlands). Briefly, the lysis 
mixture was diluted in nuclease-free water and 100 µL were added per well. Plates were 
incubated for 18-22 hours at 54 °C ± 1 °C, at 600 rpm in a VorTemp™ 56 Shaking 
Incubator (Thermo Fischer, the Netherlands), previously validated with a QuantiGene 
Incubator Temperature Validation Kit (Isogen, the Netherlands). The assay procedure 
consists of several hybridization, incubation and washing steps, using a plate magnet to 
capture the beads (Affymetrix, the Netherlands). After the final binding step, 130 µL of 
washing buffer (provided in the kit) was added to the wells and plates were read in a 
xPonent® 3D machine (Luminex corp). The protocol was defined using manufacturer 
instructions, i.e. sample size 100 µL, DD gate 5.000 – 25.000, timeout 45 seconds and bead 
event 100. The total time needed from cell lysis to read out is about 30 h. Data analysis was 
performed as follows: MFI (median fluorescence intensity) values were provided from the 
xPonent® 3D machine in a .cvs file and were analysed using excel for calculating the average 
signal (avg MFI) for each gene (exposures were performed in triplicate). Then, the value 
obtained from each gene was divided by the value for the normalisation gene. Here we used 
the CUL1 gene (avg MFI gene of interest/avg MFI CUL1). Finally, for each test gene, we 
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calculated the fold change by dividing the normalised value for the treated samples by the 
normalised value for the untreated sample, i.e. DMSO ((avg gene/avgcul1)/avg DMSO). 
Values were plotted in prism graphpad. 
3. Results
Table 2 shows the twelve marker genes and three reference genes which were selected from 
the whole genome array studies, where undifferentiated Caco-2 cells were exposed to OA, 
DTX-1 and AZA-1 [17] and to YTX and PTX-2 (unpublished data). Genes were selected 
based on their response to the different toxins, e.g., NPPB is specifically down-regulated 
by PTX-2 and to some extent by DTX-1, while RGS16 is specifically up-regulated by DTX-
1 and to some extent by OA. TMEM179B, CUL1 and SH3BP2 were not affected and used 
as reference genes. Moreover, besides OA, DTXs, AZAs, YTXs and PTXs, other 
(nonregulated) marine biotoxins like the cyclic imines (CIs) might end up in the lipophilic 
extracts, however these toxins do not lead to clear effects on gene expression, even when 
tested at higher concentrations. Figure S1 is an example of the CIs PnTX-E and SPX and 
shows that these toxins do not result in clear effects on gene expression in exposed Caco-
2 cells. 
3.1 Development of a multiplex qRT-PCR detection method 
First, singleplex qRT-PCRs were performed in order to confirm the results from the whole 
genome array studies. For that, Caco-2 cells were exposed to 3 and 9 nM of all the toxins, 
including the analogues, except for YTX, for which 12.5 and 37.5 nM were used. These 
concentrations were used for all following experiments, as these concentrations result from 
a newly developed clean-up procedure for lipophilic marine biotoxins (LMB) from mussels 
in combination with the regulatory limits (160 µg kg-1 shellfish for OA, DTXs, PTX-2 and 
AZAs, and 3,750 µg kg-1 shellfish for YTXs). Assuming 100% toxin recoveries [22], the 
regulatory limits of OA, DTXs, AZAs and PTX-2 will result in a final concentration of 
about 12 nM in the well, while the regulatory limit of YTX would result in a final well 
concentration of about 200 nM. Figure 1 shows the relative expression level of each target 
gene for each toxin concentration. Showing that each toxin except OA can be detected at 
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a concentration relevant for enforcement purposes, i.e. a lower concentration (using a newly 
developed clean-up procedure) than resulting from its regulatory limit. 
Table 2. Selected genes and representation of their expression as determined in the whole 
genome array studies [17]. Up or down-regulated compared to a vehicle control: red arrows 
up represent genes that are up-regulated with log2 values higher than 0.7 and green arrows 
down are genes down-regulated with log2 values lower than -0.7. The (*) represents up-
regulation higher than a log2 value of 2.0 or down-regulation of a log2 value lower than -
1.5. The (-) represents log2 values between -0.4 and 0.4, which are considered as no 
significant effects on gene expression. ND: not determined. 
 
Gene  
 
AZA-1 
6.25 nM 
OA 
25nM 
Toxin analogue 
DTX-1 
12.5 nM  
YTX 
12.8 nM 
PTX-2 
11.4 nM 
NPPB ­ ­   ↓* ­   ↓* 
RGS16 ­ ↑   ↑* ­ ­ 
DDIT4   ↑* ↑ ↑ ↑ ↓ 
CXCR4 ­   ↑*   ↑* ­ ­ 
TGFB2 ↓ ↓ ↓ ­ ­ 
MAFB ­   ↑*    ↑* ­ ­ 
TNS4 ↑ ­ ↑ ­ ­ 
C11orf96 ­   ↑*   ↑* ND ND 
CEACAM1 ↑ ↑ ↑   ↑* ­ 
OSR2 ↓ ­ ↑ ­ ­ 
MT1H   ↑* ↑ ↑ ­ ­ 
MT1G   ↑* ­ ↑ ↑ ­ 
TMEM179B ­ ­ ­ ­ ­ 
CUL1 ­ ­ ­ ­ ­ 
SH3BP2 ­ ­ ­ ­ ­ 
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Figure 1. Singleplex qRT-PCR results of the five selected marker genes NPPB, RGS16, 
DDIT4, CXCR4 and TGFB2. Values are shown as log2 relative quantity (RQ) of the gene 
of interest. 
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In general, genes in the singleplex qRT-PCR responded as expected from the whole 
genome array study (table 2). The responses observed for AZA-1 at only 3 nM are already 
clear and as expected, i.e. up-regulation of DDIT4 and down-regulation of TGFB2 and no 
effects on NPPB, RGS16 and CXCR4. As expected, all five genes responded to DTX-1 
and even did so in a dose related way when looking at the responses obtained with 3 and 9 
nM. Unfortunately, there were no clear responses to OA at 3 and 9 nM. However, this was 
more or less anticipated, as 25 nM was used in the whole genome array study because at 
lower concentrations no effects of OA on gene expression could be observed (data not 
shown). In spite of this, it was worthwhile to test 3 and 9 nM OA using singleplex qRT-
PCR to investigate if singleplex qRT-PCR would be sensitive enough to detect OA at 
concentrations relevant for enforcement purposes. It should also be emphasised that this 
singleplex qRT-PCR is mainly developed to confirm suspect screened samples in the neuro-
2a bioassay. For further experimentation, the concentrations of OA were increased to 25 
and 100 nM. PTX-2 is easily detected with the marker gene NPPB, that is specifically down-
regulated by this toxin at low concentrations. As expected, YTX could be detected by the 
up-regulation of DDIT4. It was remarkable that the YTX singleplex qRT-PCR profile is 
similar to that of AZAs, and also showed a down-regulation of TGFB2, which was not 
expected from the gene expression analysis. Another interesting finding is that this TGFB2 
gene is downregulated by all toxins, except for OA at the (low) concentrations tested. The 
reference gene TMEM179B did not show any relevant expression (data not shown). It was 
decided to skip the TMEM179B as a reference gene as it turned out that when we designed 
the multiplex qRT-PCR, the use of the maximum amount of six fluorescent markers 
resulted in interference. 
As the singleplex qRT-PCR results showed that the five selected marker genes responded 
as expected and in a sensitive way, a multiplex qRT-PCR was developed using primers, 
probes and dyes as shown in table 1. Figure 2 shows that this newly developed multiplex 
qRT-PCR was able to detect all toxins, and all except OA, at concentrations that are relevant 
for enforcement purposes. It was anticipated that toxin analogues would result in similar 
expression profiles and that this multiplex qRT-PCR would thus be suited for detecting 
analogues as well. Therefore, also AZA-2, AZA-3, DTX-2 and hYTX were tested. Figure 
2 shows that exposure to AZA-2 and AZA-3 indeed resulted in similar profiles as AZA-1 
and at similar concentrations. Also, the profiles of OA, DTX-1 and DTX-2 are identical as 
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are the profiles of YTX and hYTX. A table with a comparison of the expected and obtained 
results is included in supplementary materials (S2). 
 
Figure 2. Multiplex qRT-PCR profiles. Profile A) AZAs and YTXs; profile B) OA/DTXs 
and profile C) PTX-2. Values are shown as log2 relative quantity (RQ) of the gene of 
interest. 
In order to further evaluate the performance of the newly developed multiplex qRT-PCR, 
ten blank mussel samples and a mussel sample contaminated with AZAs (1,083 µg AZA-
eq kg-1), all according to the EURL LC-MS/MS method, were tested. Figure 3 shows that 
the extracts of the blank mussel samples did not affect the expression of any of the selected 
marker genes, while mussel contaminated with AZAs resulted in a “perfect” AZA/YTX-
profile. Standards of OA and PTX-2 were used as positive controls and also resulted in the 
expected profiles. 
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Figure 3. Multiplex qRT-PCR profiles obtained from 10 blank shellfish extracts, OA and 
PTX-2 standards and an extract prepared from a mussel sample indicated as ‘AZA m’ that 
is naturally contaminated with AZAs (1083 µg AZA-1-eq kg-1). Bars represent log2 values 
of the relative expression levels (RQ) of the genes. 
To further increase the capacity to detect and identify the toxins by multiplex qRT-PCR, 
especially for the discrimination between the presence of AZAs or YTXs, a second 
multiplex qRT-PCR could be developed. However, in order to have one single test method 
to detect more than 5 marker genes, it was decided to analyse mRNA expression on another 
format: a multiplex magnetic bead-based assay. 
 
3.2. Development of a Multiplex magnetic bead-based assay for 14 genes 
 
The multiplex magnetic bead-based assay enables the examination of up to 100 genes, and 
it is based on the direct detection of the mRNA present in the sample, making it less labour 
intensive, i.e. no need for RNA purification, reverse transcription or amplification. Besides 
the five genes selected for multiplex PCR, more genes were selected from the whole 
genome array experiments, i.e. seven marker genes and two more reference genes (table 2). 
The multiplex magnetic bead-based assay uses magnetic beads coupled with DNA probes. 
These specific probes hybridise with a cognate mRNA present in the sample. The 
fluorescent signal associated with each specific bead is read on a Luminex® flow cytometer, 
where the equipment detects the specific bead, representing the gene, and the fluorescent 
signal attached to that bead, indicating the amount of cognate mRNA in the sample. Median 
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fluorescence intensities (MFIs) are measured and used to calculate relative gene expression 
levels. 
The same toxins and toxin analogues as described above for the multiplex qRT-PCR 
method (5-plex) were tested in this multiplex magnetic bead-based 14-plex assay, i.e. OA, 
DTX-1, DTX-2, AZA-1, AZA-2, AZA-3, YTX, hYTX and PTX-2. Pinnatoxin (PnTX-E) 
was used as a negative control, since PnTX-E hardly affects the gene expression levels in 
Caco-2 (Fig. S1). Figure 4 shows the results for all the analogues and the twelve marker 
genes selected for this method (see also table S3). These data also revealed three clear 
profiles, i.e. OA/DTXs profile, AZAs/YTXs profile and a PTX-2 profile. As expected, 
PnTX-E did not elicit any specific responses at the gene expression level. When looking at 
more data in more detail, figure S3 in supplemental materials, it also becomes clear that in 
the concentration ranges tested, i.e. AZAs 3-9 nM; DTXs and PTX-2 3-27 nM; OA 3-100 
nM and YTXs 12.5-37.5 nM, the OA/DTX profile shows clear dose-response effects. It 
also shows that on this test format it is also not possible to detect gene expression at low 
concentrations of OA, i.e. 3-9 nM. OA starts to affect gene expression at 25 nM and 
resulting in a clear profile at 100 nM, similar to the profile obtained with DTX-1 at 9 nM, 
indicating that OA is about four times more potent than DTX-1 and in line with the relative 
potencies as observed in the neuro-2a bioassay [17, 22]. Thus, also on the bead-based 
format it is not possible to detect OA at concentrations relevant for enforcement purposes. 
The DTX-2 response is lower than that of DTX-1, this is expected, as DTX-2 is less potent 
than DTX-1 [22, 24, 25]. Anyway, at a relevant level for enforcement purposes, 27 nM, the 
DTX-2 profile is identical to that of DTX-1 at 9 nM. Just as the DTXs, the AZAs, YTXs 
and PTX-2 can be detected at relevant concentrations for enforcement purposes. 
Unfortunately, the profiles for AZAs and YTXs are still identical. The TNS4, OSR2 and 
MT1H genes were especially added to distinguish the AZAs from the YTXs (table 2), but 
just like TGFB2 in the multiplex qRT-PCR, the YTXs cause the same effect on these three 
genes as the AZAs do. In order to rule out that YTX or AZA toxin standard were switched, 
the YTX, AZA-1 and DTX-1 stock solutions in DMSO were checked by LC-MS/MS 
analysis. Figure S5 in supplementary materials shows the obtained mass chromatograms, 
demonstrating that YTX and AZA were not switched, and that these standards are of the 
quality as expected for certified reference standards. 
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Figure 4. Profiles per toxin obtained from the multiplex magnetic bead-based assay. Caco-
2 cells were exposed to OA, DTX-1, DTX-2, AZA-1, AZA-2, AZA-3, YTX, hYTX, PTX-
2 and PnTX-E. Bars represent log2 of fold-induction values of each of the 12 marker genes. 
Positive values represent up-regulation, negative values represent down-regulation. Spotted 
lines indicate ‘noise’, which is defined by expression levels between 1.5 and -1.5 (log2 
values). 
 
3.3. Testing blanks and positive shellfish samples with the multiplex magnetic bead-based assay 
 
Figure 5 shows the outcomes of the newly developed multiplex magnetic bead-based assay 
when testing extracts prepared from ten blank mussel samples, the same ‘AZA mussel 
sample’ used previously for the multiplex qRT-PCR, and a mussel sample contaminated 
with YTXs (330 µg YTX-eq kg-1), as well as an OA and PTX-2 standard. The results 
demonstrate that blank samples (indicated in grey) do not lead to a substantial effect on the 
gene expression of the selected markers, i.e. all induction values are between 1.5 and -1.5 
Profiling DSP toxins using qRT-PCR & multiplex magnetic bead-based assays. 
 
108 
 
log2 values, which are considered as ‘noise’. When another set of 20 blanks samples was 
tested, the outcomes were the same, i.e. no marker genes with induction factors above log2 
values (see supplementary materials S6). The positive controls, i.e. OA 100 nM and PTX-2 
9 nM, showed the expected and same profiles as described above in the multiplex qRT-
PCR results (Fig. 3). As expected from testing pure standards (Fig. 4), the AZA and YTX 
contaminated mussel samples resulted in the expected AZA/YTX profile of the selected 
marker genes. 
 
Figure 5. Multiplex magnetic bead-based assay. Caco-2 cells were exposed to 10 blank 
mussel samples (grey bars), OA (red bar) and PTX-2 (blue bar) standards and naturally 
contaminated mussels with AZA (green bar) and with YTX (orange bar). Spotted lines 
indicate ‘noise’, which is defined by expression levels between -1.5 and 1.5 (log2 values). 
 
In addition, five shellfish samples with different concentrations and/or mix of lipophilic 
marine biotoxins that were used in previous validation studies [23], were tested. The toxin 
levels in these five samples are indicated in table 3. Figure 6 shows the outcomes of the 
newly developed multiplex magnetic bead-based assay when testing these five contaminated 
samples and a blank mussel sample. Again, the blank mussel sample did not lead to a 
substantial effect on the gene expression of the selected markers, while the five 
contaminated samples did. The interpretation of the profiles obtained with these 
contaminated samples becomes a bit complicated, as the samples contain mixtures of the 
toxins. However, it is possible to differentiate an AZA/YTX profile and an OA/DTX 
profile from the samples. According to the profile, samples V2 and V3 are more likely to 
be contaminated with OA/DTX toxins, while samples V5, V6 and V8 show a more 
AZA/YTX toxin-like profile. The latter is correct, but V2 and V3 do not only contain 
DTXs, but respectively also YTXs and AZAs. It is interesting to mention that sample V5 
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results in a correct AZA/YTX profile but is only contaminated with a low amount of 
AZAs, i.e. 32.4 µg AZA-1 eq kg-1, and assuming 100% recovery, would result into an 
equivalent of 2 nM AZA-1 in the well. As the sample was positive in the neuro-2a bioassay 
too [22] and resulting in a clear profile now, it might be possible that this sample contains 
an unknown AZA or YTX analogue too. 
 
Table 3. LC-MS/MS results from the 5 validation samples depicted in figure 6 [23]. 
Sample OA, DTXs, PTX-2 
(1) 
AZAs 
(2) 
YTXs 
(3) 
Outcome 
    
neuro-2a bioassay Magnetic bead-
based assay 
V1 123 
 
481 Suspect OA/DTX 
V2 275 2422 
 
Suspect OA/DTX 
V3 
 
32.4 
 
Suspect AZA/YTX 
V4 
  
770 Suspect AZA/YTX 
V5 
  
620 Suspect AZA/YTX 
(1) µg OA-eq kg-1 
(2) µg AZA-1 eq kg-1 
(3) µg YTX-eq kg-1 
 
 
Figure 6. Multiplex magnetic bead-based assay. Caco-2 cells were exposed to five 
contaminated and one blank mussel samples. Spotted lines indicate ‘noise’, which is defined 
by expression levels between log2 values 1.5 and -1.5. 
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4. Discussion 
Worldwide, the mouse bioassay has been the main method to detect shellfish poisons in 
samples for human consumption and still complete surveillance programs that rely on the 
use of this animal test in many countries. Chemical analytical methods have been developed 
and proven suitable for the detection of known toxins, but countries with relative high 
occurrences of shellfish toxins in their coastal waters are still afraid to rely solely on such 
analytical chemical methods. One concern is the lack of standards for the known toxins. 
Another serious concern is that new appear that would be missed by such chemical analysis. 
In that regard, cell-based bioassays are an additional promising alternative. Especially the 
neuro-2a bioassay has been shown to be very useful for the broad detection of marine 
biotoxins, i.e. DSPs, NSPs and PSPs [21, 26, 27]. When using the neuro-2a bioassay for the 
broad detection of DSPs, samples screened negative are safe to consume and suspect 
screened samples can be confirmed by analytical chemical methods. It has been 
demonstrated that this is a fruitful approach [22]. However, in case a suspect screened 
sample cannot be confirmed by chemical analysis, indicating the presence of an unknown 
toxin, additional analysis is needed. In order to be successful, a second bioassay that is able 
to confirm the presence of such “DSP-like toxins” and also to identify the kind of DSP 
toxin present, would be very helpful. When this second bioassay also indicates the presence 
of a toxin, a bioassay-directed approach can be followed to identify this unknown active 
[28]. Figure 7 is a schematic view of the proposed strategy. 
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Figure 7. Proposed strategy for the broad screening of shellfish for the presence of LMB, 
i.e. using the neuro-2a bioassay for broad screening/detection (nonspecific cytotoxicity), 
analytical chemical analyses (LC-MS/MS) for the confirmation of known toxins, and the 
multiplex magnetic bead-based assay (specific mRNAs) or qRT-PCR for the confirmation 
of unknown toxins in case suspect neuro-2a outcomes cannot be explained by LC-MS/MS 
analysis. When the presence of an unknown active is confirmed by the second bioassay, a 
bioassay directed fractionation approach can be used to identify the new toxin. 
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In the present study, specific effects of the LMB on the gene expression in Caco-2 cells 
were used to develop a method that is able to distinguish these toxins. Previous gene 
expression studies envisioned three toxin profiles: i) OA/DTXs, ii) AZAs (and YTXs to 
some degree), and iii) PTX-2. Marker genes were selected, and two multiplex assays were 
developed, i.e. a multiplex qRT-PCR (5-plex) method and a multiplex magnetic bead-based 
assay (14-plex). 
The multiplex qRT-PCR method, using five markers only, was able to determine the 
presence of each of all regulated LMB, including their analogues and thus potentially also 
unknowns, in extracts prepared from mussel samples. The obtained profiles enabled the 
discrimination between the presence of OA/DTXs, AZAs and PTX-2, but unfortunately 
the toxin profiles were not specific enough to discriminate between the presence of AZAs 
and YTXs. As OA and DTX belong to the same group, have a similar mode of action, and 
only differ in their potency, it is not possible to distinguish them with these kind of effect 
based bioassays [17, 29]. A multiplex magnetic bead-based assay, i.e. using specific probes 
that hybridise with the selected marker mRNAs and which are attached to the magnetic 
beads, allowed us to multiplex 14 genes in one reaction and resulted in more clear and 
complete toxin profiles, showing similar or higher induction factors as obtained by qRT-
PCR. Unfortunately, the profiles did still not allow a discrimination between AZAs and 
YTXs, or a more sensitive detection of OA. The TNS4, OSR2 and MT1H genes were 
especially added to the multiplex magnetic bead-based assay to distinguish the AZAs from 
the YTXs (table 2), but just like TGFB2 in the multiplex qRT-PCR, the YTXs cause the 
same effect on these three genes as the AZAs do. The selection of those genes was done 
on gene expression analysis performed on a different platform, microarrays. Probably, this 
YTX array did not work as accurate as the ones used for OA, DTX-1, AZA-1 and PTX-2, 
as the standards were checked by LC-MS/MS and were pure and not switched. Anyway, 
both methods are able to confirm the presence of LMB and also to (partly) identify the 
kind of toxin present. 
Besides the LMB tested, also the neurotoxic brevetoxins will be present in the prepared 
extracts (lipophilic), while PSP toxins and ASP toxin (hydrophilic) will not end up in these 
lipophilic sample extracts. Effects on gene expression by brevetoxins and transcriptomics 
data are scarce [30, 31]. However, the brevetoxins were not included in the present study, 
as the neuro-2a bioassay is already able to discriminate between the presence of DSP toxins, 
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AZAs and YTXs, and the neurotoxic brevetoxins, i.e. DSP toxins can be detected without 
the addition of ouabain and veratridine, while the brevetoxins can only be detected by the 
neuro-2a bioassay by adding low concentrations of ouabain and veratridine [32, 33]. In 
addition, it is shown that the nonregulated CIs like PnTX-E and SPX, that can also end up 
in the prepared lipophilic extracts, do not elicit clear effects on gene expression in Caco-2 
cells (Fig. S1). 
In a previous study, it was shown that the use of an additional n-hexane washing-step 
improved the clean-up of the LMB by eliminating false-positives in the neuro-2a bioassay 
due to matrix effects [22]. The present study shows that this clean-up also results in extracts 
that can be used to expose the Caco-2 cells, as blank samples did not affect the gene 
expression patterns, while contaminated samples resulted in the expected profiles. The use 
of the multiplex magnetic bead-based assay allowed us to multiplex 14 genes in one 
reaction. The results show that the method performs well and is less labour intensive than 
the multiplex qRT-PCR method, but the costs are higher. However, both multiplex 
methods work, and laboratories involved in monitoring can make their own choice, as the 
Caco-2 cells are easily available. 
Although more testing and validation are required, an approach where the neuro-2a 
bioassay is used for the broad screening of LMB and LC-MS/MS analysis is used to confirm 
and identify the toxins present in the suspect screened samples, supplemented with a 
multiplex assay based on the expression of marker genes in Caco-2 cells in case suspect 
screened neuro-2a samples cannot be confirmed by LC-MS/MS analysis (Fig. 7), is very 
promising for ultimately replacing the rather cruel assay with mice. 
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5. Supplementary material chapter 4 
 
Figure S1. Hierarchical clustering of responsive genes in Caco-2 cells from Illumina 
microarrays using the programs Cluster (uncentered correlation, average linkage clustering) 
and Treeview [34]. (A) Exposure to PnTX-E. Gene selection is based on an average fold 
change of ≥2 (log2 ratio ≥|1.0|) in at least 3 of 15* microarrays. Red indicates upregulation, 
green indicates downregulation and black not affected. A maximal red or green colour 
indicates 2 times up or down regulation versus the control. *6 Microarrays of the non-
related compound palytoxin (PlTX) were deleted from the figure, as this compound is 
already cytotoxic at low concentrations (pM range) resulting in strong upregulation of 
cognate genes. (B) Exposure to SPX. Gene selection is based on an average fold change of 
≥1.4 (log2 ratio ≥|0.5|) in at least 2 of 9 microarrays. A maximal red or green colour 
indicates 1.4 times up or down regulation. 
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Table S2. Expected vs obtained results qPCR with analogues (expected results are the same 
included in table 1). Red arrows represent genes that are upregulated with log2 values higher 
than 0.7; green arrows are genes downregulated with log2 values lower than -0.7. (*) 
Represent up regulation higher than log2 value 2.0 or down regulation lower than -1.5. (-) 
Represent log2 values between -0.4 and 0.4, which is considered as no effect. 
 
Table S3. Expected vs obtained results multiplex magnetic bead-based assay (expected are 
the same in table 1). Red arrows represent genes that are upregulated with log2 values 
higher than 0.7; green arrows are genes downregulated with log2 values lower than -0.7. 
(*) Represent up regulation higher than log2 value 2.0 or down regulation lower than -1.5. 
(-) Represent log2 values between -0.4 and 0.4, which is considered as no effect. 
 
Expected results Toxin analogue
Gene AZA-1 OA DTX-1 YTX PTX-2
NPPB - -   ↓* -   ↓*
RGS16 - ↑   ↑* - -
DDIT4   ↑* ↑ ↑ ↑ ↓
CXCR4 -   ↑*   ↑* - -
TGFB2 ↓ ↓ ↓ - -
TMEM179B - - - - -
Obtained results Toxin analogue
PCR AZA-1 AZA-2 AZA-3 OA DTX-1 DTX-2 YTX hYTX PTX-2
NPPB - - - - - - - -   ↓*
RGS16 - - -   ↑*   ↑* - - - -
DDIT4   ↑*   ↑*   ↑* - - - -   ↑*  ↓
CXCR4   ↑*   ↑*   ↑*   ↑*   ↑* -   ↑*   ↑*
TGFB2   ↓*   ↓*   ↓*   ↓*   ↓* -   ↓*   ↓*   ↓*
TMEM179B - - - - - - - - -
Expected results Toxin analogue
Gene AZA-1 OA DTX-1 YTX PTX-2
NPPB - -   ↓* -   ↓*
RGS16 - ↑   ↑* - -
DDIT4   ↑* ↑ ↑ ↑ ↓
CXCR4 -   ↑*   ↑* - -
TGFB2 ↓ ↓ ↓ - -
MAFB -   ↑*    ↑* - -
TNS4 ↑ - ↑ - -
C11orf96 -   ↑*   ↑* ND ND
CEACAM1 ↑ ↑ ↑   ↑* -
OSR2 ↓ - ↑ - -
MT1H   ↑* ↑ ↑ - -
MT1G   ↑* - ↑ ↑ -
TMEM179B - - - - -
CUL1 - - - - -
SH3BP2 - - - - -
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Figure S4. Multiplex magnetic bead-based assay. Caco-2 cells were exposed to OA, DTX-
1, DTX-2, AZA-1, AZA-2, AZA-3, YTX, hYTX, PTX-2 and PnTX-E. Bars represent 
log2 of fold-induction values of each of the 12 genes. Positive values represent 
upregulation, negative values represent downregulation. 
Obtained results  Toxin analogue
Gene AZA-1 AZA-2 AZA-3 OA DTX-1 DTX-2 YTX hYTX PTX-2 PnTX-1
NPPB - - - - - - - -   ↓* -
RGS16 - - -   ↑*   ↑* - - - - -
DDIT4 -   ↑* - - - - - - -
CXCR4 - - - -   ↑* - - - - -
TGFB2   ↓* -   ↓* -   ↓* -   ↓*   ↓* - -
MAFB - - - -   ↑* - - - - -
TNS4   ↑*   ↑*   ↑* -   ↑* -   ↑*   ↑* - -
C11orf96 - - - -   ↑* - - -
CEACAM1   ↑*   ↑*   ↑* -   ↑* -   ↑*   ↑* - -
OSR2   ↓*   ↓*   ↓* - - -   ↓*   ↓* - -
MT1H -   ↑* - - - - - - - -
MT1G   ↑*   ↑*   ↑* - - -   ↑*   ↑* - -
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Figure S5. Chromatograms obtained by LC-MS/MS analysis (Gerssen et al., 2010b) of the 
individual YTX, AZA-1 and DTX-1 standards in DMSO. 
 
Figure S6. 20 Additional blank samples tested in the multiplex magnetic bead-based assay. 
Bars represent log2 of fold-induction values of each of the 14 genes. Positive values 
represent upregulation, negative values represent downregulation. 
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Summary 
Marine biotoxins in fish and shellfish can cause several symptoms in consumers, such as 
diarrhoea, amnesia or even death by paralysis. Monitoring programs are in place for testing 
shellfish on a regular basis. In some countries testing is performed using the so-called 
mouse bioassay, an assay that faces ethical concerns not only because of animal distress, 
but also because it lacks specificity and results in high amounts of false positives. In Europe, 
for lipophilic marine biotoxins (LMBs), a chemical analytical method using LC-MS/MS was 
developed as an alternative and is now the reference method. However, safety is often 
questioned when relying solely on such a method and, as a result, the mouse bioassay is still 
used. In this study the use of a cell-based assay for screening, i.e. the neuro-2a assay, in 
combination with the official LC-MS/MS method was investigated as a new alternative 
strategy for the detection and quantification of LMBs, including the diarrheic shellfish 
poisons (DSPs). To this end samples that had been tested previously with the mouse 
bioassay were analysed in the neuro-2a bioassay and the LC-MS/MS method. The neuro-
2a bioassay was able to detect all LMBs at the regulatory levels and all samples that tested 
positive in the mouse bioassay were also suspect in the neuro-2a bioassay. In most cases 
these samples contained toxin levels (yessotoxins) that explain the outcome of the bioassay 
but did not exceed the established maximum permitted levels. 
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1. Introduction 
To ensure food safety, it is most safe to test for the presence of toxins in the food items. 
The mouse bioassay (MBA) has been the main method to detect shellfish poisons in 
samples for human consumption and still complete surveillance programs heavily rely on 
this animal test in many countries around the world [1-3]. Chemical methods have been 
developed as alternatives and proven suitable for the detection of known toxins, but many 
countries are still afraid to rely solely on such analytical chemical methods, especially those 
with relatively high occurrence of shellfish toxins in their coastal waters. Not only due to 
the lack of standards for the known toxins, but also because toxin patterns might change, 
there is a concern about new toxins appearing that would be missed by such chemical 
analysis [4]. The neuro-2a bioassay is a promising alternative for the broad detection of 
marine biotoxins, i.e. lipophilic marine biotoxins (LMBs) including diarrheic shellfish 
poisons (DSPs) and neurotoxic shellfish poisons (NSPs) and hydrophilic marine biotoxins 
including paralytic shellfish poisons (PSPs) [5-8]. When using the neuro-2a bioassay for the 
broad detection of LMBs, samples screened negative are safe to consume and suspect 
screened samples can be confirmed for the EU regulated LMBs by analytical chemical 
methods, e.g. the EURL LC-MS/MS method [9]. It has been demonstrated that the neuro-
2a assay is suitable for the screening of LMBs in mussels, following the successful 
introduction of an n-hexane washing step that was needed to eliminate matrix effects in the 
bioassay without loss of LMBs (recoveries between 80-110%). In this way matrix effects 
leading to false positive screening outcomes were eliminated [5]. In the present study 
samples previously tested in the MBA were analysed with the neuro-2a assay and LC-
MS/MS analysis. In addition to the EU regulated LMBs, the applied method will also 
extract the neurotoxic brevetoxins (PbTXs), whose occurrence has been reported mainly 
in the United States, Mexico and New Zealand [10-14]. These NSPs can also be detected 
by the neuro-2a bioassay, however only in the presence of low concentrations of ouabain 
and veratridine (o/v) [6, 15]. Therefore, all sample extracts in the present study were tested 
in the neuro-2a bioassay with the addition of o/v, after demonstrating that the addition of 
low concentrations of o/v did not affect the detection of the LMBs. The present study is 
the first in which outcomes of samples obtained with the MBA, are compared to those 
obtained with the neuro-2a bioassay and LC-MS/MS analysis. 
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2. Materials and Methods 
2.1. Reagents and standards 
Certified reference materials (CRMs) of OA (13.7 ± 0.6 µg/mL), DTX-1 (15.1 ± 1.1 
µg/mL), AZA-1 (1.24 ± 0.07 µg/mL), YTX (5.6 ± 0.2 µg/mL) were purchased from the 
National Research Council, Institute for Marine Biosciences (NRC CNRC) (Halifax, 
Canada). PbTX-1, -2, -3, -9 were purchased from Latoxan (Valence, France). Stock 
solutions of these toxin standards were prepared in dimethyl sulfoxide (DMSO) after 
evaporation of the original solvent. DMSO, ammonium hydroxide, and n-hexane were 
obtained from Merck (Darmstadt, Germany). Acetonitrile (Ultra LC-MS), methanol (Ultra 
LC-MS) and water (Ultra LC-MS) were purchased from Actu-All (Oss, The Netherlands). 
2.2. Samples 
Mussel samples (mytilus edulis) collected within the routine monitoring programme in the 
Netherlands in 2016 and analysed by the EURL LC-MS/MS method, were stored at -20 °C 
and used for comparison with the neuro-2a bioassay. Samples from different types of 
marine bivalves and previously tested on the presence of LMBs using the mouse bioassay, 
were kindly provided by Dr Leonardo Guzmán from the IFOP Instituto de Fomento 
Pesquero (Fisheries Development Institute), Chile (35 samples in total: 19 positive and 16 
negative samples). In-house blank mussel samples, according to LC-MS/MS analysis, from 
the Netherlands were used as controls and for fortification. 
 
2.3. Sample extraction 
Prior to the extraction of the lipophilic marine biotoxins, shellfish material was 
homogenized with a T25 Ultra Turrax mixer at 24,000 rpm (IKA® Works Inc., Wilmington, 
NC, USA). One gram of shellfish homogenate was vortex-mixed with 3 mL methanol for 
one min and centrifuged for 5 min at 2000 × g. The supernatant was transferred to a 
volumetric flask and the residue was extracted twice more with 3 mL methanol. After the 
third extraction the volume of the collected supernatants was adjusted to 10 mL with 
methanol. 
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2.4. Further sample clean-up by washing with n-hexane followed by SPE 
A 4.8 mL aliquot of the crude methanolic shellfish extract was diluted with 1.2 mL Milli-Q 
water and extracted twice with 6 mL n-hexane in order to remove matrix substances that 
would otherwise lead to false-positive test outcomes [5]. The hexane layer was discarded 
and the aqueous methanolic extract was further diluted with Milli-Q water to a final volume 
of 10 mL, and transferred to an SPE StrataTM-X cartridge (200 mg/6 mL; Phenomenex, 
Utrecht, the Netherlands) previously conditioned with 4 mL methanol/water (30:70 v/v). 
Subsequently, the cartridge was washed with 8 mL methanol/water (20:80 v/v) and the 
toxins were eluted with 4.8 mL methanol. The eluate was evaporated to dryness under a 
stream of nitrogen gas and reconstituted in 20 µL DMSO. 
 
2.5. Fortification of samples 
Blank mussel samples were pooled (10 g) and 1-gram portions were extracted using the 
method described above. Fortification was performed at the level of the crude methanol 
extract, i.e. before the n-hexane clean-up, and at levels corresponding to 3, 1 and 1/3 times 
the maximum permitted level (MPL) in shellfish for OA, DTX-1 and AZA-1 (i.e. at 480, 
160 and 53.3 µg kg-1), except for YTX. Due to the high MPL of YTX (3.75 mg kg-1), the 
high costs of the YTX CRM, and the relative high sensitivity of the neuro-2a bioassay for 
YTX, the extracts of blank mussel samples were fortified with 3, 1 and 0.3 mg kg-1 YTX 
(all well below the established MPL for YTX). 
 
2.6. Neuro 2a bioassay 
Neuroblastoma neuro-2a cells were purchased from the American Type Culture Collection 
(ATCC; CCL-131) and cultured in 75 cm2 culture flasks containing 15 mL RPMI-1640 
medium (R0883, Sigma-Aldrich, Zwijndrecht, the Netherlands) supplemented with 10% 
(v/v) foetal bovine serum (FBS, Fisher Emergo, Landsmeer, the Netherlands), 1% (v/v) 
of a 100 mM sodium pyruvate solution (Sigma-Aldrich, Zwijndrecht, the Netherlands) and 
1% (v/v) of a 200 mM L-glutamine solution (Sigma-Aldrich, Zwijndrecht, the 
Netherlands). The cell-line was routinely maintained in a humidified incubator at 37 °C 
under 5% CO2 and sub-cultured three times per week (dilution 1/5) up to approximately 
90% confluence. For exposure, neuro-2a cells were seeded into 96-well plates with an initial 
density of 25,000 cells per well using RPMI-1640 medium supplemented with 10% FBS. 
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After growing the cells for 24 h, medium was aspirated and exposure to pure marine 
biotoxins or sample extracts was performed in triplicate in 200 µL (end volume) medium 
for 24 h. Ouabain and veratridine were dissolved in medium supplemented with 5% FBS 
and 50 µL of each were added per well, first ouabain then veratridine, to reach final 
concentrations of 0.13 mM and 0.013 mM respectively (decreasing the MTT activity by 
about 20%). Finally, the test compound or sample extract was dissolved in medium 
supplemented with 5% FBS and 100 µL were added to the corresponding well. The final 
DMSO concentration in the medium was kept at 0.25% (v/v). PbTX-3 was used as a 
positive control. At the end of the exposure time, MTT activity was measured as described 
previously [5]. In short, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (Sigma-Aldrich, Zwijndrecht) was prepared in PBS at 5 mg mL-1 and mixed with 
serum free medium. Then, the exposure medium was removed and 60 µL of MTT mixed 
with serum free medium were added to each well (final concentration of MTT in the well 
was 0.8 mg mL-1). After 30 min incubation at 37 °C and 5% CO2, medium was removed, 
and the formed formazan crystals were dissolved in 100 µL DMSO. Plates were placed in 
a plate shaker for 10 min at 600 rpm after which the absorbance was measured at 540 nm 
and corrected for background absorption at 650 nm. 
 
2.7. LC-MS/MS analysis 
Chemical analysis was directly performed on the crude methanol extracts. The EURL 
method applied for the determination of lipophilic marine biotoxins (i.e. DSPs, AZAs and 
YTXs) was previously described by Gerssen et al. [16]. Briefly, chromatographic separation 
was achieved using a Waters Acquity I-Class UPLC system (Waters, Milford, MA, USA). 
The system consisted of a binary solvent manager, sample manager and a column manager. 
A Waters Acquity BEH C18 1.7 µm, 2.1 x 100 mm column was used. The column 
temperature was kept at 60 °C and the temperature of the sample manager was kept at 10 
°C. A 5 µL injection volume was used. Mobile phase A was water and mobile phase B was 
acetonitrile/water (90:10 v/v), both containing 6.7 mM ammonium hydroxide. A flow rate 
of 0.6 mL min-1 was used. The gradient started at 30% B for 0.5 min and was then linearly 
increased to 90% B in 3 min. This composition was kept for 0.5 min and returned to 30% 
B in 0.1 min. An equilibration time of 0.9 min was allowed prior to the next injection. The 
effluent was directly interfaced in the electrospray ionisation (ESI) source of the AB Sciex 
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QTrap 6500 mass spectrometer (Ontario, Canada) which was operated in both negative 
and positive electrospray ionisation by rapid polarity switching. Two transitions were 
measured for each toxin. Regarding the detection of the PbTXs, a separate extraction was 
performed. One gram of shellfish homogenate was mixed head-over-head for 15 min with 
3 mL methanol/water (80:20 v/v). The supernatant was transferred to a volumetric flask 
and the residue was extracted twice more with methanol/water (80:20 v/v) using a 
multipulse vortex for one min. After the third extraction, the volume of the supernatants 
was adjusted to 10 mL with the same solvent and mixed. The extract was filtered through 
a 0.2 µm membrane filter and an aliquot was transferred to a 1.5 mL vial for LC-MS/MS 
analysis. Chromatographic separation was achieved using the same system and column as 
used for the DSPs, AZAs and YTXs. The column temperature was kept at 40 °C and the 
temperature of the sample manager was kept at 10 °C. A 10 µL injection volume was used. 
Mobile phase A was water and mobile phase B was acetonitrile/water (90:10 v/v), both 
containing 47 mM formic acid and 3 mM ammonium formate. A flow rate of 0.4 mL min-
1 was used. The gradient started at 40% B for 0.1 min and was then linearly increased to 
100% B in 6 min. This composition was kept for 2 min and returned to 40% B in 0.1 min. 
An equilibration time of 0.9 min was allowed prior to the next injection. The effluent was 
directly interfaced in the ESI source of a Waters Xevo TQ-S mass spectrometer which was 
operated in positive ESI. For quantification, so-called “matrix matched” calibration curves 
were constructed by fortifying blank shellfish material with different known concentrations 
of toxin. The area of the toxin in the unknown sample is then calculated using the linear 
equation of the calibration curve. The concentration is expressed in µg kg-1 shellfish. 
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3. Results 
3.1. Neuro-2a bioassay with mussel samples 
The lipophilic sample extracts can in principle contain the DSPs, AZAs, YTXs and PbTXs. 
In order to detect the PbTXs in the assay, the neuro-2a bioassay is used with the addition 
of ouabain and veratridine (o/v) at concentrations that cause about 20% reduction in MTT 
activity, i.e. 0.13 mM and 0.013 mM respectively. Fortification of blank mussel sample 
extracts was performed at levels equivalent to 3, 1 and 1/3 times the MPL for OA, DTX-
1 and AZA-1 (i.e. at 480, 160 and 53.3 µg kg-1), except for YTX as the MPL is 3.75 mg kg-
1, and costs for YTXs are rather high and because the neuro-2a bioassay is relatively 
sensitive for these toxins. The blank mussel sample extracts were therefore fortified with 3, 
1 and 0.3 mg kg-1 YTX, which should theoretically still lead to a maximal inhibition (about 
50% reduction of MTT activity) for all levels and at both dilutions, thus even for the sample 
spiked at 0.3 mg kg-1 YTX and 5 times diluted (Bodero et al., 2018). Figures 1 and 2 show 
the results of the neuro-2a assay where the standards and undiluted and 5 times diluted 
fortified mussel sample extracts were tested in the absence (fig.1) and presence of o/v (fig. 
2). A DMSO solvent control was set at 100% and a previously arbitrary decision limit was 
set at 75% [5]. Samples that result in MTT activity percentages above 75% are classified as 
negative and those that result in percentages below 75% are classified as suspect (positive 
in the bioassay). The data show that the screening results of OA and DTX-1, both standards 
and fortified samples, are hardly influenced by the addition of o/v. Standards of AZA-1 
and YTX are not affected and undiluted samples fortified with AZA-1 and YTX even give 
slightly better screening outcomes when adding o/v. This is mainly due to the fact that 
without o/v, the undiluted fortified AZA-1 and YTX sample extracts show almost no 
effect, i.e. responses for undiluted AZA-1 sample extracts around 75% (fig. 1C) and close 
to 100% for the undiluted YTX sample extracts (fig. 1D), meaning that both AZA-1 and 
YTX are not detected when testing the undiluted sample extracts without o/v, while the 
corresponding 5 times diluted fortified sample extracts result in a clear detection of both 
AZA-1 and YTX, a phenomenon observed before (for YTX) and for which we have no 
explanation [5]. However, the highest spiked amount of YTX (3 mg kg-1) is still well below 
the MPL (3.75 mg kg-1) and in real practice samples contaminated with YTXs are easily 
picked-up with the neuro-2a bioassay (Bodero et al., 2018). Altogether, the addition of o/v 
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allows the use of undiluted sample extracts, enabling the detection of OA, DTX, AZA and 
YTX at the level of their MPLs (fig. 2) and will also allow the detection of PbTXs. 
 
Figure 1. Effect on the MTT activity of neuro-2a cells of standards (control) and undiluted 
and 5 times diluted fortified mussel sample extracts. A) OA; B) DTX-1; C) AZA-1 and D) 
YTX. A DMSO solvent control was set at 100% and a previously arbitrary decision limit 
was set at 75% (Bodero et al., 2018). Data are expressed as mean ± SD (n=3). 
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Figure 2. Effect on the MTT activity of neuro-2a cells with the addition of ouabain and 
veratridine to obtain 20% decrease in MTT activity, of standards and undiluted and 5 times 
diluted fortified mussel sample extracts. A) OA; B) DTX-1; C) AZA-1 and D) YTX. A 
DMSO solvent control was set at 100% and a previously arbitrary decision limit was set at 
75% (Bodero et al., 2018). Data are expressed as mean ± SD (n=3). 
Mussel samples collected in the Netherlands in 2016 for a routine monitoring programme 
that were analysed by LC-MS/MS for DSPs, AZAs and YTXs were stored at -20 °C. A 
total of 110 samples were taken (10 samples of each of the months from January to 
November), extracted and tested in the neuro-2a bioassay with the addition of o/v. Figure 
3 shows the results of the 20 samples from June and July as tested in the neuro-2a assay 
with o/v. A chemical blank in DMSO solvent was used as a negative control and set at 
100% and a 30 nM PbTX-3 standard was used as a positive control. The data show that 
none of the samples resulted in a response below 75% viability. All 20 samples were thus 
classified as negative. The positive control, i.e. 30 nM PbTX-3, clearly decreased the MTT 
activity of the neuro-2a cells, indicating that the o/v treatment worked adequately. 
Outcomes of chemical blanks are always identical to that of DMSO controls (data not 
shown). The data for the other 90 mussel samples are shown in figure S1 in supplementary 
materials. Only 2 of the 110 mussel samples resulted in an MTT activity below 75%, while 
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none of the 110 samples tested contained substantial amounts of DSPs, AZAs and YTXs 
according to the LC-MS/MS analysis (all far below the MPLs, data not shown). The 
screening with the neuro-2a assay thus resulted in 1.8% of false positives, although it cannot 
fully be ruled out that these two samples contained a low amount of PbTXs or unknown 
DSPs, AZAs or YTXs. As no positives were found by LC-MS/MS analysis, this set of 
Dutch mussel samples is not suited to test for the rate of false negative screening outcomes 
with the neuro-2a bioassay. 
 
Figure 3. Effect of 20 mussel samples from the Netherlands on the MTT activity of neuro-
2a cells in the presence of ouabain and veratridine to obtain 20% decrease in MTT activity. 
The chemical blanc (Chem) in DMSO was set at 100%. PbTX-3 at 30 nM was used as a 
positive control. Data are expressed as mean ± SD. 
3.2. Neuro-2a bioassay with naturally contaminated samples tested previously in the MBA 
In order to establish a false negative rate and compare the performance of the in vitro neuro-
2a bioassay with the in vivo mouse bioassay, 35 samples provided by an institute in Chile 
(Instituto de Fomento Pesquero) that had tested these samples in the MBA, were extracted 
and tested in the neuro-2a bioassay with and without o/v and analysed by LC-MS/MS. 
Figure 4 shows the screening outcomes of these 35 samples as obtained in the neuro-2a 
bioassay with the addition of o/v, together with a PbTX-3 control to check the correct 
response of the neuro-2a bioassay (positive control) and a DMSO solvent control (negative 
control). Figure S2 in supplementary material shows the data of these samples as obtained 
in the neuro-2a bioassay without the addition of o/v, i.e. the “old” method that does not 
allow the detection of PbTXs. Table 1 summarises the MBA, neuro-2a, and LC-MS/MS 
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results. The details on species and origin of the samples are given in table S3 in 
supplementary materials). 
 
Figure 4. Effect on the MTT activity of neuro-2a cells with the addition of o/v of 35 
samples tested before in Chile in the mouse bioassay. The spotted line represents the 
arbitrarily set decision limit (75% MTT activity). A DMSO solvent with o/v was used as a 
negative control and set at 100%. Data are expressed as mean ± SD. 
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Table 1. Summary of 35 samples obtained from Chile. Lipophilic extracts were prepared 
and tested in the MBA in Chile and both in the neuro-2a bioassay and by LC-MS/MS 
analysis at RIKILT. 
Sample Specie MBA Neuro 2a 
with o/v 
Neuro2a 
without o/v 
LC-MS/MS (µg kg-1) 
 
    OA eq AZA-1 eq YTX eq 
M1 Mussel positive + + 
  
898 
M2 Mussel positive + + 
  
869 
M3 Mussel ND + + 
  
704 
M4 Mussel positive + + 
  
1060 
M5 Mussel positive + + 
  
569 
M6 Clam positive + + 
  
 
M7 Clam ND + + 
  
 
M8 Clam positive + + 
  
 
M9 Mussel positive + + 
  
1459 
M10 Mussel  positive + +  
 
2531 
M11 Clam ND + + 
 
  
M12 Mussel positive + + 
  
1648 
M13 Mussel positive + +  
 
1271 
M14 Mussel positive + + 22 
 
1546 
M15 Mussel positive + +  
 
1254 
M16 Clam ND + - 
   
M17 Clam  positive + + 
 
  
M18 Clam ND - - 
 
  
M19 Mussel positive + + 33 
 
1953 
M20 Mussel positive + + 21 
 
1432 
M21 Mussel positive + + 20 
 
1518 
M22 Mussel positive + + 
  
1141 
M23 Clam ND - + 
   
M24 Mussel positive + + 
  
1067 
M25 Mussel positive + + 
  
1648 
M26 Mussel ND - + 
  
272 
M27 Mussel ND - - 
   
M28 Clam ND - - 
   
M29 Mussel ND - - 
  
 
M30 Clam ND - - 
 
15  
M31 Mussel ND - - 
  
 
M32 Clam ND - - 
 
9  
M33 Mussel ND - - 
  
 
M34 Mussel ND - - 
  
 
M35 Mussel ND - - 
   
ND = not detected (thus negative in the MBA). Empty spots in the LC-MS/MS columns = values lower 
than the limit of quantification (LOQ): OA eq < 10 µg kg-1, AZA-1 eq <5 µg kg-1, YTX eq <50 µg kg-1. 
Brevetoxins were not detected, LOQs in shellfish are PbTX-1 150µg kg-1, PbTx-2 89µg kg-1, PbTx-3 46µg 
kg-1 and PbTx-9 32µg kg-1. 
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In general, the screening results as obtained in the neuro-2a bioassay correlate well with 
those obtained in the MBA. All the samples that are positive in the in vivo MBA (19 of the 
35 samples tested) are also positive in the in vitro neuro-2a bioassay with o/v. The rate of 
false negatives in the neuro-2a bioassay with o/v is thus 0% when compared to the MBA. 
Of the 16 samples that were negative in the MBA, 12 were also negative in the neuro-2a 
bioassay with o/v and 4 were positive, i.e. elicited inhibition of the MTT activity below the 
arbitrarily set decision limit of 75%. Of these 4 samples, M3, M7, M11 and M16, only 
sample M3 turned out to contain a significant amount of a toxin (YTX eq), i.e. enough to 
cause an effect in the neuro-2a bioassay. M16 resulted in a response just below 75% and 
was negative when tested without the addition of o/v. M7 and M11 might contain an 
unknown toxin not detected by the MBA or the LC-MS/MS, but most likely these two 
samples are true false positive screening outcomes in the neuro-2a, which results in a false 
positive rate of 12.5%. As the neuro-2a bioassay is intended to be used as a screening 
method, false negatives should not occur, and the number of false positives should not be 
too high, the current outcome with these Chilean samples, i.e. no false negatives (0%) and 
12.5% of false positives, is a reasonably good result. 
From a point of view of the effect side, LC-MS/MS analysis results in many false negatives, 
as none of the positive screened samples in either the MBA or neuro-2a bioassay contained 
lipophilic toxins in amounts exceeding the established MPLs. From a chemical point of 
view, both the MBA and neuro-2a bioassay result in many false positives, especially M6, 
M8 and M17, as these three samples contained no toxins according to the LC-MS/MS 
analysis and were positive in both the MBA and neuro-2a assay. It is worthwhile to mention 
that all the samples that are positive in any of the bioassays and contain levels <LOQ in 
the LC-MS/MS, are clams (Venus antiqua) (see table S3 in supplementary materials). And 
although there are negative clams too, it is possible that this matrix leads to false positives 
in both the MBA and neuro-2a bioassay or causes suppression in the LC-MS/MS (not 
validated for this matrix). The latter is not likely as the LOQs of the LMBs are very low (a 
few % or lower of the MPLs). 
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4. Discussion 
The mouse bioassay (MBA) for the detection of marine biotoxins is in use for 40 years but 
has never been properly validated for LMBs [17, 18]. The need to develop alternative 
methods to replace the MBA has been reviewed extensively [19-21], but no real replacement 
has occurred yet. Chemical methods, particularly LC-MS/MS analysis, seem suited and for 
DSPs, AZAs and YTXs it is the reference method in the EU [22]. However, due to the 
poor availability of standards, the lack of standards for all analogues, the high costs, and the 
concern about new toxins appearing that would be missed by targeted chemical analysis, 
many countries hesitate to fully switch to chemical methods [2, 23]. A combination of cell-
based bioassays and chemical analysis might offer the opportunity to face the drawbacks. 
An approach consisting of a first effect-based screening that allows the detection of known 
and unknowns and a confirmation with chemical methods is then logical. The neuro-2a 
bioassay is regarded as the most promising assay for the broad detection of DSPs, AZAs 
and YTXs [24], since it is able to detect all these toxins and is relatively rapid and easy to 
perform. It is important to consider that the neuro-2a bioassay will be used as a qualitative 
screening method, i.e. that the outcome of a sample is either negative or suspect, based on 
a certain cut-off. Negative samples are safe and suspect samples need confirmation, e.g. by 
the EU LC-MS/MS reference method [5, 22]. It has already been demonstrated that this is 
a fruitful approach, due to the successful introduction of an n-hexane washing step that 
was needed to remove matrix effects observed in the neuro-2a bioassay. It was shown that 
no DSPs, AZAs and YTXs were lost due to the extra n-hexane washing step (recoveries 
between 80-110%), while the matrix effect leading to false positive screening outcomes was 
excluded [5]. It should be noticed that fatty acid analogues of OA and DTX are probably 
lost with this n-hexane washing step. It was also shown in that study that the outcomes of 
the neuro-2a screening and EU LC-MS/MS analysis for DSPs, AZAs and YTXs in seafood 
correlated well. However, the correlation of the neuro-2a bioassay with the MBA has never 
been investigated. The present study is the first where a set of shellfish samples was tested 
with both the MBA and the neuro-2a bioassay, and in addition LC-MS/MS analysis. Prior 
to this, the neuro-2a method was further developed in order to also detect the brevetoxins, 
which can also be present in lipophilic sample extracts [10], achieved by addition of ouabain 
and veratridine (o/v) [24, 25]. In the present study it was shown that the addition of o/v 
Replacing mouse bioassay by combining neuro-2a bioassay and LC-MS/MS analysis 
 
136 
 
did not interfere with the detection of DSPs, AZAs and YTXs. It even slightly improved 
the detection of AZAs, but the mechanism is unclear. 
To study the effect of real samples, lipophilic sample extracts of Dutch mussel samples 
were tested in the neuro-2a bioassay with o/v, showing that 108 out of 110 samples 
responded as predicted by EU LC-MS/MS analysis for DSPs, AZAs and YTXs, i.e. 108 
negatives and only two false positives (1.8%). It cannot be fully ruled out that these two 
samples contained low levels of other toxins, like PbTXs, as these toxins are not included 
in the EU LC-MS/MS analysis. As samples with LMBs are rather scarce in the Netherlands 
and the MBA is no longer in use, further testing was performed with samples obtained 
from Chile that were already tested in the MBA (positives and negatives). Moreover, these 
Chilean samples were not only tested by LC-MS/MS for DSPs, AZAs and YTXs (EU 
reference method), but also by an additional LC-MS/MS analysis for PbTXs. 
The 19 Chilean samples that tested positive in the MBA were also positive in the in vitro 
neuro-2a bioassay with o/v. The rate of false negatives in the neuro-2a bioassay with o/v 
is thus 0% when compared to the MBA. None of the samples that were positive in the 
MBA and neuro-2a screening, contained toxin levels above the established MPLs. Strictly 
seen, i.e. enforcement purposes, using only the MBA would have led to 54% of false 
positives (19 out of 35), while the combination of the neuro-2a bioassay with o/v and LC-
MS/MS analysis did probably not result in false positives. Of the 23 samples that were 
screened as suspect in the neuro-2a bioassay with o/v, 17 contained toxin levels below the 
established MPLs, but although below the MPLs, they contained YTX eq levels that would 
explain the bioassay outcome. The other 6 samples could then be regarded as false positives 
of the neuro-2a screening, not being confirmed by LC-MS/MS analysis. However, the latter 
is not sure, as from these 6 samples, 3 were tested as positive in the mouse MBA too. It 
should be noticed that these 6 samples are clams, and it cannot be excluded that this matrix 
in some cases leads to false positives in the MBA and neuro-2a bioassay. Of the 16 samples 
that were negative in the MBA, 12 were also negative in the neuro-2a bioassay with o/v 
and 4 were positive. One of these 4 (M3) turned out to contain a significant amount of 
YTX eq, i.e. enough to cause an effect in the neuro-2a bioassay with o/v and another one 
(M16) resulted in a response just below 75% when tested with o/v and was negative when 
tested without o/v. The remaining 2 may thus be considered as true false positives, which 
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results in a false positive rate of 12.5%. It was ruled out that these two samples (clams), or 
even one of the other 33 samples, contained PbTXs, as the screening outcome of the 22 
samples screened suspect in the neuro-2a bioassay with o/v was also suspect when tested 
in the neuro-2a bioassay without o/v (except for M16). This was confirmed by additional 
LC-MS/MS analysis, revealing no detectable levels of PbTX-2, PbTX-3 and PbTX-9 or any 
of its shellfish metabolites in any of these 35 samples. 
The correlation between the MBA and neuro-2a bioassay on the one hand and the LC-
MS/MS on the other hand is close to perfect when looking at mussels only. Of the 24 
Chilean mussel samples tested, all 17 that were positive in the MBA or neuro-2a bioassay 
with o/v, contained high levels of YTX eq (all > 569 µg kg-1) according to LC-MS/MS 
analysis, while the 7 mussels that were negative contained no detectable levels of toxins 
according to LC-MS/MS analysis (except for M26, that contained a low level of YTX eq, 
i.e. 272 µg kg-1). However, in real practice and even when looking at mussels only, using the 
MBA only, would have led to 67% of false positives, while the combination of the neuro-
2a bioassay and LC-MS/MS analysis would not have led to an unnecessary closure of areas 
or withdrawal of mussels from the market. 
The outcomes are very promising, but there is still remaining work to do, like proper 
validation of different matrices following international guidelines [26] with each toxin 
spiked at its MPL to 20 blank samples and further optimization of the extraction procedure, 
as the present data indicate that clams (Venus antiqua) lead more easily to false positives in 
the MBA and neuro-2a bioassay than mussels (Mytilus edulis, Mytilus chilensis, Aulacomya ater). 
In addition, parallel studies with collaboration between countries that use the MBA are 
needed, e.g. by testing certified reference samples. 
To reduce the number of false positives in the MBA and also reduce the number of false 
suspects in the neuro-2a bioassay, two separate extracts should be prepared, i.e. one extract 
containing the OAs, DTXs, AZAs, PTX and PbTXs and a second extract containing the 
YTXs. The first extract should be tested undiluted, while the second extract, containing the 
YTXs, should be diluted before testing it in the MBA or neuro-2a bioassay, as both assays 
are relatively sensitive to YTX, while the MPL of YTXs is much higher compared to the 
other toxins. In case a suspect screened sample cannot be confirmed by chemical analysis, 
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indicating the presence of an unknown toxin, additional analyses are needed. Previously, it 
was shown that a second bioassay, i.e. gene expression in Caco-2 cells using a magnetic 
bead-based multiplex assay, is able to confirm the presence of such “DSP-like” toxins and 
based on the obtained expression profile, is also able to indicate the kind of LMB present. 
Three profiles could be envisioned, i.e. an OA/DTX profile, an AZA/YTX profile and a 
PTX profile (Bodero et al., in press), while samples contaminated with PbTXs can 
envisioned by testing them in the neuro2a-bioassay with and without o/v. 
Overall, one can say that the neuro-2a bioassay with o/v can be used to test for the presence 
of lipophilic marine biotoxins and shows a good correlation with the MBA and LC-MS/MS 
analysis. All samples that tested positive in the MBA were also positive in the in vitro neuro-
2a bioassay with o/v and most could be explained by the amounts of toxins as measured 
by LC-MS/MS. When only looking at the Chilean mussel samples, 23 out of the 24 samples 
resulted in the same screening outcome when tested with the MBA or neuro-2a bioassay. 
Only sample M3 was negative in the MBA and positive in the neuro-2a bioassay, probably 
because M3 contains a significant amount of a YTX eq, i.e. enough to cause an effect in 
the neuro-2a bioassay, although it is noted that samples with similar YTX levels did test 
positive in the MBA. However, combining the neuro-2a bioassay with o/v and LC-MS/MS 
analysis provides an alternative testing strategy to replace the mouse bioassay for detecting 
and identifying lipophilic marine biotoxins in mussels. 
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Figure S1. Effect on the viability of neuro-2a cells with the addition of ouabain and 
veratridine to obtain 20% decrease in MTT reduction, of 90 mussel samples from the 
Netherlands. A) mussel samples from January, February and April; B) mussel samples 
from March and May; C) mussel samples from August and September and D) mussel 
samples from October and November. A chemical blanc (Chem) in DMSO was set at 
100% and a previously arbitrary decision limit was set at 75% (Bodero et al., 2018). Data 
are expressed as mean ± SD. 
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Figure S2. Effect on the viability of neuro-2a cells without the addition of o/v of 35 samples 
tested previously in Chile in the mouse bioassay (19 positive and 16 negative samples). The 
spotted line represents the arbitrary set decision limit (75% cell viability). A DMSO solvent 
with o/v was used as a negative control and set at 100%. Data are expressed as mean ± 
SD. 
Table S3. Details from the samples from Chile (origin, type of shellfish). Data provided by 
IFOP, Chile. 
 
 
N° sample sector Coordinates Shellfish scientific name sampling month Date
1 Isla Ovalada -44°03’44’’ -73°43’48’’ Chilean mussel Aulacomya ater February 2015 7-2-15
2 Isla Ovalada -44°03’44’’ -73°43’48’’ mussel Mytilus chilensis February 2015 7-2-15
3 Repollal - Canal Puquitin -43°50’36’’ -73°48’51’’ Chilean mussel Aulacomya ater February 2015 13-2-15
4 Isla García -44°15’11’’ -73°44’40’’ Chilean mussel Aulacomya ater February 2015 7-2-15
5 Isla Julia - Grupo Peligroso -43°54’05’’ -73°42’05’’ Chilean mussel Aulacomya ater February 2015 7-2-15
6 Isla Filomena -44°29’41’’ -73°34’36’’ Clam Venus antiqua February 2015 12-2-15
7 Isla Francisco -44°29’58’’ -73°41’08’’ Clam Venus antiqua February 2015 12-2-15
8 Isla Valverde -44°17’41’’ -73°53’25’’ Clam Venus antiqua February 2015 13-2-15
9 Isla Teresa -44°50’46’’ -73°51’04’’ Chilean mussel Aulacomya ater February 2015 10-2-15
10 Isla Toto -44°15’07’’ -73°12’33’’ Chilean mussel Aulacomya ater February 2015 16-2-15
11 Puerto Barrientos -43°56’23’’ -73°58’24’’ Clam Venus antiqua February 2015 13-2-15
12 Seno Gala -44°13’02’’ -73°10’26’’ Chilean mussel Aulacomya ater February 2015 15-2-15
13 Faro Marta - Canal Puyuhuapi -44°49’30’’ -72°58’10’’ Chilean mussel Aulacomya ater February 2015 18-2-15
14 Punta Calqueman -44°39’41’’ -73°26’44’’ Chilean mussel Aulacomya ater March 2015 23-3-15
15 Isla Toto -44°15’07’’ -73°12’33’’ Chilean mussel Aulacomya ater March 2015 29-3-15
16 Isla Virginia - Bahía Low -43°47’10’’ -73°52’39’’ Clam Venus antiqua March 2015 26-3-15
17 Isla Valverde -44°17’41’’ -73°53’25’’ Clam Venus antiqua March 2015 25-3-15
18 Isla Ipun -44°38’09’’ -74°42’47’’ Clam Venus antiqua March 2015 22-3-15
19 Isla San Andres -44°55’57’’ -73°19’28’’ Chilean mussel Aulacomya ater March 2015 31-3-15
20 Canal Ninualac -44°59’48’’ -73°55’31’’ Chilean mussel Aulacomya ater March 2015 20-3-15
21 Puerto Amparo -44°55’00’’ -73°16’54’’ Chilean mussel Aulacomya ater March 2015 31-3-15
22 Isla Concoto -44°12’11’’ -73°50’03’’ Chilean mussel Aulacomya ater March 2015 25-3-15
23 Isla Stokes -44°41’24’’ -74°35’40’’ Clam Venus antiqua March 2015 21-3-15
24 Puerto Lampazo -44°56’16’’ -73°44’39’’ Chilean mussel Aulacomya ater March 2015 20-3-15
25 Isla Silachilú -44°58’48’’ -73°40’24’’ Chilean mussel Aulacomya ater March 2015 20-3-15
26 Santo Domingo -43°58’12’’ -73°06’51’’ Mussel Mytilus chilensis March 2015 27-3-15
27 Añihue -43°52’14’’ -73°02’21’’ Chilean mussel Aulacomya ater March 2015 27-3-15
28 Añihue -43°52’14’’ -73°02’21’’ Clam Venus antiqua March 2015 27-3-15
29 Isla Scout -47°53’29’’ -74°40’20’’ Chilean mussel Aulacomya ater April 2015 17-4-15
30 Isla Scout -47°53’29’’ -74°40’20’’ Clam Venus antiqua April 2015 17-4-15
31 Isla Orlebar -47°54’16’’ -74°36’06’’ Chilean mussel Aulacomya ater April 2015 17-4-15
32 Isla Orlebar -47°54’16’’ -74°36’06’’ Clam Venus antiqua April 2015 17-4-15
33 Isla Zealous -47°52’41’’ -74°36’40’’ Chilean mussel Aulacomya ater April 2015 17-4-15
34 Punta Baker -47°53’11’’ -74°28’04’’ Chilean mussel Aulacomya ater April 2015 16-4-15
35 Isla Zealous -47°52’41’’ -74°36’40’’ Mussel Mytilus chilensis April 2015 17-4-15
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6.1 Main findings 
The aim of this thesis was to develop new in vitro bioassays for the detection of marine 
biotoxins that can be used for high throughput quality control of seafood and replacement 
of the current unethical in vivo bioassays. Through this work and the promising outcomes 
an integrated testing strategy, in which bioassays and analytical chemical methods were 
combined as an in vitro alternative for the mouse bioassay (MBA) for lipophilic marine 
biotoxin (LMB) testing, was developed and evaluated. 
The main difficulties for switching from the MBA to chemical methods and/or in vitro 
bioassays is the detection of unknown toxins and so-called ‘matrix effects’ respectively [1-
4]. In this work we started with the neuro-2a bioassay, an assay shown to be sensitive for 
all the regulated lipophilic marine biotoxins and able to detect their yet unknown toxin 
analogues as well and introduced an improvement in the clean-up procedure for preparing 
extracts from shellfish samples to be tested in the neuro-2a assay. False positives due to 
matrix effects were eliminated by a double clean-up wash step with n-hexane during the 
sample extraction (chapter 2, fig 2a and 2b). Although the clean-up using n-hexane was 
used before in chemical methods [5, 6], it was never introduced before for testing shellfish 
using the neuro-2a bioassay. Chapter 2 shows that this improved clean-up procedure works 
well and resulted in neuro-2a outcomes that are in line with the outcomes as obtained with 
the EURL LC-MS/MS method analysis, supporting the applicability of this bioassay for 
the screening of samples for the presence of lipophilic marine toxins. While the neuro-2a 
bioassay is suited for screening, additional assays with specific endpoints are needed for 
confirmation of suspect screened samples in case LC-MS/MS analysis fails to do so. 
Therefore, chapter 3 presents a study with DNA microarrays to investigate the effects of 
OA, DTX-1 and AZA-1 on the whole-genome mRNA expression of undifferentiated 
intestinal Caco-2 cells. These gene expression data were analysed for two goals: 1) in order 
to reveal the modes of action of these LMBs and 2) to select potential marker genes for 
sensitive detection in additional bioassays to be developed (chapter 4). The gene expression 
data showed that OA and DTX-1 induce identical expression profiles but DTX-1 did so at 
about 4 times lower concentrations than OA, indicating that OA and DTX-1 have a similar 
mode of action and that DTX-1 is, in vitro, about 4 times more potent than OA. This is in 
agreement with what is known and OA and DTX-1 are therefore in the same toxin class 
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and together regulated at a level of 160 µg OA equivalents per kg shellfish. However, their 
currently established TEFs are the same, and thus deviate from the difference in potency 
detected in the in vitro gene expression. The gene expression profile of AZA-1 was different, 
suggesting a different mode of action for this toxin, which is in line with the expectations 
as the AZA toxins are a specific toxin class regulated at a level of 160 µg AZA-1 equivalents 
per kg shellfish and in line with previous findings where e.g. cholesterol biosynthesis genes 
were highly upregulated in other cell lines as well [7]. In chapter 4 a few of the most highly 
up- and down-regulated genes were selected to design and develop additional detection 
methods, i.e. a multiplex qRT-PCR and a multiplex magnetic bead-based assay. Genes 
selected from an additional gene expression study on YTX and PTX-2 were included. In 
total, twelve marker genes were selected to envision three profiles, i.e. an OA/DTX, 
AZA/YTX and PTX profile. The multiplex magnetic bead-based assay allowed the use of 
all twelve selected marker genes and turned out to be a slightly better alternative but is a 
more expensive format compared to the multiplex qRT-PCR. In this chapter it is shown 
that blank and contaminated shellfish sample extracts analysed by the multiplex magnetic 
bead-based assay resulted in profiles not only allowing to distinguish blank samples from 
contaminated samples, but also indicating the toxin type present in the contaminated 
samples. Chapter 5 presented the use of the neuro-2a bioassay as a screening method for 
detection of lipophilic toxins, which in combination with LC-MS/MS confirmation is 
offered as a new alternative strategy for the detection and quantification of lipophilic 
shellfish toxins. A selected set of samples tested in the MBA in Chile, where this animal 
test is still in use, was analysed using the new proposed strategy. All samples that were 
positive in the MBA were also classified as ‘suspect’ in the neuro-2a screening. In most 
cases these samples contained yessotoxin levels, as determined by LC-MS/MS analysis, that 
can explain the outcome of both the MBA and the neuro-2a bioassay, but did not exceed 
the established maximum permitted level, i.e. 3,75 mg YTX-1 equivalents per kg shellfish, 
clearly indicating that the use of the MBA alone resulted in unnecessary closures of 
extraction areas or withdrawal of seafood from the market, and that the combination of the 
neuro-2a bioassay and LC-MS/MS analysis are a promising alternative for the MBA. A 
proper validation of this combination would result in an animal free alternative for decision 
making in food safety, without a risk for not detecting yet unknown analogues of the LMBs 
and with less false positives as obtained with the MBA alone. However, the road is long 
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and besides validation, additional developments and further improvements are still needed, 
e.g. inclusion of a de-conjugation step in order to detect OA-esters. These issues are 
addressed below. 
6.2 Limitations of the method and improvements needed 
The current extraction, clean-up and neuro-2a screening procedure is most likely not 
sensitive enough to detect OA and DTX-2 at their regulated level, i.e. 160 µg OA 
equivalents per kg shellfish. In principle, if a sample is contaminated with this maximum 
permitted level (MPL), it will result in a concentration of around 12 nM in the well, which 
is theoretically just enough to cause an effect on the cells, based on results as presented in 
chapter 2, where the dose-response curves using certified standards of OA and DTX-2 
were assessed and resulted in EC50 values of 23 and 29 nM for OA and DTX-2 respectively. 
Thus, when starting a full validation experiment with 20 samples spiked at the MPL of these 
toxins, most likely a few false negatives will be obtained. One simple improvement would 
be to concentrate the sample extract, e.g. by a factor 2. However, preliminary results in our 
lab showed that this is not that easy, as 2 times concentrated blank sample extracts showed 
matrix effects and resulted in false positives. In chapter 2, fig 4b the effect in the neuro-2a 
of eight naturally contaminated samples with detectable levels of one or more LMBs was 
shown. Among this set of 8 samples, one sample was contaminated with OA only and at a 
level of 151 µg kg-1. This sample was classified as ‘suspect’ in the neuro-2a assay, resulting 
in an MTT activity of 55%, where the arbitrary decision limit for declaring a sample as 
suspect is set at 75% MTT activity. In addition, when a blank sample was fortified at the 
MPL with OA, extracted (without further concentrating) and tested in the presence of 
ouabain and veratridine (O/V) (chapter 5, fig 2), the sample was also correctly classified as 
suspect, i.e. 55% MTT activity. Although two samples are not representative enough to 
draw definitive conclusions, it indicates that the current protocol might already work 
adequate enough. Still it is important to search for improvements, before starting a labour 
intensive and costly validation process. Recently, additional washing steps with n-hexane 
were shown to allow a further concentration of the sample extracts without leading to 
matrix effects. 
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On the other hand, due to the relative high sensitivity of the neuro-2a bioassay for the 
YTXs with regard to the MPL of this toxin group, i.e. 3750 µg YTX-1 equivalents kg-1, the 
presence of relative low levels of YTXs will already result in a suspect screening outcome 
(EC50 of 1.6 nM for YTX-1 (chapter 2)). In the Netherlands this will not be problematic, 
and sensitive detection of YTXs would rather be regarded as an early warning for a possible 
new risk or changing conditions (e.g. global warming [8]), as these toxins are normally not 
detected in Dutch shellfish. But in countries with a high occurrence of YTXs in their coastal 
waters and shellfish, the neuro-2a screening would result in many suspects. For these 
countries an extraction protocol should be developed in order to obtain two fractions from 
each sample, one containing the YTXs and one containing the other LMBs. Although 
chemically possible [3, 9], this is not as easily done, as preliminary experiments in our 
laboratory indicate that it requires another SPE column and the addition of acid, the latter 
leading to cytotoxic effects in the neuro-2a bioassay, also when neutralising the pH, as the 
sample extracts become too salty. However, compared with the MBA alone, the proposed 
strategy allows the detection of YTXs at levels lower than their MPL (3.75 mg kg-1) with 
the neuro-2a bioassay and the measurement of the actual toxin levels in the second step by 
LC-MS/MS confirmation. Therefore, closure of areas or withdrawal of seafood from the 
market will only happen when LC-MS/MS analysis confirms the presence of YTXs levels 
above the MPL and does so without the need to use animals. 
DTX-3 toxins are shellfish produced metabolites of OA, DTX-1 and DTX-2, i.e. esterified 
with various fatty acids [10]. DTX-3 has been reported in some areas, being even the most 
frequent form of OA and DTXs found in shellfish [5, 11]. In the official EURL LC-MS/MS 
method [12] these toxins are detected after an alkaline hydrolysis step of the fatty acids, 
performed in the crude methanol extract [13]. The lack of available naturally contaminated 
samples and DTX-3 standards have been the major drawbacks to assess this matter in the 
present thesis. However, pilot experiments in our lab indicated that the hydrolysis step 
would not affect the neuro-2a cells, as the pH could be neutralised afterwards with low 
amounts of HCl. Still this is an important step and should be included in the procedure that 
eventually will be validated. 
In chapter 5, a selected set of 35 samples tested previously in the MBA in Chile, where this 
animal test is still in use, was assessed with the neuro-2a bioassay and the EURL LC-
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MS/MS method. All samples that were positive in the MBA were also suspect in the neuro-
2a assay. Almost all suspect screened samples turned out to contain toxin amounts that 
explain the screening outcome and all the levels were well below the established MPLs. For 
enforcement purposes, the MBA alone would have resulted in 54% of false positives, while 
the combination of the neuro-2a bioassay with LC-MS/MS analysis did not result in such 
false positives. Most of the samples that were negative in the MBA, were also negative in 
the neuro-2a screening and none contained toxins levels above the established MPLs. 
Together showing that the combination of the neuro-2a bioassay for screening and LC-
MS/MS analysis for confirmation, is a good strategy to replace the MBA and protect 
consumers. 
It should be noticed however that from an analytical point of view, 5 samples could be 
regarded as falsely screened suspect in the neuro-2a bioassay, i.e. no toxins were detected 
by LC-MS/MS analysis. From these 5 samples, 3 also tested positive in the MBA and 2 
tested negative. In cases like this, the second bioassay proposed in the strategy can be put 
in practice in order to investigate if these samples might contain unknown toxins. A pilot 
experiment was therefore performed in which 4 of these samples were tested in the 
multiplex magnetic bead-based assay. All 4 showing a clear AZA/YTX profile (data not 
shown). This result might indicate that in a worst-case scenario these 4 neuro-2a suspect 
samples are true positives, 2 were missed by the MBA and all 4 missed by LC-MS/MS 
analysis. However, these samples were clams and some clams that were negative in the 
MBA and neuro-2a bioassay also resulted in a AZA/YTX profile. Most likely some clams 
lead to false positives in the MBA, neuro-2a bioassay, and the multiplex magnetic bead-
based assay. When looking at mussels only, the mouse MBA resulted in 67% false positives 
(16 out of 24), while the combination of the neuro-2a bioassay with LC-MS/MS analysis 
did not result in false positives. Of the 18 mussel samples that were screened as suspect in 
the neuro-2a bioassay, all contained toxins levels (YTX eq) that explain the bioassay 
outcome, and of the other 6 that were negative, none contained detectable toxin levels 
when analysed by LC-MS/MS. This strongly indicates that for the mussels, the combination 
of the neuro-2a bioassay with LC-MS/MS is superior to the MBA, and that animal free 
testing is possible. Moreover, blank mussels are also blank in the multiplex magnetic bead-
based assay (chapter 4). So, the whole strategy works well especially for mussel. 
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It could be argued that too many samples tested suspected in the neuro-2a bioassay and 
required follow-up testing, but then it is of importance to realise that the 35 samples from 
Chile were selected by a targeted approach and are not representative for all shellfish 
samples. These samples were selected because they were already known to test positive in 
the MBA, in order to test naturally contaminated samples that lead to positive outcomes in 
the MBA with the new testing strategy, i.e. the neuro-2a bioassay combined with LC-
MS/MS analysis for confirmation of suspect screened samples. In addition, the multiplex 
magnetic bead-based assay is used in case LC-MS/MS cannot explain the neuro-2a 
outcome. In the Dutch situation, the neuro-2a bioassay and LC-MS/MS were tested in 
parallel in 2017 on 110 mussel samples that were taken over the year. All samples were 
negative by LC-MS/MS and 108 also tested negative in the neuro-2a bioassay. As the 
response of the 2 suspect screened samples was close to the decision limit, follow-up was 
not considered necessary (data not shown). However, the outcomes with the clams 
demonstrated that further improvements and validation of all bioassays eliminating possible 
shellfish species specific matrix effects, are needed as it is known that different species 
contain different types of fatty acids that can lead to matrix effects [14, 15]. 
It should also be noticed that there are differences between the methods in the solvents 
used for sample extraction. While the extraction protocol for the MBA prescribes the use 
of acetone/diethyl ether [16, 17], the extraction for the neuro-2a assay is performed with 
methanol 100% v/v. For LC-MS/MS methanol 100% v/v is also used for the DSPs and 
methanol/water 80% v/v for PbTXs. Thus, it cannot be fully ruled out that these variations 
could contribute to the observed differences. However, this is not very likely, as for 
methanol it is known that all the DSP toxins are well extracted (validated) [18], while 
methanol/water is mainly used for the metabolites of the PbTXs [19], and these were not 
detected in the samples tested. 
6.3 Future challenges 
This thesis focused on presenting an in vitro alternative for the MBA for diarrhoeic marine 
biotoxins testing. However, other points of attention have been identified during this work. 
As a consequence, the work was broadened to the detection of all LMBs, e.g. including the 
PbTXs, and the development of new bioassays for the analysis of samples shown suspect 
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in the neuro-2a bioassay that could not be confirmed as being positive by LC-MS/MS 
analysis. To this end gene expression studies were used to select biomarkers for detection, 
but also to address the modes of action of the toxins and their toxicological equivalent 
factors, which are briefly discussed below. 
Toxicological equivalent factors (TEFs) are ratios between the toxicity of a toxin congener 
with respect to a reference compound in order to calculate the relative potency. TEFs have 
been developed in order to convert data from chemical analysis into levels of toxin potency 
that can be used to establish if a sample is safe or not. The most early and best example of 
the use of TEFs are the dioxins and PCBs [20]. Regarding marine biotoxins, TEFs are 
mainly established in the MBA based on effects in mice that are intraperitoneally (i.p.) 
injected with the toxins [21, 22]. As humans are mainly exposed to marine toxins by food 
or aerosols, the way of administration has been a topic for discussion and the relevance of 
the MBA for human risk assessment is reviewed extensively [21, 23, 24]. Our findings 
indicated that in vitro, OA is less potent than DTX-1, which has also been reported by others 
[25]. As absorption, metabolism and distribution are not considered in our model and for 
a large part also not in the mouse as these are i.p. injected, further research where these 
toxins are tested in additional in vitro models is needed, e.g. a human digestion model, and 
models that characterise human liver metabolism and intestinal uptake. Probably these 
models will eventually explain the observed differences between oral versus i.p. injection 
toxicities and explain why several marine biotoxins are so potent in in vitro tests or the MBA, 
but not known to cause human intoxications. Possible interaction and/or conversion of 
the toxins with the gut microbiota should be considered as well [26]. Moreover, other 
factors should be addressed, for instance the pre-consumption treatment of shellfish 
products, as the bio-accessibility or stability can vary depending on the treatment, e.g. 
cooking or steaming [27, 28]. 
In chapter 3, a whole genome gene expression analysis with intestinal human Caco-2 cells 
using arrays was performed to assess effects of OA, DTX-1 and AZA-1 on gene expression, 
both with the aim to envision pathways affected and to select markers for detection. Later, 
Caco-2 cells were also exposed to YTX and PTX-2, in order to select markers for detection. 
Chapter 3 discusses the pathways affected and possible modes of action and chapter 4 the 
development of a multiplex qRT-PCR method and a multiplex magnetic bead-based assay. 
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Although these newly developed methods were shown to work adequate and were used 
successfully on blank and contaminated mussel samples, the results were surprising as it 
turned out that YTX and AZA-1 elicited similar expression profiles for which we have no 
logical explanation. It is therefore recommended to repeat the gene expression analysis 
using the same experimental settings for exposure and analysis of the data. Moreover, it 
would be interesting to further explore the mode of action of YTX, as YTX is considered 
‘not toxic’, i.e. is not causing diarrhoea when administered orally [29]. Orally, YTX showed 
myocardiocyte alterations in mice  [30]. In addition, studies on YTX in vitro showed that it 
can cause various cytotoxic effects depending on the cell line studied, triggering for instance 
apoptosis and pathways indicating DNA damage and cell cycle impairment [31, 32], and 
ER stress among other effects [33]. It has even be suggested to investigate YTX as a new 
therapeutic tool against tumour proliferation [31]. 
As discussed in chapter 3, AZA-1 showed clear indication of upregulation of genes related 
with cholesterol biosynthesis, which is in line with earlier findings [7]. Our results also 
indicate that this toxin might affect pathways related to hypoxia and glycolysis. One could 
speculate that an inhibition of the pyruvate dehydrogenase complex (PHC) [34] causes 
effects on these pathways, as is indicated by the increase of the lactate enzymes observed 
in our results. This mode of action could be confirmed through measurement of lactate in 
the media of cells exposed to AZA-1, but also through the measurement of pyruvate and 
NADH [35]. The increase of NADH could be also a reason of the increased MTT activity 
[36, 37] which was also observed in our Caco-2 cells exposed to AZA, even at lower 
concentrations (chapter 3, figure 1). Moreover, it is noticed that both AZA-1 and YTX do 
not reduce the MTT-activity as much as the other LMBs (chapter 2). This is in line with the 
observations above for AZA-1 and the gene expression data that also indicates that AZA-
1 and YTX likely share a similar mode of action. 
6.4 Future perspectives 
The newly proposed strategy provides an alternative for the MBA to detect and identify 
both lipophilic and hydrophilic marine biotoxins, protecting human health and considering 
animal welfare at the same time. The fully proposed integrated strategy is shown in figure 
1. 
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The strategy consists of 3 phases. Phase 1 is a broad screening using the neuro-2a bioassay, 
with and/or without the addition of ouabain and veratridine (o/v). For the detection of 
domoic acid (DA), which is not detected by the neuro-2a bioassay [38], the addition of a 
dipstick in the phase 1 is suggested. Phase 2 is the confirmation and quantification of neuro-
2a suspect screened samples using official analytical methods. Phase 3 is only needed in 
case analytical methods fail to confirm suspect neuro-2a outcomes and consists on an 
effect-directed identification of unknown toxins in cases that a second in vitro cell-based 
bioassay, i.e. gene expression in Caco-2 cells for LMBs or a multi electrode array (MEA) 
assay for detection of hydrophilic toxins [38, 39] indicates the presence of a marine biotoxin 
as well. In cases where the second bioassay does not confirm the presence of a marine 
biotoxin, the neuro-2a suspect outcome is considered as a false positive screening result. 
Phase 1: broad screening 
Marine toxins can be separated in two main groups, i.e. hydrophilic and lipophilic marine 
biotoxins. Extraction methods based on these characteristics already lead to some degree 
of specificity. These characteristics are already well-known and used in the first step of the 
strategy and the protocol on how to perform the screening with the neuro-2a bioassay. For 
hydrophilic toxins, which are mainly PSP toxins (STX and analogues) and TTXs, the 
protocol for the neuro-2a bioassay includes the use of high concentrations of ouabain and 
veratridine (o/v), i.e. 0.3 mM and 0.03 mM respectively, in order to decrease MTT-activity 
to about 20%. Ouabain is a NA+/K+ ATPase pump blocker, interfering with the normal 
efflux of Na+ from and influx of K+ into the cell. Veratridine is a voltage-gated sodium 
channel (VGSC) opener [40]. The use of this o/v combination causes a hyperosmotic state 
of the neuro-2a cells that eventually will lead to cell death as measured by a clear decrease 
of the MTT-activity [2]. In “simple” words, the principle of the neuro-2a bioassay to detect 
the PSPs and TTXs, which are VGSC blockers, is as follows: the addition of o/v ‘kills’ the 
cells and the presence of STXs or TTXs in the samples will ‘rescue/prevent’ the cells from 
dying, i.e. restoring the ion balance by closing the channels previously opened by o/v. In 
other words: STXs and TTXs are VGSC blockers that counteract the effect of the VGSC 
opener veratridine. This effect has been widely studied and reviewed [41-43]. Previous 
results showed that the hydrophilic marine biotoxins TTX and STX can be detected in the 
neuro-2a assay with addition of o/v, in levels below their regulatory limits [38, 44, 45].  
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Figure 1. Strategy for the detection of all regulated marine biotoxins. 
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The EC50 obtained for STX was 9 nM, with a limit of detection (LOD) of 1nM [38]. 
Considering the extraction and concentration protocol used, this EC50 value would be 
equivalent to around 40 µg STX kg-1 shellfish meat (SM), being significantly lower than the 
regulatory limit for STXs, i.e. 800 µg STXeq kg-1 SM. For TTX, the EC50 obtained was 18 
nM [38], which theoretically would allow detection of about 100 µg TTX eq kg-1 SM. EFSA 
concluded that an amount lower than 44 µg TTX per kg SM is not expected to lead to 
adverse health effects in humans, assuming an average consumption of 400 g SM [46]. 
There is no official international or EU regulatory limit for TTX. So far, fish species from 
Tetraodontidae, Molidae, Diodontidae or Canthigasteridae (puffer, porcupine and toby fish) are 
not allowed to be placed on the EU market [47]. But in the Netherlands the safe level of 
44 µg TTX eq kg-1 SM proposed by EFSA is now being used. At the RIKILT laboratory, 
the protocol of extraction of hydrophilic marine biotoxins was adjusted, allowing the 
detection of 20 µg TTX eq kg-1 SM [44]. 
These results indicate that the neuro-2a bioassay is suited for a first broad screening for 
hydrophilic marine biotoxins. However, domoic acid (DA), the toxin responsible for 
amnesic shellfish poisoning, is not detected by the neuro-2a bioassay, because neuro-2a 
cells lack the NMDA receptor [48]. However, use of a commercially available ‘dipstick’ 
lateral flow device  for DA allows a simple and sensitive detection of this toxin in SM [49]. 
This dipstick is included in the first step to screen the sample extracts containing the 
hydrophilic marine biotoxins (figure 1). 
Regarding the extraction of the lipophilic marine biotoxins (LMBs) methanol is used for 
DSP toxins, AZAs and YTXs and methanol/water 80/20 (v/v) is used for extraction of 
PbTXs. As discussed in chapter 5, methanol will also work well for the PbTXs, and water 
was only added to improve the recovery of some PbTX metabolites. Methanol extracts with 
the LMBs can be tested in the neuro-2a bioassay with the addition of low concentrations 
of o/v, i.e. 0.13 mM and 0.013 mM respectively, in order to decrease the MTT-activity to 
about 80%. The principle behind the addition of o/v in low concentrations also for testing 
of the lipophilic LMBs is the same hyperosmotic state as described above for the 
hydrophilic LMBs, only in this case lower concentrations of o/v are used and a further 
decrease of the MTT activity instead of an increase is recorded. The neuro-2a allows the 
detection of all the regulated LMBs with a low concentration of o/v needed to detect the 
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PbTXs. Cells will be unstable because veratridine will open the VGSC and ouabain will 
keep the Na+/K+ ATPase pump blocked, while the presence of PbTXs will then 
continuously open the sodium channels and lead to cell death, as measured by a further 
decrease of the MTT activity. The other LMBs are able to decrease the MTT activity even 
without a low concentration of o/v. When a sample is considered suspect using the 
protocol for the detection of the LMBs and there are reasons to believe that this is due to 
the presence of PbTXs, e.g. samples coming from a geographical region where K. brevis is 
endemic, the neuro-2a bioassay screening should also be performed without the addition 
of O/V. When PbTXs are responsible for the reduced MTT activity in the presence of o/v, 
the test will be negative in the absence of o/v. However, in a first validation effort, it would 
be better to run both protocols in parallel. 
Phase 2: confirmation and quantification 
If a sample is not compliant, i.e. it is suspect in the neuro-2a bioassay or positive in the DA 
dipstick, the sample extract should be measured with the corresponding official EU method 
(figure 1). These European official methods are the EURL LC-MS/MS for lipophilic toxins 
[12], HPLC-UV for DA, and HPLC-FLD for PSP toxins [50, 51]. PbTXs are not regulated 
in Europe, but there is an LC-MS/MS method available, although is not official yet [52]. In 
case the presence of the LMB in the suspect screened sample is confirmed by the analytical 
methods and the toxins levels are quantified, decisions and necessary actions can be taken 
by the responsible (food safety) authorities. These actions can include closure of extraction 
and production areas or withdrawal of products from the market. The permitted LMB 
limits on which these risk management actions are based are defined in the European 
regulation or for none European countries follow e.g. the FAO guidelines (see table 4, 
chapter 1).  
Phase 3: effect directed identification 
When the lipophilic extract of a sample is considered suspect in the neuro-2a bioassay but 
the presence of LMBs cannot be confirmed by the EURL LC-MS/MS analytical method, 
the bioassay based on the expression of selected markers in exposed Caco-2 cells can be 
used to confirm the presence of an unknown LMB. Three different profiles can be 
envisioned, i.e. an OA/DTX, AZA/YTX and PTX profile (chapter 4). For PbTXs, the 
General discussion 
158 
 
neuro-2a bioassay can be repeated, but without the addition of low concentrations of O/V, 
when negative it now indicates the presence of an unknown PbTX. If the hydrophilic 
extract is suspect in the neuro-2a bioassay or positive on the DA LFD, but is not confirmed 
by HPLC-FLD or HPLC-UV, the multi electrode array (MEA) developed by Nicolas et al. 
is an option to confirm the presence of an unknown PSP [38]. Limitations of the MEA 
assay are the relatively high costs and that it is not a fully animal-free assay, as it uses primary 
rat cortical neurons. However, its use in efforts of identifying new emerging toxins, for 
instance in an outbreak, should be considered. When these “second” bioassays are negative, 
the suspect neuro-2a bioassay screening outcome is considered as a false positive. When 
the second bioassay indicates the presence of a yet unknown toxin, a fractionated effect-
directed approach can be used to identify the responsible toxin, i.e. an approach that has 
been used successfully for the identification of unknown steroids [53]. However, this can 
take enormous efforts and time generally not available when decision makers already have 
to anticipate on such outcomes, preferably without using the MBA. 
6.5 Enforcement purposes 
The work presented in this thesis aims to replace the MBA for screening shellfish samples 
on the presence of LMBs. For completeness, table 2 gives an overview of the regulatory 
limits and the EC50 limits for detection in the neuro-2a bioassay and the corresponding 
limits of detection (LOD) in the neuro-2a assay derived from these EC50 values for all 
regulated marine biotoxins. Table 2 shows that the neuro-2a derived LODs are close to the 
current regulations, even lower than the LODs for some while somewhat higher for others. 
Regarding the LMBs, especially for OA, DTX-2 and PTX-2 the LODs of the neuro-2a 
bioassay are still higher than the required regulatory limits. As discussed above, these toxins 
are a point of attention regarding validation, including testing standards, fortified and 
naturally contaminated samples and improvements have already been achieved, e.g. 
lowering the LODs in the neuro-2a bioassay by using more concentrated sample extracts 
[54]. Similar is valid for TTXs, where the LOD in the neuro-2a bioassay is lowered to 20 
µg TTX kg-1. 
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Table 2. Neuro-2a derived limit of detections 
Toxin Current limit (#) EC50 LOD Neuro-2a (3) 
OA 
DTX-1 
DTX-2 
PTX 
160 µg OA eq kg-1 
 
23 nM(1) 310 µg kg-1 
5.5 nM(1) 74 µg kg-1 
34.4 nM(1) 462 µg kg-1 
76.4 nM(1) 1090 µg kg-1 
AZA-1 
AZA-2 
AZA-3 
160 µg AZA-1 eq kg-1 
 
1.0 nM(1) 14 µg kg-1 
1.9 nM(1) 27 µg kg-1 
1.6 nM(1) 22 µg kg-1 
YTX 
hYTX 
3.75 mg YTX eq kg-1 
 
1.6 nM(1) 30 µg kg-1 
1.1 nM(1) 22 µg kg-1 
STX 800 µg STX eq kg-1 8.2 nM (2) 40 µg kg-1 
TTX 44 µg TTXeq kg-1 (4) 18 nM (2) 96 µg kg-1 
PbTX-3 
PbTX-9 
800 µg PbTX eq kg-1 (5) 
 
8 nM(2) 120 µg kg-1 
8.4 nM(2) 127 µg kg-1 
CTX 0.01 µg P-CTX eq kg-1 (6) 0.9 pM(2) 0.16 µg kg-1 
DA 20 mg DA kg-1 ND ND 
(1) Chapter 2; (2) Nicolas et al, 2014; (3) estimated based on EC50 values and expressed in µg kg-1; (4) EFSA 
proposed limit; (5) CODEX; (6) US limit, related with pacific ciguatoxin (P-CTX), Limit C-CTX is 0.1 µg C-
CTX eq kg-1 and it was not assessed by (2); (#) EU limits unless expressed otherwise. All expressed per kg 
of shellfish meat. ND: not determined, neuro-2a assay is not able to detect DA. 
 
 
Overall, one can say that the strategy presented here as an alternative for the MBA is 
promising. As discussed, it needs to be further improved and then properly and fully 
validated. This work contributed to the 3R principle of reducing, replacing and refining 
animal experiments, ultimately proposing a real option to fully replace the unethical and 
unspecific MBA, that is also known to produce false positives and false negatives. 
Improving the alternative detection methods will also affect local economies and quality of 
life of small fisher communities. Less false positives will lead to less unnecessary closures 
of extraction and production areas. Moreover, in an ideal situation where no false positives 
are found, i.e. only true positives, governments have to be careful regarding shellfish 
extraction management, maybe establishing extraction quotas, to assure that the harvest is 
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being done in a sustainable way, respecting the natural cycles of reproduction of shellfish 
species. 
As a final conclusion it can be stated that the results obtained and collected not only on 
lipophilic toxins but also on the hydrophilic toxins demonstrate that the proposed strategy 
will lead to a future where a complete animal free alterative testing strategy can replace the 
MBA. 
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Summary 
Marine biotoxins in fish and shellfish can cause a number of adverse health effects in 
consumers, such as diarrhoea, amnesia, and death by paralysis. Worldwide, there are 
monitoring programs for testing shellfish on a regular basis. In some countries, testing is 
performed by using the so-called mouse bioassay (MBA), an assay raising both ethical and 
practical concerns because of animal distress and shortcomings in respect to specificity. 
The MBA may result in both false negatives and false positives. A false negative does not 
protect the consumers as anticipated and the high amounts of false positives encountered 
when applying the MBA lead to unnecessary closures of extraction areas, damaging local 
economies. A full ban of the MBA or its total replacement by analytical chemical methods 
has failed because these detection methods are unable to detect all toxin analogues and 
newly emerging toxins and will thus result in false negatives by definition. To fully replace 
the MBA, there is a clear need for new functional animal-free in vitro assays with specific 
endpoints that are able to detect both the known and yet unknown marine biotoxins. 
In Europe a method based on LC-MS/MS has been developed as an alternative for the 
MBA and is now the reference method for lipophilic marine biotoxins (LMBs) and used in 
the routine monitoring. However, as outlined above safety is not fully guaranteed when 
relying only on such a method and, as a result, the MBA is still used for surveillance 
purposes. The aim of the work presented in this thesis was to develop a new strategy to 
fully replace the MBA for detecting LMBs without the risk of missing a contaminated 
sample that can lead to an intoxication. This was achieved by combining effect-based 
bioassays and a mass spectrometry analysis, including the official EU-RL method. 
Chapter 1 addresses the safety issues of the marine biotoxins produced by algae, corals and 
bacteria and summarises the current legislations and recommendations and the methods of 
detection. In Chapter 2, the neuro-2a bioassay, a cell-based in vitro bioassay that was 
previously shown to be sensitive for several hydrophilic and lipophilic marine biotoxins, 
was studied for its ability to screen seafood products for the presence of lipophilic marine 
biotoxins. All (regulated) LMBs and their analogues were tested, and the neuro-2a bioassay 
outcomes showed that all these LMBs could be detected at low concentrations. Next, blank 
and contaminated sample extracts were prepared and tested, showing that matrix effects 
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led to false positive screening outcomes. Therefore, the standard extraction procedure for 
LMBs with methanol was modified by introducing a clean-up step with n-hexane before 
further extraction on the SPE-column. First, the possible recovery losses due to this extra 
n-hexane wash step were assessed, showing that the n-hexane did not lead to recovery 
losses of the LMBs and that the matrix effect was successfully removed. Finally, the 
applicability of the neuro-2a bioassay was assessed by testing a broad range of shellfish 
samples contaminated with various LMBs, including diarrhoeic shellfish poisoning (DSP) 
toxins. The samples were also analysed by LC-MS/MS. Overall, the neuro-2a bioassay 
showed screening outcomes that were well in line with the toxin levels as determined by 
the EU-RL LC-MS/MS reference method. 
In chapter 3, a study with DNA microarrays was performed to explore the effects of two 
diarrhoeic and one azaspiracid shellfish toxin, okadaic acid (OA), dinophysistoxin-1 (DTX-
1) and azaspiracid-1 (AZA-1) respectively, on the whole genome mRNA expression of 
undifferentiated intestinal Caco-2 cells. In this chapter the whole genome mRNA 
expression was analysed in order to reveal the possible modes of action of these toxins and 
to select genes that can be used as potential markers in new additional bioassays for the 
detection and identification of these LMBs. It was observed that OA and DTX-1 induced 
almost identical effects on mRNA expression, which strongly indicates that OA and DTX-
1 induce similar toxic effects. Biological interpretation of the microarray data showed that 
both compounds induced endoplasmic reticulum (ER) stress, hypoxia, and unfolded 
protein response (UPR). The gene expression profile of AZA-1 resulted in a different 
expression profile and showed increased mRNA expression of genes involved in 
cholesterol synthesis and glycolysis, suggesting a different mode of action for this toxin. 
In chapter 4, twelve marker genes were selected from the previous study and five were used 
to develop a multiplex qRT-PCR method. This multiplex qRT-PCR method is able to 
detect three toxin profiles, i.e. a OA/DTX, AZA/YTX and PTX profile. The multiplex 
capacity of this qRT-PCR is limited to five genes. The use of a multiplex magnetic bead-
based assay was explored, allowing the use of all twelve selected marker genes and two 
reference genes. This 14-plex also resulted in clear profiles with sometimes higher induction 
factors as obtained by the 5-plex qRT-PCR method. As a result, contaminated samples 
could easily be distinguished from the blank samples, showing the expected profiles. These 
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multiplex assays can thus detect these LMBs in shellfish samples and the obtained profile 
indicates the toxin-type present. However, compared with the neuro-2a bioassay, this assay 
has been shown adequate so far for only a limited number of LMBs (not all LMBs have 
been tested), and it is more laborious, time consuming and expensive. It should be used in 
cases were suspect screening outcomes from the neuro-2a bioassay cannot be explained by 
the toxin levels as measured with the EU-RL LC-MS/MS reference method. 
In chapter 5, the neuro-2a bioassay as an initial screening assay was combined with the EU-
RL LC-MS/MS method for confirmation and it was investigated whether this combination 
is able to replace the MBA for the detection and quantification of LMBs. Samples that were 
tested previously in the MBA (in Chile) were used. It turned out that all samples that tested 
positive in the MBA were also suspect in the neuro-2a bioassay and most of these samples 
were confirmed to be positive for the presence of LMBs by LC-MS/MS analysis. The 
results confirm that the combination of the neuro-2a bioassay for screening and the EU-
RL LC-MS/MS method for confirmation, is a promising alternative for the unethical MBA. 
The data even strongly indicated that the MBA alone probably led to false positives and the 
unnecessary closure of extraction areas or withdrawal of products from the market, a 
problem not encountered when using the neuro-2a assay in combination with LC-MS/MS. 
In chapter 6, a fully integrated testing strategy was presented for replacing the MBA, 
enabling the detection of the hydrophilic marine biotoxins. The steps and methods are 
discussed, and some points of attention and further developments required are addressed. 
Taking all together it is concluded that the proposed strategy contributes to a future with a 
complete animal free alterative testing strategy replacing the MBA. 
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I was wrong. My friend Pablo told me that Wageningen University had a nice MSc in Food 
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average) from other countries and cultures, and actually, I learned a lot from them. Is when 
I met Myrto, the hipster girl from Greece and Nacho, the Spanish guy with quite of an 
accent. Seven years later, they would be my paranymphs in my PhD defence. Wait. PhD? I 
am too old for a PhD, no way I will do one! I said to my friend Andres. Wrong again.  
My idea was to get a master thesis related with veterinary residues (because yes, I am a vet), 
and went to the Rikilt to speak with Ron. He had mentioned in a lecture that they had some 
thesis topics on that. But Ron told me immediately ‘nooo, we don’t have anything on that 
topic, but we have something VERY interesting in marine toxins’... The project was 
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and we started together ‘the agony of the MOA paper’, which is the chapter 3 in this thesis. 
I still remember those 45 or more comments of one reviewer, to finally reject the paper. 
That work was quite hard for me, and Peter was always there when I had questions (and I 
had a lot). Life as a PhD was intense and also fun. We had the chance to go to Chile in 
2015 for a workshop and a conference on marine toxins, quite convenient for me. I think 
I learned a lot of new words in Dutch on that trip. We first gave a workshop in Santiago, I 
was so sick I almost fainted and I had to sit during my presentation. Great. Few days later, 
Arjen, Toine and I went to Puerto Varas for the conference. There was a volcano in 
eruption and Toine wanted to see it. We quickly drove almost 300 km each way just to see 
‘volcán Villarrica’ and its smoke. I have to say, the volcano is really beautiful, and driving 
600 kms in a day totally worth it, especially the visit to the top. Toine, your always positive 
point of view on things amazes me, you have been in the mud with me and supported me in 
every way, and Peter, thanks for your golden patience and support. Liza, your friendship, 
guidance and your data are the best, this book is also your work. And together with 
roommates Astrid, Deborah and Corina I had very nice times. Thanks also to Arjen, my 
non-official supervisor, and Ron and his EFSA point of view. Dankjulliewel mijn Rikilt 
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Leen, Jen, Yamine, Milou, Pim, Ashraf, and also to the former colleagues Si, Jeroen, Agata, 
Emeli, Erika, Victor and Vale.  
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cool...although I didn’t enjoy waking up at 6AM and have to listen Nacho with the guitar 
in the bus (joking Nacho, you are great but please don’t sing that backstreet boys song 
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Salva, Henrique, that made Wageningen a nicer and friendlier place.  
Muchas gracias a la Chilean community that provided enough barbeques with plenty of 
benzopyrenes, wine with enough antioxidants, Chilean-speaking conversations and fútbol. 
We celebrated our Independence Day in September, often in the-rain-will-not-ruin-our-
barbeques kind of situation, and we organised the famous Chilean Wine Tasting. There was 
also a band called ‘Saonda’ that spiced things around here. Gracias Bego (the artist!), Dani 
B, Pame, Mauricio, Grace, Marcelo, Niko, Maite, Jose, Manuel, Naomi, Cata, Silvi, Victor, 
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Very special thanks to my paranymphs Myrto and Nacho. We have some stories together I 
will not disclose here, you know... privacy issues. I still remember when Myrto was sowing 
the lions for my birthday, haha. Myrto, you are a great scientist and toxicologist, I admire 
all what you have achieved at your age! I missed you when you moved to Utrecht, but we 
were always connected, thanks for that. Nacho, we still have some discussions about the 
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thesis, to my co-authors that put a lot of effort in this work, and thanks my new team at 
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I feel super welcome. 
Gustavo y Silvia, papá y mamá, ustedes son lo mejor. Me alegro haber nacido en la familia 
que nací, y de haber crecido juntos, ustedes como papás, yo como hija. Como dice la 
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importantes en alguna u otra forma durante esta etapa, aunque los veo poco, porque 
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mijn Nederlandse familie zijn. And of course, the biggest thanks to Gerlof, who is my 
support in everything (he is the best).  
In summary, I would like to thank my friends, my colleagues, my Chilean family, my Dutch 
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